var title_f22_59_23472="RA enlargement ECG tutorial";
var content_f22_59_23472=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F78126&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F78126&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Electrocardigram showing right atrial enlargement",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 201px; height: 173px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Delayed activation of an enlarged right atrium leads to simultaneous activation of the right and left atria; this results in a relatively narrow P wave which is of increased amplitude.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_59_23472=[""].join("\n");
var outline_f22_59_23472=null;
var title_f22_59_23473="Lung ca II PI";
var content_f22_59_23473=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F60551&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F60551&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 564px\">",
"   <div class=\"ttl\">",
"    Stage II lung cancer",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 544px; height: 398px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This figure depicts a stage II cancer. In stage II cancer, the tumor is bigger than in stage I or it has spread to nearby lymph nodes or it has spread into the large bronchial tubes.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_59_23473=[""].join("\n");
var outline_f22_59_23473=null;
var title_f22_59_23474="Patient information: Blood in the urine (hematuria) in adults (The Basics)";
var content_f22_59_23474=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/15354\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_figure\" href=\"UTD.htm?26/28/27072\">",
"         Anatomy of the urinary tract",
"        </a>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?15/21/15698\">",
"         Patient information: Benign prostatic hyperplasia (enlarged prostate) (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?16/51/17202\">",
"         Patient information: Blood in the urine (hematuria) in children (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?36/31/37363\">",
"         Patient information: Glomerular disease (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?42/56/43905\">",
"         Patient information: Kidney stones in adults (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?19/47/20210\">",
"         Patient information: Urinary tract infections in adults (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?9/53/10066\">",
"         Patient information: Blood in the urine (hematuria) in adults (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Blood in the urine (hematuria) in adults (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/blood-in-the-urine-hematuria-in-adults-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H294739703\">",
"      <span class=\"h1\">",
"       Should I be worried if there is blood in my urine?",
"      </span>",
"      &nbsp;&mdash;&nbsp;It can be scary to see blood in your urine. But try to stay calm. Blood in the urine is not usually serious. Still, it is important to see a doctor or nurse. The medical term for blood in the urine is &ldquo;hematuria.&rdquo;",
"     </p>",
"     <p>",
"      Blood in the urine can come from the kidneys (where urine is made) or anywhere in the urinary tract (",
"      <a class=\"graphic graphic_figure graphicRef79864 \" href=\"UTD.htm?26/28/27072\">",
"       figure 1",
"      </a>",
"      ).",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H294739710\">",
"      <span class=\"h1\">",
"       What causes blood in the urine?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Blood in the urine can be caused by lots of problems, including:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Bladder infection, which often also causes burning or pain when you urinate",
"       </li>",
"       <li>",
"        Kidney infection, which often also causes back pain and fever",
"       </li>",
"       <li>",
"        Kidney stones, which usually also cause back pain",
"       </li>",
"       <li>",
"        Certain kidney diseases",
"       </li>",
"       <li>",
"        Intense exercise",
"       </li>",
"       <li>",
"        Injury (for example, if you fall off a bike and bruise a kidney)",
"       </li>",
"       <li>",
"        Enlargement of the prostate (called &ldquo;benign prostatic hyperplasia&rdquo;), which is common in older men",
"       </li>",
"       <li>",
"        Cancer of the bladder, prostate, or kidney (cancer is an uncommon cause of blood in the urine, and it usually affects people older than 50)",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Sometimes, urine can look as though it is bloody even though it isn&rsquo;t. This can happen if you eat a lot of beets or food dyes, or if you take certain medicines.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H294739717\">",
"      <span class=\"h1\">",
"       Should I see a doctor or nurse?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. See your doctor or nurse if you see blood in your urine, or if your urine is pink, red, brownish-red, or the color of tea.",
"     </p>",
"     <p>",
"      Sometimes, doctors find blood in the urine when they do a routine urine test. That can happen even if the urine looks normal. It means there are microscopic (trace) amounts of blood in the urine.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H294739724\">",
"      <span class=\"h1\">",
"       Which tests should I have?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Your doctor or nurse will decide which tests you should have based on your age, other symptoms, and individual situation. There are lots of tests, but you might not need any.",
"     </p>",
"     <p>",
"      Here are the most common tests doctors use to find the cause of blood in the urine:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        <strong>",
"         Urine tests",
"        </strong>",
"        &mdash; Urine tests can show what kind of cells are in the urine. This can hold clues about what might be going wrong.",
"       </li>",
"       <li>",
"        <strong>",
"         Blood tests",
"        </strong>",
"        &mdash; Blood tests can show whether your kidneys are working normally, or if you might have certain diseases.",
"       </li>",
"       <li>",
"        <strong>",
"         CT scan",
"        </strong>",
"        &mdash; A CT scan is a special kind of X-ray. It creates a picture of the kidneys and urinary tract. Doctors can use it to check for kidney stones and other problems in the urinary tract.",
"       </li>",
"       <li>",
"        <strong>",
"         Kidney ultrasound",
"        </strong>",
"        &mdash; A kidney ultrasound is another way to create a picture of the kidneys. Doctors sometimes use ultrasound instead of a CT scan.",
"       </li>",
"       <li>",
"        <strong>",
"         Cystoscopy",
"        </strong>",
"        &mdash; Cystoscopy is a procedure that allows the doctor to look inside the bladder. To do a cystoscopy, the doctor inserts a small tube into the urethra, the tube through which urine leaves the body. Then he or she threads the tube up into the bladder. The tube has a tiny camera that projects images of the bladder onto a screen. If the doctor sees anything unusual, he or she might take a sample of tissue (biopsy) to look at under the microscope.",
"       </li>",
"       <li>",
"        <strong>",
"         Kidney biopsy",
"        </strong>",
"        &ndash; During a kidney (renal) biopsy, the doctor takes a small sample of tissue from the kidney to look at under the microscope. The most common way to get the sample is by inserting a needle straight through the skin in the back and into the kidney.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H294739731\">",
"      <span class=\"h1\">",
"       Should I be treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;That depends on what seems to have caused the blood in your urine. If you had blood in your urine because you exercised too intensely or because your kidney was bruised, you might not need any treatment. On the other hand, if you have blood in the urine because of a bladder or kidney infection, you will probably need antibiotics.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H294739738\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?16/51/17202?source=see_link\">",
"       Patient information: Blood in the urine (hematuria) in children (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?19/47/20210?source=see_link\">",
"       Patient information: Urinary tract infections in adults (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?15/21/15698?source=see_link\">",
"       Patient information: Benign prostatic hyperplasia (enlarged prostate) (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?42/56/43905?source=see_link\">",
"       Patient information: Kidney stones in adults (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?36/31/37363?source=see_link\">",
"       Patient information: Glomerular disease (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?9/53/10066?source=see_link\">",
"       Patient information: Blood in the urine (hematuria) in adults (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?22/59/23474?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 15354 Version 7.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-180.241.123.62-C1AFB1FE5C-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_59_23474=[""].join("\n");
var outline_f22_59_23474=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H294739703\">",
"      Should I be worried if there is blood in my urine?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H294739710\">",
"      What causes blood in the urine?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H294739717\">",
"      Should I see a doctor or nurse?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H294739724\">",
"      Which tests should I have?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H294739731\">",
"      Should I be treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H294739738\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/15354\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?26/28/27072\">",
"      Anatomy of the urinary tract",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?15/21/15698?source=related_link\">",
"      Patient information: Benign prostatic hyperplasia (enlarged prostate) (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?9/53/10066?source=related_link\">",
"      Patient information: Blood in the urine (hematuria) in adults (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?16/51/17202?source=related_link\">",
"      Patient information: Blood in the urine (hematuria) in children (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?36/31/37363?source=related_link\">",
"      Patient information: Glomerular disease (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?42/56/43905?source=related_link\">",
"      Patient information: Kidney stones in adults (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?19/47/20210?source=related_link\">",
"      Patient information: Urinary tract infections in adults (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f22_59_23475="Rotation mentum posterior to anterior";
var content_f22_59_23475=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F59795&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F59795&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 531px\">",
"   <div class=\"ttl\">",
"    Mechanism of labor for right mentoposterior position with subsequent rotation to mentum anterior and delivery",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 511px; height: 626px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Mechanism of labor for right mentoposterior position with subsequent rotation of the mentum anteriorly&nbsp;followed by&nbsp;delivery.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     <p>",
"      &nbsp;",
"     </p>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_59_23475=[""].join("\n");
var outline_f22_59_23475=null;
var title_f22_59_23476="Anterior knee anatomy";
var content_f22_59_23476=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F65193&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F65193&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 512px\">",
"   <div class=\"ttl\">",
"    Anterior anatomy of the knee",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 492px; height: 401px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAGRAewDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6pooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAPN/j9/pHgW30pc79V1WxsVx/tXCMf0U16RXl3xTuPtPxH+GOigbvN1KbUGHoIIWIP5vXqNABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAHmfw9kk0X4l+OPDl5PK5uZk1ux81y26GUbXC56BXXGOgyK9Mryv4vhPDHiHw18QufI0uU2GpAZ5tJzt3f8Acq2O+TXqaMroroQysMgjoRQAtFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQB5pIi6v8AtCREDdFoGhksf7s1zJgD/viM/nXpdeXfB9ZdQ8W/EfX5DujutZ+wwt6pbJ5eR7ZJH1Br1GgAooooAKKKKACiiigAooooAKKKKACiiigCjrmlWmuaPe6XqUSzWd3E0MqHurDH5+9cL8FNWvv7IvvCniGTOveHJRZybjlprfGYJvfcnGfUc16RXlXxXt5fCWv6f8SNMgkmNkgsdYgQE+bYs2TIAP4o2w30zngUAeq0VFaXMN3bQ3NrKk1vMgkjkQ5V1IyCD3BFS0AFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFY/jHWU8O+E9Y1mQZFjaS3GPUqpIH4kAVsV5j8eLn7Vo2h+FI2YSeJdThsZCvUW4YPMR/wFcf8CoA1fgjpr6X8K/Dsc6sLq4theTlvvNJMTIxPvl67mmxRpFEkcShI0AVVUYAA6CnUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFR3MEVzbywToskMqFHRhkMpGCD+FSUUAeUfDSZ/A3ia6+HepSN9hG678P3ExOZrcnLwZPVoyfXJU5wBXq9cb8UPCDeKtCjfTpPs3iDTZPtmlXYODFOvIBP9xsYYen0qX4aeL18XaCZLmIWutWUhtNUsuhtrheGX3U9QcnI79aAOtooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigDzKf4v6ba6jqq3uj6pDpGl6l/Zd3q37poIZsgAsofeEO4fNtI5Fbo+IGi20OpTaxd2tmlrqcmmIElM7yyIqtjYq7t2G5UA4AzmuSu/g9cX1x4gtL3xGG8N65qv9qXunx2AWVyGVhF5xkOFyi5woJx1FSa18IDqNlqsC6vbBr7XJ9ZVp7BnMJkjRNiskqOCu3O5WXOeRxQB0Ft8VPCtz4pTQob1zPJYi/ScpiIplsrk/MHAUsQVxjvniq2ufFjw9Z+GNV1fSJhqcmnNbia0G6CQCaVY1bDrnHzZzjBxiqNp8Lr6yv7O6tPFt8JU0FtCuZ5ofMuJF3O6ypJuHlurPxkNwoHvXP2/wIlXTNXtrnxJE82o2lpbNNHpxU5guFm8xszEuzbcEkjk59qAO7+KPxAsvAGm6fPdQG6ub+6W1t4fMEYyRkszEHCgdeCeRxV228eeHJdaGjPqtqmsLuSS2DFgsiLueMPjaWUZyoORjpT/Gvhf/AISeTw6/2z7L/ZGrQ6pjyt/m+Wrr5fUbc7+vPTpXGWfwdisvFNxqVtqkDWct9LqCwXFj5k0MkmdwSXzAAuWPVC2OM0Abh+MHgARyP/wlOnlUCsSCxyGJAI45HBzjOO+K2dR8ceGtO1i30u81m0jvpxGUj3Ej5+E3MBtXd2yRntmuDg+C/laQlj/b2dvhmXw5v+x/35RJ52PM7Yxs/HdVnVPhCL66u1TXXi0zUlsBqdt9lDPO1oFCGOTd+6BCLkYbpwRk0AdY/wAQvCa3Oo239uWj3Onb/tcMZLyRbJFjbKgE/fZV6ck8ZqhN8S9Gml0IaM41KLU9U/sp3RjGbaQRs53qwznAHBx1FU5PhtOPCXijRrTX57SbW9Xn1UXUMJUw+ZIrmIgPl1wu0kMuQe1ZHhv4OHR7mynOtQubfXBrRjgsPKQ/ufK8pR5h2jvnJ9MHrQB65RWD4i0fUru4ivdD1mbTr6FdgjkXzrWYZziSIkf99KVb3I4rNg8ZNps8dp40sf7Fndtkd2H82xnPQbZsDYT/AHZAp9N3WgDsKKQEMAQQQeQRS0AFFFFABRRRQAV5dbSp4p+PlzkbrTwhYCNOOPtd1yxz7RqB9Sa9G1fUINJ0q81C8dUtrSF55GY4AVQSefoK4b4F2Nwvgka5qkZTV/ENxJqt1uGCPMP7tR7CMIAKAPRKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAryr4j6dd+DvES/EPw7A0kSIItfsYhzd2w6SqOhkjzntlc88c+q0EZGDyKAKej6laazpVpqWmzLPZ3cSzQyL0ZWGRVyvIbEH4UeOFsGIi8Ca/MxtmY/Lp183Jjz2jk5IzwDxx39eoAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAoorkbT4keELuW5S2160kNvHNNIw3bfLhGZHVsYZVxyQSKAOurz74y+Krzwppnh6ayv7bTo77WYbG5uriMOsULRyszYJA42A59q0ZPiZ4NTTkvx4hspbV5mgV4WMm51RXYAKCTtVlJOMDPOKh8S654I1GG1udc1Kzki0g2+twyecyrFklIpwVIDKS5A6gk9KAPJLTWvFHi3xR4AaLWI7W6efXILPVvsWUu7dFiEc/kkgfMM47d8VJB8VfGsugeD5oo7aa68VWQtrKRbf5Yb5bkI7uM/cMRLY9VPbp6r4q+KXhbw1dW9vfXxllkvksJBbrvEDsm/c5yPlC4zjJ+YcVg6f448E+I/HcSawYbXxHo2qXGmaWs07nzCyKDIqjCAuCVG7J+U4NAHK6p8Q9fX4jatoNxfQ3NihuYY7eygjlARIWOZ1JEsZ3DlxlPTg5rGuPiXr+j6T4Kisrq2t7K50i0la0sYI5bp5XbGFhkIMiYxgRncOckV734l8X6D4Zkij13UorSSaN5Y42DMzqmNxCqCTjIzWRF8RdIfX76zLp/ZttpcOqjUUfekkcrlVCqBk9B0znPSgDN+LvijUfD174dt7fUotD0q+knF5rEtuJltike6OPB+UFzkc/3cDk1z3hDxj4z8TeI/C2nTy2mjvd+Hxq97HLZGRmZblYyFBdSm9CCM5xnoa6jVvi74Q07TbS+/tB7i3uNQTTW8qMhoJG5zIr7WVQME8Zx0BraHjzwwddg0YazbHUZmVEi5wXZdyoWxtDkchSc+1AHTVHPDFcQSQ3EaSwyKUeN1DKwPUEHqKkooA4xvCV9oJMvga/SziH/MIvN0lifaPHzQf8Ayv+was6V40tnv4dM8QWs2g6xKdsVvdsDHcH/pjMPkk/3eG9VFdVVXVNOstWsJrLVLSC7s5htkhnQOjD3BoAtUVxR0LXvDXzeFL0ahpy/8wjVJmOwekNxguvsr7x6FRWnoXi7TtVvDp8yz6ZrKgltOv1EU2B1ZOSsi/wC0hYe9AHRUUUEgAknAHUmgDy/42PLr39h+BNPmZbrXbpXvNvWOxiO6Vj9SFUDvkivToo0iiSOJQkaAKqqMAAdAK8r+Eyr4u8U6/wDEOeMhLl20rSgR0s4m5f6u+T+FerUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAY/i7w7p/ivw9eaPq8Ky2tym3pyjfwup7MDgg+1cj8KfEeoCe98GeLZ/M8UaMoJmI4vrUnEdwD6kYDDrn616NXB/FTwnea1a2Wt+G5Ft/FWiubixkI4mH8du/co44+uPegDvKK5v4feLbPxp4ag1S0R4JsmK6tJOJLaZTh43HUEH16jBrpKACiiigAooooAKKK5rxj430DwdNpcXiG++yvqU/2e2Gxm3NkA5wOANwyT60AdLRVG91jTLGYRXuo2dvKWVQk06oxLfdGCep7etU7HxVol9rWq6TbalA+oaVt+2QnK+VuXcDkgAjHUgnHQ4NAG1RWfba3pN1apc22p2M1s7FFljuEZGYDJAIOCQOcVXtvEWnynU2lkFtbWDKJLmd0WJgyhgytu6cjk4oA2KKpf2tpv2eGf8AtCz8iZDJFJ5y7XUdWU5wQO5FLqmqWGkwCfVL61soWbaJLmZY1J9MsRzQBcorOutc0m0hSW61SxhidBKryXCKrITgMCTyCSOazPGfjXQ/CGmNe6veR8eWUt4nUzSB5FQMiEgsMsMkdgaAOkooooAKKKKACiiigBk0SzQyRSDKOpVh7Gvnfwv8LvFV1cR6Tqwew0Gx0XUNJtLi4SAygXI2g7YpW37RzuPl5wBgHJr6LooA881j4cz3Fr4YbSdbFhqeh2D6ctw9mJo5oniVHzGXGD8gIIbjodwrJvvgnpVy3haJdRnXT9Isf7Pu7d49xv4lYSIGbI27ZBv6H04r1migDyPT/g7Np/g/TNMt/EZfWLHWk1z+0prLeJZUUoqvHvB27MD7/bPtWh/wq0lHD6yGZ/Fkfigt9l7rs/c/f77fv+/3a9MooA8y+IvhTxFrvxA8P32gXEVhbwafe209/LCs4iMuwAeUXUsSAcHkDHPpVJfg2tpp17Z6R4ivLBZtFt9Iilji/ex+VKZDIWDDIfJBUbeCcH09aooA8cs/gvNaaddRwa/bxXz6xaazBLFpu2GGWBcBTF5pLKev3gfc1dj+EIi8ZNraarbyRTajFqs0FxYGRhcLtLGJ/MAQMV7qxXPBr1aigAooooAKKKKACs3XtD0zX7P7LrFnFdRA7k3DDRt/eRh8yMOzKQR61pUUAcV9k8UeGOdOmfxNpK/8ut1IqX0Q/wBiY4WX6SbW9XNct8TfHEWu+FP+Ec8I3TxeKNbnXTFtJ42iuLVWGZZJI2wyqsYb5uncE169Xiuk2UXxO+Jesa1cWkqaPovmaTp2oW9y8EyzoQZJEKkHqWXPTA75IpN2LhHmvrY9b0HSrbQ9FsdLsEEdpZwJBEoH8KjA/lV+uL+0eKPDHF5FJ4n0leBPboqX8Q9XjGEm+qbW/wBhutdDoGvaX4gtGudHvYrqNGKSBch4nHVXQ4ZGH91gD7UyDTooooAKKKKACiiigAooozzigAoqta39ndtItrdW87R/fEcgYr9cHirI56UXuNpxdmFFFFAgooooAKKKKACiiigAoorPTV7GV7uO0uI7u4tU3ywW7h5B1wMA9Tg4zSbsVGEpbI8x+IMU/wAP/F8fjTQB5trqHya3pMY3S3iovE8K/wB+NclumVFeoaHqtjrmk2mp6Vcx3NjdRiSKVDkMD/XsR2PFcm8j+NdDvJtNjXTtet1ktop5MuICzfMgkXjcQoDFc7c98YrgNPmu/h9Ne654Zsrl/DqSgeIPDZy0umS7QWngP8SEfMccMORj+FRlza9DWtSVK0X8S3X+Xlb+tj3miqmk6lZ6xpltqGmXEd1ZXKCSKaM5V1PeqXiPxJpnh6OL+0Zz9onJW3tIVMk9w392ONcsx+gwOpIHNUYGxXMaz4vt7bUJNK0W1l1rXExvs7VgFgz3mlPyxDvg/MeymqP2HxF4q+bVpZvD2jNyLG0lH22ZfSWZeIh/sxEt/tjpXT6NpOn6Jp8djpFnBZ2iZIihQKMnqT6k9yeTQBV8OW+tRRzzeIb22nuZiCtvaRbYbYD+FWPzOfVjjOBhVrzf4ofCvV/H3iHVbq51e2s9O/swWFhCsfmlmLeZI0m5fk+dYwChJwvbofYKKAPCdY+EWu+IdP8AEMviA6Bda3qGi2dhBcsXfyriLO+TcY8qG+U5UZ9uKs6/8IdT1K+8cLBLo8Fv4itbXy7sBvtEE0Kx70I24McjISxDZ5+6ete20UAeEad8GtQkutPfVbTQzbLq0N/e232mS5jnRIZIz8rRKuTuX5cYwOSa09Y+FWpT3etT2D6SsL63ZarZWMm4QSR28Ij8iUBPlU9RtDAbV47V7JRQB4ro/wAHpxqvhufXo9FvtPtLvVb2809ozJBGbrYY4oUZMMiFM/Nt55Arrfiv4U1jxVDo8ekS2H2e2uGku7e7YxechQqNsqozIQTyABuBxkV3tFAHgmhfBTUYtMsrbXP7Evja+F7rR49+6QJdSTtJHKu6PhQrY3D5hzgVV1H4L+JZNJubKGXw/cyXun6TbSXV1JKJbR7NYw6wkRnKPsJz8p5OR6fQtFABRRRQAUUUUAFVdU1C00rT577UrmK1s4F3yzSsFRB6knpVquP+L2j3/iD4aeIdK0iD7Rf3dqY4Yt6pubI4yxAH4mgDa8O+JdE8SwSzeH9WsdSiiYLI1rMsmwnoGwePxrWrwq++FWtW+hi6hvbq+1/UrzSxf+Q62YgtrfCsqlWGSFJywYk4GKZ44+HniNteu4/DltdTQNBZxaLqB1Nh/YzRyEzM4d977gc5AYnoaAPeKqaTqVrq1hHe2EjSW0hYKzRshJVip4YA9Qe1eT3HhjxM3xdGrpp13/wiP25Hex/tBPnn8th9t2bsCMEgeXncSN23tXMr8OPFuo+G/D9hrVpeSG203WFuI/7SC/6RJMz2u4rJ83G0jqBxnGKAPoms/VNZ0/SrjT4NQuVhlv5/s1spBPmSYLbRgccAnn0rwmHwF4z07R9VSy02S7m1HQdOW7ivNR80T36uPtHJl+8FzjkIemSOKXwd4B8XWU2ipe6ddJZ2Xin+0I0uLqBmhtTbFScI5UfOfuL69Mc0Ae+T6hZ299a2U93bxXl0HNvA8gWSYIAX2KTlsAgnHTNZmneK9F1G+tLK0vN11dwyXEMTROjPHG+x2wwGMNxz16jiuN+JPhG71X4keBtftdJl1G105riK8EV2IWjDhPKkwzrlVYMSBkkcYbpXmrfD3xd/Zuh/2t4au9Xnh0rUrSVF1OGNo5pbt3hZnMoyAu08bsccZGKAPo2HUbWbU7nT43Y3duiSSIY2ACtnHzEYPQ9DxUWqazp+lXGnwahcrDLfz/ZrZSCfMkwW2jA44BPPpXi0/g7x5b6Rr1u8KaxcTaLpdohnu/kuJoifP25dTux3faG755FU/B3gHxdZTaKl7p10lnZeKf7QjS4uoGaG1NsVJwjlR85+4vr0xzQB9C0VW1KS6hsZpNPto7q6UZSGSXylf23YOOM9vy61zKePNPtGSPxPaX3h2ZjjOoxjyCfa4QtF+BYH2oA6+io7eeK5gSa3lSWFxuR0YMrD1BHWpKACiimXE0dvBJPPIscMSl3djgKoGSSfTFAHF/F3xJPoHhU22lMf7f1eQabpaL1M8nAb2CjLE9sCqfhjwK/hzwnL4eGpyRacscU0N6kuyaK4GN56YKlxu567iD61zPw/vh4++Jj+Kb+NprC3gkGgwMAPssO7Y1w4zw0zBgnfajdOK9ivrO3v7Oa1vYUntplKSRyDKsPQ1Mo3NqNZ0np5fg7lFtatrbWLbSbpplu5ot0crRERzEdQG6buM7fSqXiDwjp2r3i6hGZ9O1lF2x6lYv5c6gdAxwVkX/ZcMvtVmSK70bT7K30i0N9BD8jpLcnzQnYqzcNj0JHFVs6bpuuXVvFqM0Gpagu9Ip5HeLec4KK3y545VSOlLma3NHSjPWH+ez3aWsVb1M0a3r/hr5PFFkdU05eBqulwszqPWa3GWX3aPcO5Ciup0nU7HWLCO90q8t7y0kGUmgkDq34isqxvdStbOW11C50u/wBaQ5jhhfyPMXjBYEsQep44rn/EGjW9nAviC0j1Dw9rUz4nfTI/tCuxzzPCoKSjA+8RuGeGFPmRDw872jr2t19Fvb5HoFFcCPHknh77LH46hhs4LkDyNWtcm1m4By6H95AeRndlR/f7V16azpjz20CajZtNcqHhRZlLSKehUZ5HB5FO6M/Zy7F+qGtatZ6LYtd6hL5cQIVQBuaRj0VVHLMewFQ2mqyXmqXlnFp97FHbgj7XNGFid/RcnLDnqBj3qvpkqWc1tpur6pHqGsSFpwDEqlRjqqr91QMgE9cnk1Ll2NY0bP3+mtlvbfs0vn9xNqDXYuYLxtRhsNJhQSzK8YDufRmY4VcY7Zz3ql/oFvNHrGj6TPqVxfAt9ogZTheO8jDap9B6dKvaZZX0kFyPEE1rd+dJuSCOIeVEoPygZ5Y8A5PfpitbpRa+pTqqn7q16aaJrz2b1MOUWul3qQ2mgSFLvCyz2sEYQZJH7zkHuSeD1qmg0W3mufDOmzzaZdzDzALZWQrkA5RiCvQdB+VdRRRykqv3v9/Xo3e97djEmTVbfR44dIurXUL+FtryXzbd45yCYxw3Tt2qa+1SewW0E2mXlw0oAka0USLE3HXJDY56gdBUtvo2n2t7d3dpaRW91djE0sS7WfqcnHfk81X/ALN1C20ie2sNWma6LAxT3qLN5Y4+Ugbdw4PJOeaLNFqVOT1tv1Vt99r6L+uxLJrmnRawulSXIW/cArEVYbsjPBxg9PWrUV9aS3clrFdW73MYy8KyAuv1XqOtZs0XiFdFgSC60x9WD/vJZYXELLk9FDZBxjv602/tNY8q0l0z+x49QIAupZoXIbgZ2YIOM56k9qLsXsqbslLy3699tn06mrbXtrdvIlrcwTvEcOscgYoffHTofypttqFldtItreW8zRjLiOVWK/XB4qhPZajDqtu+kjS7ewYg3StA3mucnO0ggdPUGkttPvINemmjGmppciYMcdsVmJx3fOCM54xRdk+zp2bUul1/k9N+xeTVLCS1muY761e3h5klWVSqfU5wKqXev2kWlR6haLPqMMr+XGLFPNLnJHGOMcHknFQ6BYanaXF2l8NIFi5zElnbtG3X+PJIPGOgotdGvLnTL2z8RX6X8Nz8uyGH7OETuuVbJz65ovJovkoxlq7pNfNdem69UVbtdSfVYNU0pmvFmjEKwPOI7e3XOXdtuS7noMdMVctvD8drrX262uZbe3AOLKBEjiLEYLNtXLHnPJ4NatpbQWdrFbWkSQwRKESNBhVA7AVNQodyZYmVuWOi29V+X3eY1FVBhFCjJOAMcmuJ+I3huwuAviT+1X0TU9NgcJfC4EURXqFmyCrIDnhhjk+tWbzxi1/dS6f4NtBrV7Gxjlud+yytW7iSbncw/uIGb125zWfqvgwXGmXWpeKJb/xFq0cZkhitW8hbZh/z6x7sK47OzM/bdg4qzmPFPB/jLUvDesPp2ln+wvDmr3UaySzW5kTT7iRmBkgjcqywyFR98FUY9GGC30b4d8LaboUktzAstzqU4AuNQu3824m9mc9F9FXCjsBXlGvQr4w0OaG6lS81JIMSPb8R31s52b9h+62R5cijmNwrfwrW38BvFst9YT+FNXknfVdHjUwzXClHubUkhGIPO9CPLcdmXqaAPWaKKKACiivPPHXxRtPCPiKbSZdG1PUHttL/ALYuZbQxYhthIY2bDupYggcD1+uAD0OiuVT4g+Fmv7GxOs26Xl6kMkUTZB/erujDHGFZgeFYgnsKr6p8TPCentqUb6qk0+npK00cKM2WiUl0VsbC4wRt3cHrigDsqK4a3+Kvg+Tw7pmsz6slrbX8XmxxyoTKoABbcq5xtyAzfdB71Z1b4i+GbJ721i1nTptUt7Z7lbQ3AUuogM4OcHCmMbt3IANAHYUVyb/EHw3atpkOp6taWl5fQQzrFvLqgkxtLOBhQScAtjPar+neLvD+pa7caLY6taT6tbs6zWiPmRChAbI7YLDmgDdooooAKKKKACiiigAooooAKKKKACuY8d+Kx4Ut9HZdPlv59U1GPTYIo5FT946uwJLcY+TH4109cl8RPBcXja20S3ubyS2h07U4tRcR7g0oRHUxhlZWQnf94HIx0oA4G6+Kut33iLwxb6Fok0k8s+q2Wo6QZogzXFqI8ATNgbRuJyOvTFXB8dNKGkWN6+k3qtqGnJe2MO9d1zIbgQNAnq4Yg/7pzxzjsLfwp4P8NTeH5Et7XT5bGWW30xpbplLS3A/eKNzfvZHCfxbm4OK5yx8C+FtZ1bwwfD9xEmleCL65g+wiJ5GFzhW2mV23DYxV/wCLJxzxQA29+LUaeLtR8OHTJLO4tllXzbi5SOVykRffFEw/eJxwQcnrjFZv/C5o9N0/wvHdafNcSapp0N4b29njs43LnG1WxsL9yMqACOa7ub4eeGJ9Yl1S4055ruRpJD5l1M0avICHZYy+xGIJ+ZQDzWM/gnwDe6tB4fezMt1ptlAfsBurjy/s6sfK8xN2yQBgfv7jxzQBseNPF0mgano2lafpcuqaxqxmNtbrMsK7YUDSMzt0wCoAxyT2rA0T4rw6/qOg2mgaDf3zarpo1PcJYo/s8QmET797DO05+7knsK6bxtonhrWYLBPFQgXFwIrOR7praTzpAVCRurK2WGRtB+bpg1Y0vwloWk6laX+m6fHbXVpYf2ZA0bMFS23h9gXO37wBzjPvQBu0jKGUqwBUjBB6EUtFAHJ3PgLR1mkuNEa68P3btuaXSZfIVm9WiwYnPuyGoy3jTRySU07xJaDpsP2K7/I7onP4xiuwooA5W18eaKbmK01ZrnQ76Q4W31aI2+4+iSHMbn/cdq474767JNbWPhLTpmV9TVrjUmiPzpp6cOAexkYrGvqWxXqt7Dbz2ksV7HFLbMp8xJVDIR7g8EV8z/C/wvYeOfGGq6/oDz6JYRz+bapZxp5EcUb4t0MTqVO5kklIA+X5MYJzQB7v8PvDy6DoSebaW9rf3QWS5jg5WLChUhU91jQKg9dpPc109eZapqviXStQsv7ZtbXWLZZc217o8v2WYsuQ8bxSsY2yB93zBnBwMgY6nSvG2hajerYm7ay1Nv8Alx1CNrWc/wC6kgBYcjlcj3oA6SkIB6jNLRQBSl0rT5dQiv5bK2e+j+5cGJfMXjHDYz0NMttLS11C4u4Li6/fgloXlLxBifvBT0PsCB7VoUUrIv2s7Wv5GKtlfS2kw1aPTNQuIstbHySilscbgS23nHIqHTbS9stDP2TRtIs9QQlY7eF9sIUtn7wQEdWONvU+9dBRS5S/bN7pf1006MyNQstU1CxtY01H+zJ8g3BtUEhbjlUZxxz3xmtJLeFJ3nWJBO6hWk2jcwHQE/ifzqWinYh1G1y9P6+/5hRRRTICiiigAooooAKKKKACiiigAorP13WtN0GwN5rF5FaW4YIGc8sx6KoHLMewAJNc153iXxXxapN4Z0Vus0yA6hOv+whysAPq25/9lCM0AaviHxXp+jXKWKrPqGsSruh02yTzJ3H94jICL/tuVX3rK/4R7WPE/wA/jG5W105umi6fK2xh28+YYaT3Vdqdjv610Hh7w/pnh+2kh0u2EbStvmmdi807/wB+SRss7e7E1q0AQ2drb2VrFbWUEVvbRKEjiiQIiKOgAHAFTUU2R0ijaSRlRFBZmY4AA6kmgDw34m3Unhf4iWp+yG10nU0aaGaMgxz3mD50DLjI86IBfdwjDBBrE8aqdA1fTfGGiX8t1NZZuljIx9rh2K8qbv8Appb4kGf44pD1Jru/iZq2j+MvDd1pfh6G51/VreRbizl02HzYre5jO5GackRL8wwRv3YLDFcxq15rvjPwfp/iNI9O0uxuLbz4ILNDPcGSBWkEZaRQiHAmXGxhyRkg0AeyReJdGbw5a69JqVrb6RcQrPHdXEoiTawyMliMcdqxh4zl1MhfCeh3+rKel3MDZ2nXr5kg3OPeNHFeffAnQ9Gs9b8QaTNaRX0+kSxXGk312fOl+wzrvh2FuExgg7AvuK9xoAz9DGq/Yc661ibxmJ22Sv5aL2XLHLHr82F+grj/ABN8LtK8T/ERPEmvMt5ZrpS6d/ZzowUsJjKJGYONw5I2FSO/tXoFeTeOvGWo6b8QJNJuNft/DOlxWUc9pNNZfaP7RmZyGjBP93CjYvzndnpQBc1r4UpqPiC+uYdXNro2oXdpfXmnrags0luFCCOXcNinYuRtPTgjNU7f4PlPE+rao+vNDbahHdxyWtjbG3WXz1K5lHmMjlc5BVEJYAnNYE3j/wAW2vhjUfE91qNl/Zdnr7abJAmnktDbrdbHleQMc4TjhR65NMuvipq18NQksNRtrPQx4i/s860bQutna+QHDFTxlmOA7fKM+4oA2Lv4MXFzYaCs3iC2lvtK07+yQ82mloJrUY2K0QmB3DHLB+e4xxW1pvwuWx0nxlYpqibfEOmW+nApaBBbCKz+zBgof5gfvbflx0z3rgj48uNPk8Z6lBqkeofZtNsGi1ezsFDS75pE3lGO0KAPvfd6sARgViXHxA8U6r4b069uvE8NjDp3i2KxuNRtVBia3aHcHlK7VaME4IwFbK+gyAejan8GxeQTWkevvDp+oWNhY6rF9kDPcraYCNE5b90SBg8N+fNdt4K8Lf8ACMS+In+1/aTq+rTap/qtnleYqL5fU7sbOvHXpXlen/EbxTP8VTpNzd6dbWiasbEadcIsck9qRhLiP+NmbIbj5cccYqX4vX8tj8QNfmjCyCHwJdyiKTJjZhcp1HegD3SivnPxd8T9f0STUIoNSs9L/s+y0s6fYPahzqIn2ebIGbkBNzLhf7vNaR+J2tf8Lkg0W3v0fTW1h9LmsbmCOOVAEJEigfPtyMh2bDdloA96or5j074jeP77w9BqH9v2EbXXhy91sKumKfKa2cjYCX5345JBx2HetPxb8VPFttqtiLafTNKhfTLK/t0u1Cxag0qhpVDNluPuhU+bPPNAH0TRXhEXjnxe2vw3R1SzOlv4zn8M/YfsQz5QL7ZDJuyWAUcADPfNQ/DDxRqCeHrmDXfiFb2+owahdQyw39sJJo9srAAlnyBjBA7AgdqAPfaKKKAGTK7QusT7JCpCtjOD2OK+SfBkWqaveS6Rosdxca6mgatHqF3BqQnS7u5F2xSM+/CMSQAH2sPQAZr65ooA8M1z4eaxBofhVLbTL/WLeO2lfVdNfVmEjXrwRok2+STaQhQjaGwucqDVXWfh547uofDunjUZXjv9Ii07XbxLrBt5IZFlWQZIZmYZjLKMkcmvfaKAPnS8+Hni7WfC+mat4n0mW/8AEX/CRRX95p8eoIrCzSLyikbbwgJwG+8D8x5ByKvW3w21231t9attOubfUz42S+V0vwB/ZjBPMJXzNpzhgRjeQMYIxXvtFAHinxqiub74h+GtOt9Mu9YS40u//wCJfBdi3Ejfu9rMzMq4UnPOfYE1lL4F8cWVhqhNrBqupSeGLLTlknuQFnnSYtImd6sSEPDNgMcZOCa+gKKAPmWL4Y+KJPDs0F1ol7PBa+IrPUrXT5b+FJHtgo89UKSeWjE9tw9Qe53ovAvi1PifFq1xb6k1qupwXNtdW97FtgtAFDW0geTdtUbgQqsGJznPNe+UUAFFFFABRRRQB598dtauNH+HF8mnvs1DUpI9Nt2HUNM21iPcJvP4Vz3gyQeHfCWjW9pbmO5kQTQR5wIzMCkCsO7LCnOerY9ayPjnf3d78Q9E0qzUvFpthJfSAdFlmbyEY+6qZGH0NegaAsOtappt3JaPbFFe++zsPucCGLd+CuR9KALNpNdaffXS39uJAQsl5HHlkbOAJ4xjnGCHUY5AYDnnodQsNM17TvI1C1tNRsZhnZNGssbg98HIo1WwjvfKZZWt7yLcYJ0PzISOeOjA4GQeP0NN0fThYrIxWOOaVi0qwFhEzHq4Qn5Se+PzPWgDAHguTTSG8Ka5qOkqvS0lb7ZaH28uQllHtG6UDW/E+kca7oCajADg3eiSbyB6tBIQw+iNIa7CigCno+pWmsaXa6jp0vnWl1GJYn2lSVPqDgg+oIBB4NXK4/wb/wASnxB4h8OtxFHN/admO3kXBYso/wB2ZZuOwZPauwoAKKKKACiiigAooooAKiubiC0haa6mjhiX7zyMFUfUmvOfHvj++ij1ix8E28N5d6XA82oahKc21iFGSnH+smxkiPIA/iI6Vn6H4Q0TVzpx8XWtz4o1dhG0lzqUheNC8ZkOIf8AVoANowF6sOtAHo0XiTQ5nCRazpsjngKt1GT+Wa1FIYAqQQehFedL4F8C3V3fteeFPD0NhE62kLGyiTc6glyCAOhOOP7hqLTPAOlR6cJPCV3qPhO4mLPbfY7xpEkQHh2gkLRkEYOAMgEcg0Ael0V5n4Y8f3FtqMWleLHtJoZJfstr4gswVs7yfOPKIOfLkzkYyVJBAOflrpda8X29tqEmlaLay61riY3WdqwCwZ7zSn5Yh3wfmPZTQB0k0qQxPLM6xxIpZnY4Cgckk9hXHP4qv/EDtB4GtYriDO1tZvAws194gMNcH/dIT/b7U6Lwjda1Kl145vI9RKsHj0u3BSxiI5G5TzOw/vSccZCKa7FFVFVUUKqjAAGABQBzmheEbTT78apqM8+r65tK/wBoXmCyA9ViQALEvsoGe5J5rpKx9f8AE2jeH1T+2NSt7WST/VQs2ZZfZIxlnPB4UGsc+IfEOrkr4d8OyW0J6XutsbZevVYADKfo4j+tAEmu3T6P410vUr65MWjT2slixZ9scU7OrIzdvmCsoY9DgfxVZ1fxroem3jWP2pr3U162Gnxtc3AP+0iAlBweWwOOtZ83gmbWonTxjrl7qsUgIeyts2VoQexRDvYezyMPameArWHwpcS+Efsywwwg3GnzrEqLcwE8qdoAMkeQrE8sNrdzQBN9s8Y6z/x46fZ+HrQ/8ttRYXVyR7QxsEU+5kPuvY8xr+g2t7e/2ULq58U+JHGWk1Q+bZafx/rJIEAhB7qhXcxxzjLDttV0zWtT1IKdWGn6Oh5is0/0if2aU/cHsgz/ALQrS0XR9P0Sy+yaVax20G4yMEHLuerMx5Zj3Ykk0AJ4f0i10HRbTTLBNltbJsX1J6lj7kkk+5rhPB729vZeKtMkAWDRNfeSNf8AnnHIUuPy/euPpXV694kWyvF0zSrZtT1p9p+yRMAIUbOJJm/5ZpweeSeigmvOPAIurrV/i7He3lreztPGrzWybYxJ9kAZVGT90gLyc/LzzQBDo8Y0T4p+BFtDiK5stS0KU+q2sheMH6BTj2zXtteEWNwZvij4PQnP/FQaxIo9Fay3n9ZK93oAKKKKACiiigAooooAKKKKAOb1vwRoGuatHqOrWct1PGyMEe6m8klDlSYQ/lsQe5U10lFFABRRRQAUUUUAFea6D4quP+F0eMdE1PVIk0+2t7E2VvKyJh3Ql9vQkk445r0qsW+8J+HL/Vl1S+0DSLnU1ZWF3NZxvMCuNpDld2RgY54xQB43F8Y9d1OXU7fTodMaCfSr6902/iV1AMGeSr5LDrglVBI6EUqfFnxVa6D4TtY7LTdS1zUtGGpvPltkwCriPau0LKSSWx8q9gRXsdl4U8O2N7JeWWgaTbXkm/fPDZxpI2/7+WAyd3f171HL4M8Ly6bFp0vhvRX0+JzJHbNYxGJGPVgm3AJ7nFAHD6Z8SdZ1HVNa26bpdlpOj6Za6nezXV1IZIlmtnm2gIjB9pXBII4BxnNcHqvxa8Qaxo1/aOkVhPFJpl3b3liXiMkM1yqkFSxIBHqQSDyBX0Ha6Nplo9w1pptlA1xGkMxigVTKiKVRWwOVUEgA8AHArOtfBXhW0jeO18NaJBG+3csdhEoba25cgL2b5h6HmgDM+JHiy88NtoNnpkNmb3WL4Wcc985S3g+RmLORySduAuRknrXCa58XNa0iXVN9roNzHocVs98ILlyb0zStHi1/3dvOc/Nle2a9j1TTLDV7J7PVrK1vrR/vQXMSyo31VgQaor4V8PLJYSLoOkh9PAWzYWcebYA5AjOPk554xQB5tqnxP8QWniC+EWl6W+iWPiCHQ5maaQXD+bsw6jG0Y3jqefbrWHZfELxL4l8b+DZ7J7G0sL251aGDTUnfzHMEEgT7UOn30DAAcZ717ZJoGjyed5mk6e/nXC3cm62Q75lxtlbjlxgYY8jAqG38L+H7bVzqtvoelRaoXaQ3iWkazbmBDNvA3ZIJBOeQTQB4brvxa1fxT8OdfvtHgfSTpsOnJc3Ebsksd7JdossK/wCyFBB7/MK6ofFPWbj4i3OjWWiwPpVpq0elXDO5WZd2B5+SQoXLDC4JYA4Pau38OeBNE0TQ7/Sjb/2lbX97Jf3f9oIkpnmdw+5htCnBVcccbR35rUuvDeh3erxardaNps+qREGO8ktY2mQjoQ5G4Y+tAGlNIIonkYMVRSxCqWOB6Ack+wrmP+E80j/nz8Sf+E5qP/xiuqooA5X/AITzSP8Anz8Sf+E5qP8A8Yo/4TzSP+fPxJ/4Tmo//GK6qqWt6hFpGi3+pXBAhs7eS4fP91FLH+VAHy1e+ME13xj4mubeDUy2pamLRGTTrh2W2iVbdcKEJBzNMxXG7K4wCQD1vxG8Xpq3iLQ7Dw9/wkEcs2qC+uxHpN5HIbe2QAIE8oMymQkEAYB6letQfDOWLSIfCrXERnv7qOO9ugOMGXzJyfbm6g/75ArQ0Oe6T42XcxkaObTdDtoSrD92z3EhnkV/7u4k4boCFz6EA9U8PahB4r07zLxYlnjZZYxHvSSIEcN8wDLzuH4EEA7lG/qF9b6fbNPdyiONcdslieAABySTwAOTXOG+htr37dp5KSXBIutOmOyYkD70aE/f45A4YYIOcEusH1zU7iKZRYxWsLsq3M9s4mmXjlY2wU7jJJz1wB1AOg02W5mtFkvYVglYkiINuKrn5cn1xjOO/r1q1RRQBx/jb/iVaz4f8RrxHbXH9n3h/wCne4KoCf8AdmELZ7Dd05rsKoa/pdvreh3+l3gJt7yB4Hx1AZSMj0IzkH1rN8Bapcat4WtJNQI/tO3LWd6B/wA/ETGOQ/QspYezCgDoaKKKACiiq99cm0hDrbz3DFgoSFQW578kAD3JoAsVwvxE1q/mvbPwj4YuRba9qcTyvdYz9htV4ebH94khUHqc9q0fFesXel6Lf6lfEafpdpC0kjIRLcyccKg+6rE4AOWySOBXm/h7R7i3sv7d1xFGsaw4uZluy0iLHt2JAWblDECUY9fmZ+3ABJ/ZMCRXXgrw9AtpYaxp8F3Jcr0FuoZLgs/eRiEUk8nzCT0Ndnpl9PLLeanEkcL3Mn2TT4TzvdgPncDkYVFJHYK1c3rGn30tmG0pmuHt5nurQvkNLC2PtVo4GMOCN4HG4gD+9WhPqenxaBb6n9r+zeH5LfEM0sgT9wfvEMSP30hBJJI2rknBzkAm82K8nXzFkn0jTi1pB5v39QnHMhXPG3KkFumA2OCay9a1iKa5KareSQ/aWEbx2o3XU/yhvssEa/PjkEjGQPmcrkANtrzXPElv9q0UroGjNF5R1e6i2ssefljs4jtYKRj94+NxwVUgCqunajo3hqa5i8O2Gr314F8m6ukgM99M5zhXnfEUXPPl5zknCKc0AbeqeHtS8V6A2manFbeHPDzR7LbSITH9omx9xZJMFYuQDtjyR/f7VH8Hdc0nR/h/NZancWOmtoV1JYXksuy3VnU5WR+g3MhUse7BqW30vxreCNoLPT9AtmId9k4ur9vczyKyA+2xsdjxWN8MfClhY/Fzxn9ttUvb2CCxuVubxhczRSyCXcRIwyCQqZxjoO2KAO5HjOXUyF8J6Ff6sp6Xcw+x2nXr5kg3OPeNHFH9g+I9XGfEPiE2UB62WiIYR9GnbMh+qeX/AI9hRQBjaB4Y0Xw+ZG0nToLeeT/W3GC80v8AvyNl3/4ETWzRRQAVjeKtEGtaeghk8jUbWQXFlcgkGGZehOOqnlWHdWIrZooAyfC+rPrGlLNdW/2S/iYwXdtu3eTMv3lB7joQe4INVtfh12/vFsdMmh07TniJm1BSHuAxJGyJCCoOOd7Z68Keo0dc1KDRtIu9QuseVbxlyNyqWPZQWIGScAZPUiuFv7tdXsY5fHOowabp9wi3EOh2sjefLHjIE2AJHPrGigcYO4UAOshaX1lc6Z4UlFn4fiLjU9b35eZl4dUkJyz9d0xyFxgHP3eb8BT6anhnxLrekg2eiajrZWIxxbf9FijSJiFxnkRyHpnnPWrvjnxLHBo7z6nZT2WiWluLm30SJMXd4U+YGZF4itxtGQSM9Gx9xuc8K22p2WgNo+sXM7yvLbWjQgDy4bi6t5JZHI4PEk43HJ4HAoAPD4S5+MXhKS3fzLb7TrN1E396PyoYlb8dtfQFeIfDKwZPija2rssg0PQJImdehlmvH5/FYsj2Ne30AFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAV55+0Fcva/BzxOYc+bNbrbKB1YySLHj8d2K9Drzj42/6VZeE9I6jU/ENlFIvrGjGVv0joA5DwXpRhvdb1JomnFmv2OFFBP3CYQfb/j1j/MVy91rlnJ8ePGtnfW1xFFOIo7TVok3izltoAshZf448SnzF5G08jHI9Y+Cbfa9H1fUlOYrq/cRH1VVUH/yIZK8ruNIv9Y+F2teMfD0zQ65pvia/1u3kXGXjVzHInuDGvTvtx3oA9X8Pa3PBPDYXRtVuSo+x288v7i6woIeznOd6kc7Dll9cYJ9AhZ3hRpIzG7KCyEg7T6ZFeC+FdasNc0OzeztrFrTUf9Ro11hbK4lU7v8ARm5+yz8k+WeD1Xj567zwzcQL4kFnB4g1exnXLy6Fq22RmGMZidwWZQe6Oy8UAeg0UUUAFcfp/wDxJfiPqFkfltNdtxqEPoLiILFMPxQwMB32ufWuwrkviVG9vokGu2yM1zoNwuogKMs0SgrOo9cwtJgeu30oA62imQyJNEksTq8bqGVlOQwPIINPoAKq31/a2Pli6mVGlO2NOrOfRVHJP0pupW11dKkdtetaR5/eNHGGkI9FLZA+uD+FcF4u8Z6T4TEp0i3j1LV8pbszyMWd2yI4hJgl5GYD92Dxyx2gE0AZHiLxDaeLPiZo3ha+kksrPT2TUbi33EyTzE/6PG+0fu8H95gnsmcE4rpruCPTL6TTNbYtpt+xeO73bdk3PJ4wrEYzjgnnHzNXmGk+Gb7TIvEXi/Wb2K31mC/gbVJxkxTJtVriE8/6tfNULjoYARzzXqlrOdV0+XRtUcrKT5UU+fMKSBchXJGGOOQTxIp+ooA5DVr/AF3Srw6LHZS3WrxjzhdZEVuI12rHelsFiVDbHjVWyBzgEE5Vl4agsNcs9Q8XEalayzuVtI4D5NnfMxYxRRbigSYsrK5+YkAFgHIr0GFLqWKG3kWaOWCXZDOwLvaTcfuX4+aFgeGz90gHBANKdFt77SrpILZlf/UXenM4DBMAiNXBGCpO6Nu2cDA6AF15JPt0c19Gt1qSkSRWitiGwUg/NI/Izjd8xGT0UYyaQahBEi6ldzzao8ZaRHt0CW0AwQSHYhMAZ+ZmJ64x0rhtFtNTvNRfw5dX8cX2hWuI9SnVXlvI0YAkQsNpuF4EhkDbcLtXB46Hxx4FtLjwm4hgudVvbVopwt7cPO06o6s6EMSvzKGGAAMkYFAF2Lx/aTQG4jNiLbGRK10xXHruSNlx7hiKpfCNTqsviTxewUJr16DbhW3A28CCFGBwMhirsOBwwrnrdtSj0u/8M6hrLwNe2x0KOaTJ+z3SxkQPj+ETwlWxxh1IHJrsfhlrdrc6T/YD2UWk6xokcdtd6YhysAx8jIf4o2AyG/A8g0AdnRRRQAUUUUAFFFcb4zOh2t8lx4i1i+Mc6CCHSYpm2zt/sxRjfIT3ByPYUAaktxo3iuPUtLdfttpbsqzyLkRiQNnasgI+dSoJ2n5TjkGsHVfBMl2jX/hbxLe6beTomLnEd0JoxyFLuDJtI7q461U1XamhiPVYY/DHg63KxrYwqPtF6hHEWyP/AFasTjYm526fLkg2H1YeH7CfxR4kSbStLtYhaadpEBLHYWAQtGvBmc7VVBnYOM5LYAOO+I8MGnv4d8OafaQLqms6hZ3OtkTNNI9usyKVMj/OwaQgDPZX4ABreF3BbTN4gW9gS2vNWlmLuhdZEUxQDGO+yFsHoM5rkdGj1PXdak1K6iil13UZ3ihlgfItXUFCFboY7WNnyw+/PJgdAa0vibYwL/Z3h2xb7LpdoI7cYPEapGVz9c3EPPtQBH+zXJcajqfjTVrpWDSy2lsM9tkO5l/OUn8a9yrzb9n21Vfh6uqCMRtrV7c6ntA6LJIQg/74VK9JoAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAMXQPE2la9Hq0mnXG5NKvZtPu2kUoI5osbxk9QMjnpVfU/G/hnTdCn1m51uxbTIJEikngk88K7sFVcJk5JI7dOegJrgND8FeONHPjbT7SXw2NL8QalqGoR3MjyyzQmdCIwYjHsYAqm4EkYLdeh5eH4I+IJtB8V217Loi3eqwWPkfv5ZkE9vJuZmJiXaGGVG0cBiMY6gHvT61paT2kD6lZLNdjNvGZ0DTD1QZy34UsusaZCkzzajZxrCGMpadQIwpAbdzxgkA56ZFeLeIPg/q+p+JZ9UWLRfs97FZ77RbqWBbCSAAAQlYiXTIyB+7OSfWtY/CzUIPD3jMaeNDi8R6zq9xeQX0kAdvssk6SiF3aMsv3ewYK2CMkZoA7+/wDGWjWsmiiO6W8j1e8+w20toyyp5m1m5YHAGFPrWtqOqafpibtSvrW0XBbNxMsYxkDPJHGSPzrxnwn8JNd0m70+WebS444PEn9stFHcyy4i+z+WVDNGCz7vXAI7jpXUfE74ez+MfENje7NNltbbSr+zCXgLETTIojcDaRgEHJ6jsDQB30Wq6fL9q8q/tH+yYNxtmU+Txn5+fl455qKPXdJlslvI9UsHtHJVZ1uEMZIGSA2ccAGvFJPgfqLaHd6fbXWlWH2nQdOsZDbq22a7t5A8jyAKNyPjG77xzkjsbemfCDUC+l/2ja6KIItbTVLy2+0yXMcyiFoyQHiUbiSvG0Djkk0AetR+ILGbULC2tH+1R3sUk0VzA6PDtTGfmDc9ewPQ9Kkt/EGjXNrc3Nvq+ny29txPLHcoyRf7xBwv415BpPwf1axuNu/RzYrDrMKW4klVQl2R5SYVQQoAw2CMfw5qlpXwa8R22iPbT3ujsIL+yvLXT5SZ4ZVtw4MU0wiR2Q78hSrbSvfJoA9xttY0y6h8621Gzmi8oz7451ZfLBIL5B+7kEZ6cU2XWtKhu7a1m1OxjurkBoIWnQPKD0KrnLZ9q8f134beLry81G90yLwlp76roNzot1aRGZYoRJLI6yRkINzHzPmJUc5OD0pkHwl1+Dxjo2q2tzpNtHbJp63cvmNMZ/s8SIR5LxFd2VO11dMDB27hmgD3OiqWr6ZBq1mbW6ku44iwbda3cts+R/txMrY9s1hf8IHpH/P54k/8KPUf/j9AHVV438cNT+xeOPACk4WD+0tQY+nk2jEH9a7r/hA9I/5/PEn/AIUeo/8Ax+vDPj34as7PxEkVnNq8rweHb6dRPq11O293jhUAySMQCXwVHDdCCKAPYfhHbf2L8G/D27hxpq3b/wC9Iplb9WNcD4CuBoP7JVxfXbfPJpt7Nk92leTb+ZZa6rxP4L0nw78NtUnN5r+7T9KlbjX74JlIj/B523HH3cY7YrmpfhbDqHwBtbOxl1c6udHgmjhOq3bQtMqLJtEBk8sAsMABeM5GCBQByXhzw9qHg7Q4zYwvcRQ2KJq+nSxify2wD5nl9ZoCckhTvjJJXIO09pYapbzaRZW9tPZ3FhOu6K01t/tNjKCOUt70AmMr2SUbh02irXge3sdZ8J6dq2hC8MQYDElxJc3WlyqAHhfzGLtGrDhQQyhjgEMaur4Nmu7jUNZ0K4is9Ulfa15pVwqrc+vnwMpikcEkHcqn3BoA6vwNpUVks01tHqtpAyhFs7m++1W477oTuYgduo/3RXWV403hDxH4eiku4dK02/lxl5NEvZtHlf1LQDfC59+Kt+HfiXcQI9ve+FvF1xPu5C/Zrvb7AxuCfxFAHrVNdFkRkkUMjAhlYZBHoa4ST4jsB+78F+NJG9BpgX9S4FRQ+NvFV/JjTPhzqqRn/lpqV7b2uPqoZ2/SgDU+GrtaaTd+H52Jn0G5axUscloMB7dvf906An+8rela2u61Fp8DJBJFJe/ww/Mx9yQgJ/PA9x1rzPxAnje18ZafqDX2heG49bVdOmkiRr3Y0YkljLF/LXcQZVDYx90c8VqXngDQvFYFn4n8Val4huMbngF+sMRx38iHav5g/WgDN1Pxdd+INTGkaBFNr95EpM625WOzif0lkG5Fx/dLSE4xtzyL2neG4/BdkPEXiK4h1PxMU+zWUMalbeOaQ8RwocnczfekOWIBPCjA1L3UZvAF5YWIjudS0S5heO0t4IU863ljXdsG0KpRlB+ZsbSpJbB4pbLzU73+2fEYGdjpZafE5CiMhd5LEfd7PKcArwAFPzgEb22fDEGn6hMbyORJi86JvFzO+7zp9veNS5CDuxXjhTWV4Dnkj8LWkGtRtLbQ2y2zR7fmeBI03q2P442YupU527sZIzW6blPNudVvJ7cfZo/OkuWyIrRFUlZCpPAAJ8tMc5LnqMVfA1rfXHhbT/Lke3llmDt5ijKyG2R0JHscqwGAQxFAHRXiX9rej7LKH1LyittOw+S8hGDsc9PNXkg9+ccFsR/25Dew2uqWaC31NT9nmVxhM8Hy5TjKgnO1iODwcZINrQ2ttV0z+yb1mfaPNtycq6qrYGD13xuNhPXgE9azdStLi3vpJz5f9sKmyQOgEWpxYAIAJwH4AK/TtggAq+IbZdTM1xloM3CESQ7Y5bWVTxvJyEkHRZOVYNtYYINbHhDxWb2dNJ1sxw6yqsUKjal0qkgso/hcfxRnlc5GVwxzrNjLCtzphkUwqIHt2VpJLRckFGTgzRZGP7y84PUDN1XT7bUbVIXiYROVWFEdn4RtyvCykF1XqAMSR4OOPlIB0/i7wmusXIu7Qwx3EqLa3iyA7bi23ZIyOVkQ5ZHH3W9jXJ+JNOmjvdPj1u/l07XbN2TRvEiDMc4IGIboAAc9CpwrYypBOBr6J4o1LTxFFq0cuqWjlit5bKsk0SZwGkRBiSPt5sY9NyKc10t14h8OzaJ9su9U0x9KnBQyTTJ5UnYrycH0IoA57RPHv2bULfRPHFsmia46/u5d2bK8/wBqGU8c9djYYe/Wu8BBAIOQe9eU3194R0exNpbR6jqOi3KkHS3RXsiD0w1zhUUHoFcKPSuPs7uy0iylHhTxXY+E1B+SybXU1RFyegt9r4+iOKAPoaivEU1P4mRtst9UutQcdz4W8lD+Mk8Z/SqR8c/E9Z5reGw02eeJirK+nsCpHBB8u4YUAeqeMrK71EwW9uNa8naWcafdRWyuc/ddyRIP+A4rH0Hw9rdm4TTrHQ/Dln/E0Ye+u5PXMjbQD7nfXn6eIvi9ePidbawU9BZ6FPM3/kRlX/x6tW80vxFqdmo8T/8ACR3NmRiU3uqWukwEdwVtiz49mY0AdBf6p4b8K67sRr7xP4wuSRHAjC5uVHoOkdunr9wdTzXK6zcagPFdjceK1jvfEmN9tplmjT2+n27kgqq7lMtw6hgZDhUGWO0AbtDS9Y0PRLeLSfDmt+GNDtEIM9voUZ1K6Y/ULwf9pkY1WtrQ6hdXqp4e8R3ul3RJuIVt3hm1Ag8Gee7aJgmB/qlAXBI5HFAHX+G72K90nT7zT7KxtL27uBp8T2gLKltE7MVV2UbgFVuVG0seCRg15z8ab1LrR9QubQSIsNvcXLShj87t+7hUL6lpID15AFdxqereL57icWPh/TtLtra3+zo15f8AzrJKQE2rFGykjCjbuA+Yc15Hqtpr2veM9F0c31pFZ3esJaILO1ODHZIsryAyM24AmMcjB2DjqCAfRvgfR/8AhHvBuh6QfvWNlDbt7sqAE/nmtiaWOCJpZ5EjjXlndgAPqTXKjwW05zqnifxNfeoF6LQf+Syx4qSH4feFI5Fll0Kyu5l+7LfKbpx9GlLH9aANrS9Z0zVnnXS9Ssr1rchZhbTrIYyc4DbScHg9fSuW8R/EzRPDnjqDwxq4mt5ZtOfUhdsB5IRfMJUnOd2InPTtXZWlrb2cIitIIoIh0SJAq/kK4fxV8MNJ8V+M31rXyt3Ztp0ViLEoVw0c7SiTeG77ipXHTPPOKAIvDfxc8M6x4Pt/EV3LLpVpcXEltFDdLumdk+9hE3E4HJx0HWn+NPix4Z8N6AdQivoNRnks/t1ta27kmeLOA24AhATxlscjHWucf4JINK02KLXQL/T9QvL2GaSzLRMtyQXjeMSAnG1cMHHT3qK/+CU7aXeWOleIrbT4dQ01dOvUTSwyMFkZ1aJfNHl/fIIy2euc80AdxD490uNdVl1OSK1gsJoYCY3ady0kYcAoq5B56c8DNRwfEPSr7X/C1ho7LqFrry3hju432iI26qWVlIzklsYOCMVz+q/Ci4u4dbFr4je1fUtQtb5gLYmMrDEIzDKokBkRsZIyvIHXHLvBnwl/4RvU/Dt5/bKT/wBkXGoz+Wln5Sy/awg2j5ztCbPfOe1AHqVFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRVLWdVsNE02bUdXvILKxh2+ZPO4REywUZJ6ZJA/GrtABRVYX9mdSOnC7t/7QEIuDa+YvmiIttD7M525BGcYyMVZoAKKKz9O1nT9Rv9RsrK5WW606RYrqMAgxOyhgDkc8EHigDQooooAK8S8bW8esfGK/t5cGODTNLs8H1l1ASMPxWL9K9trwCTUPP+O+swg/63XNLtR9IbKeU/8AjxFAHfftAXJtfg54pZThpLUQD3MjqmP/AB6uwkkj0Tw60m0mGxtS20cZVE6fkK4L9o75/hhPb/8APxf2UWPXNzGf6V3/AIgtWvdA1K1j+/PbSxL9WQj+tAHgfwt8M32q6Ja+JfDPiiXSfGmpI+q6jbSqZbW8WWaTy98ZI4GCu5eRz3rubbxz4v0OaWPxZ8Pr1ogctfaBIt2kh6bvK4cDjvk4rx34e+FLGfwL4a8TRX11dX6x/ZJZjeGMadIsjLHGxTDRQsCQWHKtsfkbhX0f4L1q2u7X+zHlvU1SyXZPb6gR9o/38gASKezrkH1zmgDnE+NvgEOIrzW2sLjvDe2k0Dr9QyVcj+J3w6vJI5z4o0AyIco8twisv03YIruJ7eGdds8Uci+jqD/OqEnh7RZSTLpGnOf9q2Q/0oAw5Pid4Fjxu8Y+Hzn+7qER/k1ULj4x/D23OH8WaYf+uchf/wBBBrpk8LeH48+XoelLn+7aRj+lWotH0yH/AFOnWUf+7Ao/pQB4r4x8d/DXWfDt/beHp4rvWRi4tGtdLmmYXCMHjyRH0LKAeeQSO9dDpvxSn1HTILnwr8PPEt5HKgZWMEdrCT3Adm5AORkCvVURI1xGqqPQDFcj4N/4lPiDxD4dbiKOb+07MdvIuCxZR/uzLNx2DJ7UAc9oul+JPFurw634u0VNJe2WSG00+a5WeKINjMrKn+tc4A5KhQOhJzWxJp817qs1hHJLGyj/AEi7uUbzboc/d+Xb5YLcKDgnqMDDdzRQBxl54UfXNHNpqA+z2krLvtZP3jMu8F2kYH5pGUYzyFycZ611Nvp9tbptjjwPOafr/GScn9cfSrVV9QDmxn8uaWB9hIkiQO6+6qQQT7YNAFW50y3Vo54WFpJFObgyKBg5++Dnsw6++D1Fcv4j8RaBqk8cGnzR61e2bGRrO0gN0silSrIxUFUJB4JI5AzxmqUcWo3GgiO20p5YGmNy954unB8s9NwhXJGB0X92Bz0qioi1z/iXw3Gr+II4ARJHpijT9NZv7pkBBceqh39xQBkatqtzY6+i2ECaVPKzeSb+4U3TK2PuwQiSR8FRywGV4bOFIt3+k+MdevBFp6f2fZyDNzMbZLSKWTIPmKjmV9+Rw21D755G1o+up4fkubBtI0lLsAbLTRm3LbIAebqdgqJzjrgnnAauh8OeLbfW7lLW2t5p5UTNzc2yM9pFIBygmYLvP+6D74oA82uPg54h1O8mGo+Nr62sVlLwraPKZXyMMzsz8Me+Bg9810/hf4MeD/D7tMtpcX14xy1xdzszknqflwMn6V6RXC+J/idoWi3U1laedq+owqWmhsQGS346zSkhIh/vHPsaAGal4et9K1Af2F4B0a/QqGa6kliifdzx8yEntznvU/8AbHiSyhLf8IZY28KDJP8Aa0aKB/3xXL6LJ8TfHMhuLyez8H+HZeY1tU86/lTsQ0g2pkdyoPt3rpNM+FfhW0m+0X9nNrd6TlrnWLh7xyfo5Kj8AKAMG9+MtlprEana6YhHVINes5H/AO+S610lp8SfBWr2hjh8WaTBLLHgr9uiSSMkducZHtkZFbE2mR2LRrpOh6W0OPmA2wlT7AIQfzFFxbwPEWufDyTY6qEhc/hkigDAstN8KajaNaf8JNc6oJF2sf7flLMP+2cgx+GKzNe8FfDHwvZrqeu6TZRQNIsf2u582cqxzjLksVHHUkD1Nbcmm+Dr1xDqfhzT7eR+At9pqID7Byu0n6GsHxD8J/C96kU2hWR09wWMkml3Ulu2NpxtCHafmA6joTQBrrY+A9Ns9NuoZrC2tL+UQWc8N4yxzOQSFRlbGTg963rLw9Hp+qLe2+p6sIlVg1pLdtNC2e+H3MCPYivnO78F6toWsWZ0PWbe4TVL06VcWGqxiS2vWMTsplCgBgTEwzjcNykE9K9V+HsSzeB3stMv70W93dGxNjdyb5NMZCVuIEk+8ygK+zOcDHOOgBqa1fLaaML3UbgxSMZNUZPvFQBshXA/ulkP1T61xHwcgl1P4izyXkTD/hHtIihCsOEuLtjPJ/wIJsQ/StvxlqMF3dhY4CLaSYRtMeVW2iVzIwHT/VpcY95I/UVp/AWGS58EyeIrtSt94jvZ9VmB/hV3KxqPYRqmKAPSKKKKACvFPjJ428UaD4l1e18P6ha2lrpnh6PWWSW0EzTP9paMpkkbQQB2J44xXtdFAHz7rXxF8Z6Pa+J7R7m2vJbDUtPibUEsxGLS2uYPNdimSMIdqhmz97JzU+ieN/GOvXHhPR7TXtJiuNUl1OJ9St7ZblXSBInjYAEJu+cg4yte90UAfNWh/EfXtQtjrv8AxKYdYbwal0Lm4iYJ5v26SL5sdFwM+gY5OFzi3pHxQ8Q3eiae91qzWNjPqslpea9cWcMkNqiw71CPGTE4d/l3kAL0I719FUUAfOviL4xaloWm+LYjrNreXcFhZXOh3P2Bo1vQzETSBehHTvj0rdsfiBrsvxsfw9cX0UunG8kgitrCGOXZGqE5mDESxnI5fBT04Oa9tooAKKKKACiiigAooooAKKKKACiiigAoorzAfFgDw3qPihvD92PClsJxFfieMvM0bmP/AFXVQzggEn6gUAaHx78Pap4q+E+u6NoNr9r1K58jyofMWPdtnjdvmYgD5VJ5PauO+J+meMvHOm6av/CHTWSRtcpJEb+3edGKJ5cinzPLCltwJ+Zxt4Azzf134m6obyw0xLB9G1m38Q6XYahbu6XCtb3WSNrgYyQpB4BBFVLT4tX+leHLm71K1i1W7OrahbRRJMsDiGCTACoFLOcdTjA/iI4yAZWm/D3xXFr2k6lNY3A1WTwkumPqJv1JsdRVXAkkG/LjBUfKGGecd6x7D4deN7fwfrtnb2WrW2pXdraRsv8AaMAjnmjuomeVGEhbcUEmWbaSOME13Vn8Xbq58ToRoxXwufDS+IZJy6/aIk+YsxG7BA27NoGcjOcVHa/HK3fQdU1S58O38UdpBb3USpIriaOaZIgN2AFcF1JXnjoTQBgfGD4d+I7ueKz8HaTczWVtYn7HdpqO64S5MzSMHkuJdwHzZBXJJ4JAAA9F+HOhatpXifxpe6tbmKLUru3mt5DIjeaFt0RjhSSPmBHOKxvGvxdl8Iw276p4anSYwG5ubT7dE9xBH5rIGKx7wQQobJYLzjJION7wD4jvtc8VeNLW6lD2enXkEdmuwKUR4FcgkcnknrQB1er2U9/ZGC11K70yUsD9otViZwB2xKjrg/7tYX/CL6v/AND34k/78ad/8i11VFAHK/8ACL6v/wBD34k/78ad/wDItfOOhafqF18eharr2qKzeIb1GvBHbeZvhtMb8GLZuIYrjbtx2B5r64r5w+HtsJvifa6l1Fx4k1d1/FZkB/KKgDtPikTc+DfDFnJd3V80vieytGuLpYxJLtuTkkRqq4+Q4wo4A7163Xjfxd1Gw0HRfh9d6lOLewi8RQ3U8pUkKAkzk4AJPJHQVm+NvEmteONPlghlv/BnhCUeWNRuYcXmpuwIEMMOQwU8knqQOwzQBzHw7s7SLxX4g03QNSiMh1a8sIZNwntirq08UcidHiYLOjDPDLlSCTn6F8MaKuiafHbJLKYwo2QtIZEt+OUjZhu2egJOAABjpXz18FdR0+08V37X+l6dp84tLS8sbOMeXm1iWZDcooZz5hWRnKMSSrZBPWvpxWDKGUhlIyCDkGgBaKbG6SAmNlYAlSVOeQcEfnTqACiiigArj/G3/Eq1nw/4jXiO2uP7PvD/ANO9wVQE/wC7MIWz2G7pzXYVQ1/S7fW9Dv8AS7wE295A8D46gMpGR6EZyD60AX6K57wFqlxq3ha0k1Aj+07ctZ3oH/PxExjkP0LKWHswroaACuR8Y+LJ9GuksLK0U3k0ZaGa5J8tm/uoiZkmYAZKouAMZYZrrqY0MbTJK0aGVAVVyo3KDjIB7ZwPyoA8vtvCOueK5rC78U3M8VtEPM8q4VDKz9isC5hix2Y+ZIP7ymqviNvFVzDqmnWNveRaJYxrbReV5jPPyFyZCRLK2OoUxr1zKea9drlL3SdR8S3ssetg2mhQysi2Mb5a+UcbpmB4jPJEY68bj/DQB4UkGoeJ9W0vR/CkHnR6b5ZeYlGgtnzuzhAYI/u8lfMY5xubkH1vTZNP+GWkONb1O51PXdUmM5t4VMs93N3WGMfMwAwMngADJUDA7rTtNstMt2g0y0trOJmLlIIlRdx74A69KwfCngy00S7l1O9uJtX8QT5Eup3gBlCk58uMdI4x2RePXJoA5DxCus6zZtdeN7ifR9EusQ2vhzTJc3l7IQcRyzLySQDlIyAB95sA10HhLwTBaR2U+pWdrbpZuZNP0q2A+z6fkYzwP3kvUmQ5wSduOSeyktLeW6huZIY3uIAwikZcsgbG7B7ZwKmoAKKKKACiiigBGwRhsYPHNcNqkWi3Hi6C0nsLCOC33SzOyhWkfYSOg5UDJO444J/hrf19/tdhqMEYxPaeXOhz/EpDqfzWuAshEmjC0hnYahqErzXNyWy8cHBYljwowCcnsGxyaAMG30ax8QfEbSbzSraG0tdNBvvLiQIFLzLDb5A7lI539cEegx3E1jYaFdeINQ0lXWQzSOxO6RVuplUzS45+6iIcD0YDk1yfgy7t7e1/4SSCNtmsXf2u3tzkM0EYMFpGB15RXl/3iK6m7W0MsVtfT7Le0SSa9C8puAElw7HuPmVPpIw+gB5N498WNc2FxpdpHrCS6kkekRA6RdIUM7KZ9oaMElLaOJQoyxLlgCDmvadN8X6DpunWtjZ2HiSO1tolhiQeHNR+VFAAH+o9BXBeALGfW/isJr/96uiWj39wf4U1C9O7b9Y4AiD0x717hQByv/CeaR/z5+JP/Cc1H/4xR/wnmkf8+fiT/wAJzUf/AIxXVUUAYOk+K9P1W+S0trfWklcEhrrRry2j4GeXkiVR+J5rzr4l/FTUvBPxLh017FLvQBpAu5vLjJmE7ySpEAQfus6Rp04L5r2OsttA0xvEba81qG1VrVbIzF2P7lXMgXbnbwxJzjPvQB474a+NWow+DtLn8RaZFd+Ir++vLWO3tW8mELb43ksd2MbgBjOSe3WpfF/xlvZ/COo3HhPRruG9ttJTUbme8KR/YS7lVUxsD5jZVvQYwfau9vfh54Pt9D8ifTfJsrSeXUFkS5mSSGRsmR1kVt657gHHtXPxeFfhl4tms7GGE3k02krcRqt3dI01k8jbWdtwLjfuI3ksDQAz/hZUmnR+JZrgG8ksL21tI4J5Y7dS0sKvhCAWY8k4wzegxUOgfE668T+KfAqWEElhZam2qQ39pMoZhLbKm3DYzgFie2c8iun13wT4KEUo1i3gt/7Sv7eUPJeyQu92i+XD5bhwVk2jaAhBPPXJq7ovw/8ADOi3OnXGm6aYZtOkuJbZjcSuY2uMecfmY53bR1zjHGKAOpoorPuNZ0+21uz0ie5VNRvI5JYISDl0TG45xjjI6+tAGhRRRQAUUUUAFFFFABRRRQAUUUUAFec6r4Z+Huj6tcw6hZJHc6ha3Vy9oXneJ4gAZ3WEEoDgjlVDHPFejV5V8WfC+va14hgvdCtWkEfh/VbNZVmSMrcTRKIlGWByWHXoO5FAHRaT4A8IjTrR7HTWaE3cGqxSyTzNK00YHlOzu287R0VjgDjFJefC/wAIXcaJNpLDZNPOGju5423TnMuWVwSrHqpO32r5++K0eqaW8+m6mJ7zXrjQ9Nt9Kjg1ECaxmGFnAiDbnLsp+dQ3Tk4ru9W8H+Mrj4wW+uQaU8FtFrcUhu7W7jWOSw8va28NJ5hboCgUL6A5zQB6fB8PPC8Fzps8WlhZNOsv7Og/fykfZuf3TruxIvJ4cNyc9aqx/C3whHptzp66ZMbG4VEaB7+4ZFVJFkVUBk+QBkU4XA4x04rye2+FXiC4m02TUrK/Zp11hNT/AOJqcOrNuslIEuNu7nC8A/eqDW/h549vrbQTqEep3Zh0W2tgLS/hWaxuo/vtueRVJY7cyKWPGMEUAe0eK/h34X8V3r3eu6a1xcSQC1kaO6mh8yIHcFcRuoYAnIznHar3hfTvD9tPql94dNvI95OBeSwXBmDSxKI9p+YhSoUAgY6c815JqHw+8TXGsX+tC3vG1ZPE1tdWco1HAFkBGJSE3hAD8+VIBPpjFdX8EfCV34PTxLZ3uky2fm6jJLBdG7EyXMJdzHtXeSpUHncFJ3DrjgA9OooooACcDJr5w+DDmbVfCE56zTXVyT/11N838ttfQWtz/ZdGv7jOPKt5JM+mFJr59+Cy7JPBO0Y2Lap/31YXTn/0IUAdf8XoDdeHtBQQicRQXVwqEA5eOAuMZ6NgNg1a8V6DrdzYx6nfqs2qXr+XNDGxe3srYKzGMMcbUbAEsgG5wSqjlcS641hZw2n2yUCOS5WQ/wDTNJojayMf9kMwY/j6Gus8N6xKngK31PWoZobi0tW+2RsnzB4QVkwD1yUJHqCKAOD8NfDiDV/CNxrE0ssXifU5hqVrqU0SrLbMoxD8g4VNmN0fTDFewq94I8S3l1I9rdQSw69pBNrdWA+VJVABKpnhsD5o243IcHncRufDS/vxbTaVqej6jYiMvdWs9yyyLPBI5YAupIEi7tpU+gIyOnP/ABU0e8l11dd8NMzeILO3WGO1jYD7Wg3yMp/2lwrL05ODw1DHFXaV7HbvPHYN/bFmxk0u5Ae4SNc7Cf8AlsAOf94egz2OegBBAIIIPIIrzPwj4jvZfDceuW9vZX1jekNKLSTbEsjfekyRlOciRCPlYZzgsa3bW61PRba3tUsIPKnP+jRy3JVLf1iaQKQefu8dOP4RlXLVJvZrtuv6+Z19FYurDWpUtf7OutOs8DddmZGlKjjhOVGOvJqtcXNjeFtbs9Rvb6Cy4+zafL5iMwHPyr984I4JIpORcaDaTv8Ad+Hlr6msdUsf7SXT/tcJvmUt5AcFwB3I7fjTbO7uri6uo3sJLaCM7Y5pXU+ac9QoJIH1x9Ko29xdz6Ub3StHS1vrl8vFfEQtxxufYGycAcenpU93Z6rdpYldTFi6DNytvCriRuOFLg4HXtnmldlOnGOjsumrvZr0+7r/AJc1oOl67YeJtehu5Y44NYhS9S6soSI7e5QLE4w5YZZBEwz12ucda3Ro7TaUdNl13UZJw/mNcxypHPjP3flXAH4VduNItrjVrfUZXuTPAu1FE7iMdeSgO0nnqRUlrpWn2l9cXttZwRXlx/rZlQB3+p6npRyh7ZJXT132W/8Al/VjOutHN5YWltaa7qUDWvWeGZGeXj/loSpz+lXb2DU3mtzYX1vFCoxKs1uZC/uCHXH5GmWfh/SbFbtbPT7a3W7XbOIkC+YOeuPqfzqC18L6VZ6RcabZQS21pO251inkVs8dGzkdB0NFn/TKdWD+1t3iuu/X7v0Ll0mpnUYGtZ7NbEY82OSFmkPrtYMAO3UGkxqv9sZ32P8AZW37ux/Ozj1ztxn2qJ9GT+yobCG91CFIjlZUuCZT14LNkkc9/apb6xubhrf7PqdzaCL74jSNvN6fe3KfTtjrRqQnHZNdVqvx0vqNsjrH2+7F8lh9i/5djCz+Yef4wRgcelRWVzrI064l1DTrb7Yh/dw21xuEg/3mC4PWrNzZ3EuoQXEeo3EMEY+e2REKSdepKlh+BHShbO5GqtdHUrg25GBaFI/LHGM527vfrRqHNFrW349Onz/porXWuLY6ONQ1Cxvrdd2x4Vi86ROcZIjLcd8ip01nTmtLW5a7iihuhmEznyi/GeA2Dn2qOztNStWvHm1L7bvBMEcsKxiM88FlGSOg9eKryzSvotzL4h0mNzBkmGAfahKAByi7QT9MZ4ouyuSnLbXXo+/RJq+n9dzcznpRXN3CaDqDaf4gu3e2aIhYZZ5Xtscn5GUlQec8EVqx2s39pG8TUZ3tXT/j2IQx5wMMpxu/XHNNSuZypKK1dn5rr26/oX6KyNPGuQpfHUG0+5IybUQBoi3X5XzkDsMj34qSO71L+zJZpdMVbxThLZLhWDjjneQAO/X0o5hOk07Jp/P/ADKOp3UVlZ+I752ysMWG/wCAxZx9fmrzjxLYy6b4dstNg3DUfEyR2ksg62tmsIa6kwBnIUMO/LIPaun8Wx6hB4PtbCz09n1LVb5VnjeVflyxkkdmHGAqEewIFYnhEnxx4z1XxPE8sulxILKxQ/KjQxvk/N38yVd+Rn5ETPDYp3IlFx3NKxt3hv3uItNW3Nkkfk24cZJZVWCDA4RVAUnuCueh5zPFN/YWWktDrPy2skb3l2Y15eyt23yFs8/vpmCgfxK/rmt+eJ7i+h06WdvtW9muZYF2qZnXMj59I4yEB7GRO44888RRf8Jn4k0nwu8ISz1yVLuVFH+q0e0J8pCf+msmWz2DAUyT0D4H6JeaX4JF/rHOsa5cSateZ6q0uCqZ/wBlNox25r0GkVQqhVACgYAHaloAKKKKACvJvHXhjV774gSalc6Hc+I9HeyjhsoYNSFr9gnDku5BZeoKneu5htxivWa8e+I/j3U/Duv+L4VupIrDTNEtb2IQwxtIsj3BRiN4weMDB4oAxLPwJ4xXxNNNJazCfzdSe81Vr9WTUYJUYW8Ii3ZXaSnDAKu3IJqpF4C8ZWWlxG00WCW7j8FWuk+VPdIEa5W5LyRZVwchCSDkITgE4zXd3nxVSHxC9nBodzNpkeuQ+Hn1Dz0X/S3IyBGeSq7hk9+1VtP+MNrc+KptHl0phH5d29vd29ys0cptwS6kgBQcDszYyAcUAedRfDHxRJ4dmgutEvZ4LXxFZ6la6fLfwpI9sFHnqhSTy0YntuHqD3O9F4F8Wp8T4tWuLfUmtV1OC5trq3vYtsFoAoa2kDybtqjcCFVgxOc55rRk+OskdjJdv4O1AQrpkOsg/bIObN3KGQ88EMMBeSe+2tm6+MNknjL+xLTR727to7yGxnu4yMxySAHcI8ZKLuXccgjnAOKAOTi+H3iS1+FFpbtpc994jub/AP4mUFxqJlYWwnmZTCrSiHcFZDgkA5OckVY+FvgjxZpHiPwtca3ZTpaaauqRFprqKVoo5XQwr8rHOQDwOB7Vt23ximu57RYPC94ttfve21lcvdRES3FurkoVByqtsI3HHPtzXU/CPxPqfjDwHp2t61YRWVzcruAhbKSLx86jJKgnIwTnj3FAHZUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAc98RZTb/D7xPMOsel3T/lExrxn4RxlIPB0nTbdWCH6HR5T+pI/KvXfiwCfhb4xAGSdGvOP+2D1598GNKXULPTJHlZPsVppF/HgZ3k2DRFfpyfyoA72Pwst5Opvo0EUMl1C0bruFxBKxIGc8YDsPxNdYqKsYTGVA24PPFOooAK5TWtME+sXJgJjkukit3YHB2uf3rA9iY4lUemK6us7U4JRJDcWcKyzCZN4aTYNg3AnPPQMT70AecWWk6do3x3Nna26x2eo6W98sKZWOO6SQK5AHGXRwSP9nPeu2i8G6JDcvNFbzIXXY0YupfL28fLs3bQOBwBXG+M7ibSdL8PeL5AWmg1hZpwTytrODCygd8IY2x6pmvVKVkaupVtdt2tb5dvTyM3T9D03Trq8ubOziinvG3XDjJMhyTzn6n86vxRpDGscSKiKMBVGAPwp9FCSWxEpym7ydwooopkhRRRQAUUUUAFFFFABRRRQAUVzuq+IJFmjg0mNJ5DMYd7ZKs4GSi46kfxN91QDnJG2tXTre6i3yX12Z5pAMoqhY48dkHXHuST9KAJ7y0t72BoLyCK4hbrHKgZT+BqnfaJY3slq80cita8QmGZ4to44+UjI4HBrSopNJ7lxqTh8LaKE+mrNqUd4bu9Qpj90k5ETY9V6HrQmmqmqNe/a70sQR5LTkxDjHCdKv1S1rVLPRNJu9T1SdbextImmmlboqgZP1+nejlQ/azta/S3yPOPirLc2kMHhrwvPczeJPEchiBlneT7Ja8+dMAxwgCnaMY5IxnFdrYWNn4O8KwWWnqojt0WGFWOPMkOFUe2TgcdB9Kw/hzpM95c3njLXbdU1jVwBboR81pZDmKL2JB3v/tNjsKh8WXsmseK4NIhkWGx04far64YgBV2/MM54+U4/wCB9gORKxMpOTvJmdqkqNpaWNxfSP8A2vHIZ7tBs8iwj+e4nJ/hDlsD2kTH3SaPgjYSaiuq+NL2BYW1hxDpke3HkabF8sCAdg3Le+Qa5XxXLL4uu7Dw/ZGeNvGBV2wmw2OiwHIwP4TKeef7+McCvdrK1hsrOC1tY1it4I1ijReiqowAPoBTJJqKKKACiiigArmtf8DeHfEE2pS6vp32iTUbWOzuj58ieZCj71X5WGMNzkYPvXS0UAeWar8IoNS+IUfiOTUo4LZNQh1M2dvbujSTRAbS7GUoeRkkRhj0zW/Y/C/whYagt7aaS0c6C4VALucpGJwRKEQvtUNk8AADtiu0ooA49/ht4TkszavpOYDpiaMV+0y/8eivvWPO/PDHO773vU9x8P8Aw1PrQ1ZtPkjvsxs7w3U0SymPGwyIrhZCMD7wPSupooA5m08CeG7RdNWDTQq6dczXdsDNIwSWXd5jct82d7cHIGeAKu+FPDOleE9LOnaDbvbWXmGQRNPJKFJABC72JUcD5RgD05NbNFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBznxIjeb4d+KYoxl30q6VR6kwsBXN/BCyZPBfh7UUC+Rc6DYQnnnfGHzx9HH5V6JcQx3EEkMyhopFKMp7gjBFeZfBPU4dJ8JX/hvVLqGK48L3kmnyvK4QGIuTA5zwAykAfSgai3oj1CimLIjRCRXUxkbtwPGPXNZ2pas9pd2cFvp17e/aCMywKPLiXI+ZmJA75wMmk2kVCEpuyNSqWsXo07Tprk21zdbAMQ2yb5HJOAAPxqJ7jU/7WEMdhB/Z4wWuXuMMeOgQL6+pFZ1hHa2mr3ul251Ka6uUM9zeMxYRE8Ku48KcfdCjgDmk5djWnS6y162Xbrft+fkc5qUUGteFls9c0i8n1S1tvs76Yh3DMoMSy8fKRgNh/4ee9a/wt1O5vfCsdlqsofWdJkbTr7nJ8yM4DH/AHk2OD33VvaNo1lo0MkdjEymVt8sjuXeRsY3MzEkmuM1oJ4O+JNpraRONM8SGPT9QdfuxXS8W8rf7wJjJ9dlCXUmrUUkoR2Wz8u1ru3U9EoooqjEKKKKACiiigAoopkzmOGR1RpGVSQi9W9hQBmaleXMt4NO0shbnaHmuHTckCE/q55wPbJ4wCNoNs7mWS4v3nznzPtcikfQAhR9MYqbRLJrOyHnu0l1MxmndurSHr9AOAB6AVoUAULS0ttHs5mTzmHMssjFpZJDjknqSfYfQCsyDVryTVjEtvJHHPHuihvR5RJHXYyhgRjkq2GHJxjp0VZmuCQiw8n/AFn2uLH0z83/AI7uoAbo+lNaubq8aOS9ZNn7pSscSZzsRew9T1JHPYDVoooAKKKKACvNi5+I3ikRxl/+EP0S4zJuX5NUu1OQFP8AFFGRz2ZwOoWpvEN3qfjTV7nw3oZuLHRLd/K1bVSpQyj+K2tz/eI4aT+EcDJ6dxpOnWmkaZa6dptultZWsYihiToigYAoANVv4tNsXuJctj5UQctI54VQO5Jryu9mjWC7XVLj7OXi/tXxBMVwUtFyUg9EMhH3TzsDA84Ndjretw23mavMTNa2r/ZrG2Rctd3bfL8nqc5QY/2yeBx5xeaVceLfFMfgie6+0xWs0er+K72NcR3EhwYrMD+7gLwT91B1OaAOq+DWn3OoLqnjjV4Wh1HxEyvBA45tbJOIY+emR8xxwSRXpdIqhVCqAFAwAOgFLQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFeX/ABT8M39pfN418KQx3GqW0Hl6hpciAxarbrztYf8APRBkqeTxj2r1CigadndHCeDL+28WfD+2v59GspdNkUTWtrZMHSRcdNpChWB3Aqe4NdBNBe6pokUNq0+hFjtZdiNKkYyMLglVJGMHnHpXB+DlTwL8VtV8J5YaV4gD6zpmc4jm6XEI9uA4A6CvV6nkN5Yht3t1v3X3O6M6bRrK4Nk15GbmWzA8qSViTkY+Y9ieAc4rRooppWMZTlLRvYKwvHdnZah4M1u21VHaxa0lMvlnDgKpbcp7MCAQexArdrlPixcNa/C/xbMhw6aTdbT7+U2KZJifA7xjceKfCFtBq6TR65ZW8BuBN96aORN0M+eh3pycdGDCvRq8m16xXwv4T8I+L7dpYpvD9nb296sfSexZUWVWHfZxIPQqfWvV43WWNZI2DowDKynIIPQigB1FFFABRRRQAUUUUAFFFY+uaRe6jLE9n4h1XSVRSGSzjtmDn1PnQyHP0IoA2KyFH27xCzCQmHTl2bBnBmdckn1whGP981kXPh3U7a3lnn8feI0iiUu7NBp2FAGSf+PWqWheE9WXTlm/4TbxJFJck3Ei/Z7AHc/PObUnOMD8O3SgDu6K5X/hF9X/AOh78Sf9+NO/+RaP+EX1f/oe/En/AH407/5FoA6qiuV/4RfV/wDoe/En/fjTv/kWj/hF9X/6HvxJ/wB+NO/+RaAOqrI124dyum2sjxTToWknQ4+zxD7z5PQ9h789AawdS0TU7C1Mr+OfEzsSEjjWHTt0jnoq5teprE1nQZPDvhbVNY8U+OtcigaHzNQ/cWEiMNu3ywGtTkfwhRgEnpyaAMvxX4mbT7O01zT7aW4uJm/svwppZ6TyMADdsOuMZwT0T/rpXc/DTwgngzwxHYyXDXuozO1zf3rj57mdzlnJ6n0GewFeefDrwJruvXEPjXxH4i1yx1R42h0uJIrMPbWLcoHQwFBIRySqjA49q9E/4RfV/wDoe/En/fjTv/kWgDqqK5X/AIRfV/8Aoe/En/fjTv8A5Fo/4RfV/wDoe/En/fjTv/kWgDqqK5X/AIRfV/8Aoe/En/fjTv8A5Fo/4RfV/wDoe/En/fjTv/kWgDqqK5X/AIRfV/8Aoe/En/fjTv8A5Fo/4RfV/wDoe/En/fjTv/kWgDqq4rxV8TPD3hfWk0rVhqa3khCxCHTp5VlYru2oyqQxx2GcVuaJo99p1xJJeeI9W1ZGXaIryO1VUOfvDyoUOe3JI56Vh+PPCl94g8S+DNQs5bZIdG1Bru4WVmDMhQrhMAgnPqRQA+6+Imj2kVpNeRXtvDdajFpkbzRqmJJIzIGYFsqoUHO4AgjpW3/wkNi97pcFs/2qLUUleK5gdHhAjAJy27vnjAPQ5xXl3iH4X69eXF9cWp0W5MniuLX47e8lkWN4UgMflviNsMWI4wRjv2pNB+FWu6bqGh3y32lQz28usXM8cKs0NvJeKgjSFCvzRoV5DbfpQB6Drvjvw/pHh6+1n+0Ib+zsnijnFhKkzIZJFjXIDccsOvbNdRXzfF8EfFcljqqXF1oaXF5ptpZs0dzKyvLFeRzM5HlKEUohAVRgHA9TX0hQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQB5p8eIJbPwvZeKrCNm1Hw1eR36Mg+bychJ1/3TGxz9K9Htp4rq2iuLd1khlQSI6nIZSMgj8Kh1Syi1LTLuxuFDQ3MLwyAjIKspB/Q1wX7P8AeXc3w2tNO1Nt2oaLPNpM/OcGFyqj/vnbQB6PRRRQAVxXxpyfhV4oRfvSWTxD/gXy/wBa7WuO+LaiTwLdQH/l4ubS3+u+5iX+tAHRahpdtqGh3GlXcYe0uLdraRPVGXaR+RrnvhJqDX/gDS0lbdc2Ctps/r5luxiYn67M/jXYVw/w+hj0zxH420iPjbqY1FR/s3MSsf8AyIstAHcUUUUAFFFR3EghgllIyEUt+QzQBDp9w90k7sECCZ40KnOQp2kn3yDVqsrwrF5PhvTQeWaBZHPqzDcx/Ek1q0AFFFB460AY+ulbq4stLMYkW5fzJgegijwST9W2L/wKtisTRr6LVNVurqBP3KQRJHIRywbL/kQUNbdABRRRQAUUUUAQzW0ElxDcSxq0sG4xu38GRgkfhx+deTWoPxa8bC7csfA3h65IhQ/NHq12uR5noY4z06gn8RWl8U9Vvtb1S1+H/hqRkv8AU4/M1S8jPOn2WcM3++/KqPx9677QNIstA0Wy0rS4RBY2cQhiQdlHr6nuT3NAF+iiigAooooAKKKKACiiigAryTxV4y8SaN8WNU0+CXT30S08Ntqq2kvyu7q0gyGC5LFlC7c7dvPWvW6oXejaXeajb6heabZT39srLBcywK0sQIwQrEZUEE5x60AeH+Mfi1d6p4PuotIlt7e6m8ILrr3FncZktbgyxIYhjpjeevPFXL74wavolprNre2Gm3l9ZSafDDc2sztAv2oNjzieQV2knGN2R92vVIPBfha3jmjt/DWiRRzRNBKqWESh42YMUYBeVLAEg8ZANWLTwxoNlplxptnoml2+nXB3TWsVpGkUh45ZAMHoOo7UAeX6f8TfFt9faHpEOgaVHrOoXF/ATdXLxQ4t44pFk+UOyhll+6QTkdQDmrOn/FXULjxZDbSWGnjS7jWLrRo4Vmb7ZG8CsTLID8oQ7TkcbQQcmvR9N8MaBpbWraZoel2bWpkaA29pHGYS4AcpgDbuCqDjrgZ6VLHoOkR6vLqselWC6pKuyS8FugmdcYwXxuIx70AeD3Hxh1jULG6g1Wzh028R7WZLS3kmimEb3UcW4TDKSp83JUjPTBGcbUXxE8WaWfiBf36adqNhoOpiMWyErNHbZj3FQFG4KjFssScgjpivU7bwd4ZtIZobXw5o0MM7rJKkdjEqyMp3KzALyQeQT0NM13who+r2msxm1is7vV7VrO7v7SKNLl4mXaR5hUk8cc5xQBV+G3iefxhoE+stbRwWE15OmnspO6a2RyiyMD0LFWOPTFdVVHQtKtdD0Wx0rT02WdlAlvEp67VAAz6njk1eoAKKKKACiiigAooooAKKKKACiiigArjvi/4jvfCPw41vXdKEJvbONHjEylkyZFU5AI7E967Gs3xJoWneJdEutI1u3+06ddKFmi3sm4AhhypBHIHQ0AeW+FPHPiC4v/DMWvTXaNqmoPbqh0ZrEMqwGTkSszMuejJjkYqh4G+Md+ngzSbzxbpc0s95pV9qMF5E8YF0bUM8ibF/1fy4wT1r16+8PaZfXmkXV1a+ZPpLmSybzGHlMUKE4Bw3ykjnNYGhfC7wdoQkXTtGASS1ey2z3M1wqwv99FEjsEDZOduM55oA5D4jfFaex8PTLoUMlrqT6RYa1FPIFdUjnu44TGVPVsM3PvWxqPxWt7D4gQeG5dMMsE1+mnC9guVk2TOm5Q6gYXuMFt3GcVetvhB4Htrae3h0QiKeCO2kBvJzujjlWVFyXyMOqnj0x04q9L8N/CsviD+2m0xhqAvV1Hct1Msf2lRgS+WH2bsdTt575oA6LV72ewsjPa6bd6nKGA+z2rRK5B75ldFwP96sL/hKNX/6ETxJ/wB/9O/+Sq6qigDlf+Eo1f8A6ETxJ/3/ANO/+SqP+Eo1f/oRPEn/AH/07/5KrqqKAOV/4SjV/wDoRPEn/f8A07/5Krznwd4j1PR/i54105PCOtldSjt9WjsllsxJGdvlSOSbgIQzKvRieOQK9wrzbxUo0343+CNQj4OqWd7pc3uFVZ0/VW/OgDtdD1O71JJjeaHqOklCAq3r27GTOeV8mWTp746961KKKACuK+Ksu3TNBh/5769p0f5XCt/7LXa1598W5MXvgOAdZvEtt+Sxyv8A+yigD0GvPY2ew+PcyciDVfD6v9ZLecj/ANBmFehVxfiuMQfEPwRfngO95YFv+ukPmAfnBQB2lFFFABTJoxNC8bfddSp+hFPooAy/DLONEtYJ8Ce2X7PKAc/Mny5/HGfoa1KoW9k1vrN3cxkCC6RC6/8ATRcjd+K7R/wEVfoAKpXt2xW6t7F4TfRxB8S52JuJCs2O3yk468dqk1O7TT9OubuQZSCNpCM9cDNc3eI9ze38SwyeVqkkVqOCh8tUJlc5wQMEqPfHrQBd8E2SWujLLHK8y3GHR2GCY1UJHx/uKp/GugpFUIoVAFUDAAGABS0AFFFFABWB478UWXg7wve61qJJjgXEcSjLTSHhI1Hck4Fb9eTRj/hZHxQaUlZ/CHhSUCMdUutSHVs9xEDj03HvQBufCXwvfaPpl3rPiYpJ4r1uT7VqMi9I/wDnnCvoqLgY9c9a72iigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAorm/G3jPSfBdlHea6bxLV92ZYLSSZUAxkuUB2jkcnFZsHxK0WfSrnUorbVPsVvZT37yS2hhJjhUM2Fk2sSQeCBg+tAHbUVzaeM9Im8NnWrKU3kKpC7wW7o00fmldoddwCn5skE9j1rVGs6WdUOmDUrI6iOfsvnr5vTP3M56c9KAL9FFFABRRRQAV5l8WJPs/jT4ZXHTGtND/33A616bXlHx+LQv8Pbtf8Alj4qsgT6Bt4NAHq9FFFABXnXxK/fePfhpa9m1Web/vi1lP8AWvRa4Lxinm/FT4ej/nn/AGhL+UCr/wCz0Ad7XA/F2f7FD4RvckCDxFZhj6LIWiP/AKMrvq8/+PEJf4ZahOvD2k9rdqfTy7iNifyBoA9AooooAKKKKACiiigDF8YMo0GUSttieWFJGPZDKob9M1citml1Rb8zEw+QEii242knLMc9zhR7YPrWf45t1ufDVxFJ9wywFuAeBMhPB47VvAYAyc+9ABRRRQAUUUUAcR8X/E954a8IsNEQTeINSmTT9Mhzy08hwG/4CMt6cc1reAfC9p4O8KWGi2XzCBMzSn700p5eRj3JOTXFeH9njj4x6lrm8vpPhQNpdmucq94w/fyf8BUhK9WoAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKAOX+J3h+68VeANc0PT5II7u+tzFG87EIDkfeIBOOOwNcj4p+HWratLG1tcWChfCd1oR8x3H7+VFCtwp+Tg5PX2NerUUAeAS/BvxDeaFqcMr+H9PvJdN0/TIYbJ5PJlFvcJK88reWD5hCkDCntk961NX+GHiXUPiZba/LdaS9nb65FqMcgkeKVbdU2mLy1j2s/8AtliSAOnSva6KAKWr2U9/ZGC11K70yUsD9otViZwB2xKjrg/7tYX/AAi+r/8AQ9+JP+/Gnf8AyLXVUUAcr/wi+r/9D34k/wC/Gnf/ACLR/wAIvq//AEPfiT/vxp3/AMi11VFAHK/8Ivq//Q9+JP8Avxp3/wAi1538cvDupWvhXTLufxZrl6tvrNi4WeKyAjJmChxst1ORu4ySPUGvbq85/aFXHwj1ucZ3WrW9yCO3l3Ebf0oA3P8AhF9X/wCh78Sf9+NO/wDkWj/hF9X/AOh78Sf9+NO/+Ra6lGDKGHQjIpaAOV/4RfV/+h78Sf8AfjTv/kWuS1nw1qjfEvwzE3jHX3kFjfyrO0NjvjAa3UhQLbbg7hncCeBjHOfV65C5+f4uacP+eOiXLdP708A/9loAl/4RfV/+h78Sf9+NO/8AkWua+JXhPVJPh94j83xlr90qWE0nkSw2ISQqhYA7bZWxkdiD716fWX4ri+0eF9YhIyJLOZMfVCKAMKx8PardWVvcJ478SbZY1kH7jTuhGf8An1qf/hF9X/6HvxJ/3407/wCRatfDu4+1+APDVxnPm6ZbPn6xKa6CgCjo1jcafaGG71S91SQsW8+7WFXA4+XEUaLj8M89avUUUAFFFFAGN4r+fTYrb+K6uYYRj0MgLf8AjoY/hWzTJIo5GjaRFYxtvQkZ2nBGR74J/On0AFFFFABXN/EfxF/wifgbWtaXYZrW3YwKx4eU8Rr75YgYrpK8r8bofF/xX8N+GYpCbDRP+J3qa9VZgdtvGR3Jbc2PQfSgDqPhX4d/4RfwJpVhKG+2vH9pvXb7z3EnzyE/8CJH0ArrKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAK4r42W/2r4R+L4+uNMnk/75Ut/Su1rnfiNF5/w98TxYzv0u5XH1iagDQ8M3H2vw3pNznPnWkUn5oD/WtKuS+Ed0bz4W+Epycs2l2wJ9xGoP6iutoAK4xSG+MjjjMegL/49cN/8TXZ1xFq+741akuT8mgW3H1uJ/8ACgDt6g1CPzbC5j/vxsv5g1PQRkEHvQBw3wOuDc/CHwlITnGnxJ/3yNv9K7mvPP2fjj4SaHEP+WDXEH/fFxIv9K9DoAKKKKACiiigAooooAKKKKAEZgqlmICgZJPavMPgjCurv4n8btyfEWoN9mJ/59ICYovz2sfxFdD8XtW/sP4Y+Jb4Z8xbKSKIDqZJBsQf99MKv/D7Ql8MeCND0UfesrSOJz6vj5j+LEmgDoKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKzPFEJufDOrwDky2cyfmhFadIQGBDAEHgg96APPv2fJfO+DHhRs5xabfydh/SvQqgsbO10+0jtbC3htraMYSGFAiKOvAHAqegArhNMct8bteUgfJoVkB/3+uDXd1welH/i93iIY/5glic/9trigDvKKKKAPPvgWvleAmh/546pqCfldy16DXC/CBDFoOsRHP7vXdSUZ9PtUh/rXdUAFFFFABRRRQAUUUUAFFFFAHlnx+kkn0/who8Qz/aniOyhkHrGrGQ/+givU682+JCC6+Jfwxs25H267uiP+udsxB/NhXpNABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFcTars+NOpE9JdAtsf8AAbib/wCKFdtWcdItT4gXWfnF6LU2f3vlMZcPyPXI6+5oA0aKKKAOV+H2mXWl2utx3kDQ+frN5cxBiDujeUsrceua6qiigAooooAKKKKACiiigAooooA848Zf8lq+HIP3fs+qEf73lxf0zXo9eb/EVxa/E/4ZXbHCm7vLQn/rpbHH6qK9IoAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooA8x+MH/I0fDT/sYF/9EyV6dRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAf/2Q==);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Anterior view of the knee with the patella removed, demonstrating the relationship between the bones, menisci, and major ligaments.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_59_23476=[""].join("\n");
var outline_f22_59_23476=null;
var title_f22_59_23477="Causes of seasonal allergies PI";
var content_f22_59_23477=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F77269&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F77269&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 517px\">",
"   <div class=\"ttl\">",
"    Common causes of seasonal allergies",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 497px; height: 457px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_59_23477=[""].join("\n");
var outline_f22_59_23477=null;
var title_f22_59_23478="Necrotizing periodontal dis";
var content_f22_59_23478=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F58606&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F58606&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Necrotizing periodontal disease",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 427px; height: 575px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Presence of alveolar bone sequestrum 35 year-old Caucasian male HIV-positive.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_59_23478=[""].join("\n");
var outline_f22_59_23478=null;
var title_f22_59_23479="Mechanism for medial condyle elbow fracture";
var content_f22_59_23479=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F65109&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F65109&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 584px\">",
"   <div class=\"ttl\">",
"    Medial condyle fracture mechanisms of injury",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 564px; height: 598px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Panel A) A direct force applied to the posterior aspect of the elbow causes the sharp articular margin of the olecranon to wedge the medial condyle from the distal humerus. Panel B) Falling on the outstretched arm with the elbow extended and the wrist dorsiflexed causes the medial condyle to be avulsed by both ligamentous and muscular forces.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Beaty JH, Kasser JR. The elbow: Physeal fractures, apophyseal injuries of the distal humerus, avascular necrosis of the trochlea, and T-condylar fractures. In: Rockwood and Wilkins' Fractures in Children, 5th ed, Beaty JH, Kasser JR (Eds), Lippincott Williams &amp; Wilkins 2001.&nbsp;Copyright &copy; 2001 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_59_23479=[""].join("\n");
var outline_f22_59_23479=null;
var title_f22_59_23480="Catamenial epilepsy";
var content_f22_59_23480=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Catamenial epilepsy",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/59/23480/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/59/23480/contributors\">",
"     Sabiha Merchant, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/59/23480/contributors\">",
"     Cynthia L Harden, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/59/23480/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/59/23480/contributors\">",
"     Timothy A Pedley, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/59/23480/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/59/23480/contributors\">",
"     Janet L Wilterdink, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?22/59/23480/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 28, 2011.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION AND DEFINITION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Catamenial epilepsy refers to a pattern of seizure clustering that is related to the menstrual cycle [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23480/abstract/1\">",
"     1",
"    </a>",
"    ]. It does not describe a seizure localization, seizure type, or epilepsy syndrome. Catamenial seizure clusters have been described with every seizure type and epilepsy syndrome.",
"   </p>",
"   <p>",
"    The definition of catamenial epilepsy has varied among investigators. The most accepted criterion requires a doubling of a baseline seizure frequency during a specific phase of the menstrual cycle [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23480/abstract/1-4\">",
"     1-4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This topic will discuss specific aspects of seizures and epilepsy that relate to a catamenial pattern of seizure clustering. Other aspects of seizures and epilepsy are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/39/40570?source=see_link\">",
"     \"Overview of the management of epilepsy in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/4/31818?source=see_link\">",
"     \"Initial treatment of epilepsy in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/32/37385?source=see_link\">",
"     \"Pathophysiology of seizures and epilepsy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The reported prevalence of catamenial clustering among women with epilepsy varies widely between 10 to 78 percent. This is mainly due to methodological differences among studies, which have used different patient populations, various criterion for diagnosis, and different recording mechanisms to link seizures with menstrual cycle phases [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23480/abstract/2,5\">",
"     2,5",
"    </a>",
"    ]. In studies that used the above definition, and rigorous recording methods, approximately one-third of women with medically refractory epilepsy have a catamenial pattern of exacerbations [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23480/abstract/2,6,7\">",
"     2,6,7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    While catamenial epilepsy necessarily affects women of child-bearing age, no other demographic features or other risk factors have been clearly defined for this phenomenon. One study found that a catamenial pattern was more common in the younger half (median age 40 years) of their population of 100 women of childbearing age with intractable focal epilepsy [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23480/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     PATHOPHYSIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Among the theories regarding the pathogenesis of catamenial seizures, those implicating cyclical changes in hormones are the best established.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     The normal menstrual cycle",
"    </span>",
"    &nbsp;&mdash;&nbsp;The hormonal fluctuations of the normal menstrual cycle are depicted in the Figure (",
"    <a class=\"graphic graphic_figure graphicRef62189 \" href=\"UTD.htm?14/16/14601\">",
"     figure 1",
"    </a>",
"    ) and are described in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/2/27685?source=see_link\">",
"     \"Physiology of the normal menstrual cycle\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In summary, the average time interval between menstrual periods is 28 days, however cycles between 24 to 35 days are considered normal. The menstrual cycle numbering begins on day 1 of a 28-day cycle, which is the first day of menses. Ovulation occurs on day 14. The follicular phase (days 1 to 13) is the time period that precedes ovulation during which the ovarian follicles grow in size and have increasing number of follicular receptors. The follicle with the maximum number of follicular receptors is named the dominant follicle and is the ovulatory follicle. Ovulation consists of the gradual release of the oocyte, on day 14. The rest of the follicles gradually degenerate. Following ovulation is the luteal phase (day 14 to 28). The dominant follicle goes on to form the corpus luteum and is responsible for progesterone release. Progesterone levels are higher during the luteal phase than the follicular phase and decrease rapidly in the several days prior to menses (",
"    <a class=\"graphic graphic_figure graphicRef62189 \" href=\"UTD.htm?14/16/14601\">",
"     figure 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Inadequate luteal phase cycles",
"    </span>",
"    &nbsp;&mdash;&nbsp;Abnormal follicle simulating hormone (FSH) secretion leads to poor follicular development and a poorly developed and functioning corpus luteum that has impaired progesterone production. Ovulation does not occur. Estrogen secretion is unaffected. This condition is termed inadequate luteal phase (ILP) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23480/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Etiologies of inadequate luteal phase cycles include defects in the hypothalamic pituitary axis, primary ovarian defects, and defects in luteal cell steroidogenesis. Menstrual cycles with varying durations, unusually short or long, may result [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23480/abstract/10\">",
"     10",
"    </a>",
"    ]. ILP cycles are may occur in as many as 29 percent of women but are an uncommon cause of infertility [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23480/abstract/11\">",
"     11",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?3/18/3367?source=see_link&amp;anchor=H18439229#H18439229\">",
"     \"Causes of female infertility\", section on 'Luteal phase defect'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    ILP cycles occur more frequently in women with epilepsy than in healthy control women [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23480/abstract/12,13\">",
"     12,13",
"    </a>",
"    ]. Idiopathic generalized epilepsy syndrome and use of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?25/11/25785?source=see_link\">",
"     valproate",
"    </a>",
"    are risk factors for ILP cycles in women with epilepsy [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23480/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Hormonal influences on seizure occurrence",
"    </span>",
"    &nbsp;&mdash;&nbsp;Both direct and indirect evidence suggest that catamenial seizure patterns result from cyclic changes in hormone production during the menstrual cycle. Hormones appear to influence seizure occurrence by multiple mechanisms including direct membrane-mediated short latency effects, receptor-mediated post-transcriptional intermediate latency effects, and receptor-mediated long latency genomic effects [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23480/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In most patients with catamenial seizure clustering, seizures appear to occur at times of the menstrual cycle when there a lower ratio of progesterone to estrogen, either in the premenstrual period, at ovulation, or during anovulatory or ILP cycles, when progesterone production is impaired [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23480/abstract/14\">",
"     14",
"    </a>",
"    ]. Some studies have found a positive correlation between seizure occurrence and a higher estrogen to progesterone ratio [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23480/abstract/10,14,15\">",
"     10,14,15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In laboratory experiments, estrogens appear to have excitatory neuronal effects, reducing the threshold to electroshock and facilitating kindling in rats [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23480/abstract/16,17\">",
"     16,17",
"    </a>",
"    ]. Estrogen appears to enhance glutamate-mediated excitatory transmission and decrease gamma-amino-butyric acid (GABA) mediated inhibition [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23480/abstract/1,3,18,19\">",
"     1,3,18,19",
"    </a>",
"    ]. Intravenous estrogen administration administered to 16 women with epilepsy was associated with epileptiform activity on EEG in 11 and provoked clinical seizure in four [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23480/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In contrast, progesterone's effects appear to be anticonvulsant [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23480/abstract/21\">",
"     21",
"    </a>",
"    ]. In animal studies, progesterone elevates seizure threshold and suppresses kindling [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23480/abstract/3,22\">",
"     3,22",
"    </a>",
"    ]. Women with catamenial epilepsy were found to have lower progesterone levels in the relevant phase of their cycle compared to similarly timed levels in healthy control patients [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23480/abstract/6,23\">",
"     6,23",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Progesterone's anticonvulsant effects appear to be largely mediated by the anticonvulsant properties of its metabolites. Inhibition of progesterone metabolism appeared in one case report to exacerbate catamenial epilepsy [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23480/abstract/24\">",
"     24",
"    </a>",
"    ]. One metabolite in particular, allopregnanolone, enhances neuronal inhibitory responses to the neurotransmitter GABA by acting on a specific steroid recognition site on the",
"    <span class=\"nowrap\">",
"     GABA/benzodiazepine",
"    </span>",
"    receptor-chloride ionophore complex [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23480/abstract/25-27\">",
"     25-27",
"    </a>",
"    ]. Allopregnanolone has targeted, distinct binding sites on GABA-A receptors that are distinct from those for GABA, benzodiazepines, and barbiturates. Normal physiological levels of allopregnanolone are sufficient to activate these receptors. This suggests that an acute \"withdrawal\" of allopregnanolone at the onset of menstruation could decrease this inhibitory effect and thereby potentiate seizures [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23480/abstract/28\">",
"     28",
"    </a>",
"    ]. The development of an animal model of catamenial epilepsy based on abrupt progesterone withdrawal after previous induction of high levels provides additional support for this potential mechanism of catamenial epilepsy [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23480/abstract/29,30\">",
"     29,30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other adrenal-derived and androgenic neurosteroids are also being evaluated for their potential role in catamenial epilepsy [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23480/abstract/31-34\">",
"     31-34",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Changes in circulating hormone levels may also bring about changes in seizure frequency during perimenopause and menopause. While data has not been entirely consistent, there appears to be a relative increase in seizure frequency during in the transition to menopause (when estradiol concentrations are maintained relative to decreasing progesterone levels) and a decrease in seizures after menopause (when both estradiol and progesterone levels are low) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23480/abstract/15,35-38\">",
"     15,35-38",
"    </a>",
"    ]. These changes in seizure frequency during the transition to menopause appear to be more frequently observed in women with catamenial epilepsy than in women whose seizures occurred randomly. Hormone replacement therapy was shown to increase seizure frequency in postmenopausal women, particularly in those women with catamenial epilepsy [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23480/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Changes in antiepileptic drug metabolism",
"    </span>",
"    &nbsp;&mdash;&nbsp;Another factor that could contribute to the development of catamenial seizures is cyclical alterations in antiepileptic drug (AED) levels. The decrease in circulating estrogen and progesterone premenstrually may induce hepatic isoenzymes utilized for AED metabolism. This may lower the levels of circulating AEDs and increase the risk of breakthrough seizures [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23480/abstract/40\">",
"     40",
"    </a>",
"    ]. Some studies have found cyclical lowering of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/48/35594?source=see_link\">",
"     phenytoin",
"    </a>",
"    and other AED levels in women with catamenial seizures [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23480/abstract/23,40-42\">",
"     23,40-42",
"    </a>",
"    ]. However, such changes have not been consistently observed [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23480/abstract/43\">",
"     43",
"    </a>",
"    ]. It is unclear what role altered AED metabolism plays in cyclical seizure exacerbations [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23480/abstract/4,6\">",
"     4,6",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     CLINICAL FEATURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Symptoms of perimenstrual syndrome are not any more or less prevalent in women with catamenial epilepsy compared with other women [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23480/abstract/6,44\">",
"     6,44",
"    </a>",
"    ]. No other systemic symptoms have been identified.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Epilepsy syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;Catamenial tendencies may be more common among women with focal epilepsy compared with those who have generalized epilepsy, but can occur across epilepsy types [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23480/abstract/2,4,6,14,45,46\">",
"     2,4,6,14,45,46",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In one study of 100 women with intractable focal epilepsy, catamenial seizure patterns were more common in those with left-sided temporal lobe epilepsy, while seizure patterns appeared to be random in those with right-sided temporal lobe epilepsy as well as in those with extratemporal or multifocal epileptic foci [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23480/abstract/8\">",
"     8",
"    </a>",
"    ]. This appears to confirm the results of a previous study that also found that catamenial epilepsy was more likely to occur with underlying left rather than right-sided temporal epilepsy (37 versus 7 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23480/abstract/47\">",
"     47",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Catamenial seizure patterns",
"    </span>",
"    &nbsp;&mdash;&nbsp;The predominant seizure pattern in women with catamenial epilepsy is an increase in seizures beginning immediately prior to or during menses. Some women have seizures that occur in a cyclic manner during other phases of the menstrual cycle. In one study evaluating seizure diaries and midluteal progesterone levels in 184 women with intractable epilepsy, three patterns of catamenial clustering emerged [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23480/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The perimenstrual (C1) pattern was the most frequently observed pattern and was defined as maximal seizure frequency during the menstrual phase (days 25 to 3) compared to the midfollicular (days 4 to 9) and midluteal (days 16 to 24) phases of the menstrual cycles.",
"     </li>",
"     <li>",
"      The periovulatory (C2) pattern was the second most frequently observed pattern and was characterized as maximal seizure frequency during the ovulatory phase (days 10 to 13) compared to the midfollicular and midluteal phases in ovulatory cycles.",
"     </li>",
"     <li>",
"      In the luteal (C3) pattern, maximal seizure frequency occurred during the ovulatory, midluteal, and menstrual phases than during the midfollicular phase in women with ILP cycles; this was the third most frequently observed pattern.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    During ovulatory cycles, most women had either perimenstrual or periovulatory seizure exacerbations, and during anovulatory or inadequate luteal phase cycles, most women exhibited an increase of seizures in the luteal phase. However, catamenial seizures can also occur during the luteal phase in ovulatory cycles in association with high midluteal estradiol to progesterone ratios [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23480/abstract/48\">",
"     48",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    These patterns of seizure exacerbation seem to be explained by the neurophysiologic effects of estrogen and progesterone as they surge and withdraw throughout the menstrual cycle (see",
"    <a class=\"local\" href=\"#H6\">",
"     'Hormonal influences on seizure occurrence'",
"    </a>",
"    above).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of catamenial epilepsy is established by careful record keeping of menstrual cycles, characterization of the cycle, and seizure diaries. At least two, preferably three or more, cycles should be recorded. If the seizure frequency doubles during the perimenstrual, periovulatory, or entire luteal phase compared to other days as described in the above, the patient may be considered to have catamenial seizure exacerbations.",
"   </p>",
"   <p>",
"    It may be more challenging to make the diagnosis in the setting of a luteal pattern of seizures. Ovulation occurrence (or its absence) can be assessed by documentation of regular periods and presence of premenstrual symptoms, dysmenorrhea and basal body temperature charts. An increase in basal body temperature is due to the presence of progesterone in the post-ovulatory period. A more definitive method is to determine progesterone levels measured between days 18 to 24 of the menstrual cycle. A progesterone level lower than 5",
"    <span class=\"nowrap\">",
"     ng/mL",
"    </span>",
"    generally indicates an anovulatory cycle. However, progesterone levels can fluctuate and a single abnormal value does not reliably indicated ILP cycle. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/6/26724?source=see_link&amp;anchor=H5#H5\">",
"     \"Evaluation of the menstrual cycle and timing of ovulation\", section on 'Serum progesterone concentration'",
"    </a>",
"    .) In addition, some women have both ovulatory and anovulatory cycles, and thus analysis of multiple cycles may be required [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23480/abstract/49\">",
"     49",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Establishment of a catamenial pattern of epilepsy does not preclude the need for other investigations to determine the underline epilepsy syndrome and identify relevant pathology. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/9/25753?source=see_link\">",
"     \"Evaluation of the first seizure in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/52/2890?source=see_link\">",
"     \"Evaluation and management of drug-resistant epilepsy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is no specific treatment shown to be effective in a women with catamenial epilepsy. Patients should be managed with AEDs appropriate to their seizure type as are other patients with epilepsy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/4/31818?source=see_link\">",
"     \"Initial treatment of epilepsy in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?2/52/2890?source=see_link\">",
"     \"Evaluation and management of drug-resistant epilepsy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/39/40570?source=see_link\">",
"     \"Overview of the management of epilepsy in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Acetazolamide",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?5/39/5752?source=see_link\">",
"     Acetazolamide",
"    </a>",
"    at a dose of 250 to 500 mg daily for three to seven days prior to the onset of menses has been used in the treatment of catamenial epilepsy, based on anecdotal reports of efficacy [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23480/abstract/50-52\">",
"     50-52",
"    </a>",
"    ]. The mechanism of action for acetazolamide's anticonvulsant effect has been postulated to be due to the production of metabolic acidosis; however, seizure frequency and bicarbonate levels do not appear to correlate [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23480/abstract/3,53\">",
"     3,53",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The efficacy of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?5/39/5752?source=see_link\">",
"     acetazolamide",
"    </a>",
"    given either perimenstrually or continuously was evaluated retrospectively in a nonrandomized cohort of women with catamenial epilepsy [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23480/abstract/52\">",
"     52",
"    </a>",
"    ]. Forty percent of women reported a 50 percent or greater reduction in seizure frequency. The effects appeared similar for those with generalized versus partial epilepsy and temporal versus extratemporal epilepsy.",
"   </p>",
"   <p>",
"    The initial recommended dose of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?5/39/5752?source=see_link\">",
"     acetazolamide",
"    </a>",
"    is 4",
"    <span class=\"nowrap\">",
"     mg/kg,",
"    </span>",
"    with a therapeutic dose range of 8 to 30",
"    <span class=\"nowrap\">",
"     mg/kg/day",
"    </span>",
"    in one to four divided doses, not to exceed 1 g per day. Adverse effects include paresthesias, drowsiness, ataxia, nausea, vomiting, malaise, anorexia, fatigue, diuresis, intermittent dyspnea, depression, hyperchloremic metabolic acidosis, dysgeusia, renal calculi, growth suppression in children, and aplastic anemia. Tolerance is a reported side effect; alternate day or cycling doses for several days around the time of seizure exacerbation may help reduce the development of tolerance [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23480/abstract/54\">",
"     54",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Intermittent benzodiazepines",
"    </span>",
"    &nbsp;&mdash;&nbsp;While benzodiazepines are broad spectrum AEDs, their use for epilepsy is limited by habituation and tolerance. Intermittent dosing according to the menstrual cycle phase may limit the tolerance that develops with continuous dosing.",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?39/49/40727?source=see_link\">",
"     Clobazam",
"    </a>",
"    (not available in the U.S.) is the only benzodiazepine studied systematically for the treatment catamenial epilepsy. In a double-blind cross-over study, clobazam (20 to 30",
"    <span class=\"nowrap\">",
"     mg/day)",
"    </span>",
"    was administered for 10 days in the high risk phase of the menstrual cycle in 18 women with catamenial epilepsy [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23480/abstract/55\">",
"     55",
"    </a>",
"    ]. Fourteen patients reported better seizure control with clobazam than placebo. Long term follow-up of patients who continued to use this treatment strategy revealed seizure remission",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    significant reduction of seizures in five of nine patients [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23480/abstract/56\">",
"     56",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    These limited results support a fairly common practice of treating catamenial seizure exacerbations with intermittent benzodiazepines with a long-acting agent such as",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/8/8329?source=see_link\">",
"     lorazepam",
"    </a>",
"    . A reasonable dose of lorazepam in this setting is 0.5 to 2 mg two to three times daily.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Modification of AED regimen",
"    </span>",
"    &nbsp;&mdash;&nbsp;Because there is some evidence that AED levels may decrease premenstrually due to endogenous metabolic effects, a reasonable treatment strategy may be to intermittently increase AED doses slightly at susceptible times of the month. This treatment approach should be used for patients who can manage a somewhat complicated treatment regimen, whose current AED dose allows for slight increases, and for AEDs with predictable pharmacokinetics and a linear dose-level relationship (thus",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/48/35594?source=see_link\">",
"     phenytoin",
"    </a>",
"    is not a good option for this approach).",
"   </p>",
"   <p>",
"    <a class=\"drug drug_general\" href=\"UTD.htm?6/28/6602?source=see_link\">",
"     Lamotrigine",
"    </a>",
"    may be a particularly effective AED for catamenial epilepsy according to some uncontrolled observations [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23480/abstract/4,54\">",
"     4,54",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Hormonal therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;While hormonal therapy holds promise for the management of women with catamenial epilepsy, controlled studies of its effectiveness are lacking. The use of hormonal agents is complicated by drug interactions with many AEDs, most notably the enzyme-inducing AEDs, which can lead to enhanced metabolism of both estrogen and progesterone. Hormonal therapy may also increase the clearance of the AED",
"    <a class=\"drug drug_general\" href=\"UTD.htm?6/28/6602?source=see_link\">",
"     lamotrigine",
"    </a>",
"    . (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/61/43994?source=see_link&amp;anchor=H5#H5\">",
"     \"Pharmacology of antiepileptic drugs\", section on 'Lamotrigine'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h3\">",
"     Medroxyprogesterone acetate",
"    </span>",
"    &nbsp;&mdash;&nbsp;",
"    <a class=\"drug drug_general\" href=\"UTD.htm?1/24/1417?source=see_link\">",
"     Medroxyprogesterone acetate",
"    </a>",
"    (MPA) is a synthetic progestin-only contraceptive agent that suppresses normal ovulatory functioning. It is not metabolized to allopregnanolone, and its mechanism of action toward reducing seizure frequency may be related to progesterone effects alone [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23480/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Support for MPA use in catamenial epilepsy comes from uncontrolled observational reports [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23480/abstract/57,58\">",
"     57,58",
"    </a>",
"    ]. In one study of 14 women with uncontrolled seizures (not clearly with catamenial clustering), depot injections of MPA every 6 to 12 weeks were associated with an overall reduction in seizure frequency of 39 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23480/abstract/58\">",
"     58",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The usual dose of depot MPA is 150 mg intramuscularly every 12 weeks. Patients taking enzyme-inducing AEDs may require a higher dose of MPA or more frequent dosing to maintain its effectiveness, but contraception failure is rarely observed in this setting, and serum AED levels were not affected in the above study. Side effects are common, and there is a 3 to 12 month delay in resumption of menses after treatment ends. Consultation with a gynecologist is recommended prior to use of MPA. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/45/34522?source=see_link&amp;anchor=H7898336#H7898336\">",
"     \"Depot medroxyprogesterone acetate for contraception\", section on 'Drug interactions'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Natural progesterone",
"    </span>",
"    &nbsp;&mdash;&nbsp;Natural progesterone is metabolized to the neurosteroid, allopregnanolone, which is thought to be responsible for its anticonvulsant activity. The efficacy of natural progesterone for catamenial epilepsy has been evaluated in observational case series.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In one study, eight women with a diagnosis of temporal lobe epilepsy and ILP cycles were treated with vaginal progesterone suppositories in doses that ranged from 50 to 400 mg (dose adjusted to achieve target midluteal progesterone level) every 12 hours during days 15 to 28 [",
"      <a class=\"abstract\" href=\"UTD.htm?22/59/23480/abstract/59\">",
"       59",
"      </a>",
"      ]. AED levels were also measured during and after progesterone use and dose adjustments were made to maintain therapeutic levels. The average monthly seizure frequency decreased by 68 percent during the three-month treatment period; six women had fewer seizures.",
"     </li>",
"     <li>",
"      Another study evaluated oral progesterone 200 mg three times daily in 25 women with temporal lobe epilepsy and either perimenstrual seizures or ILP cycles [",
"      <a class=\"abstract\" href=\"UTD.htm?22/59/23480/abstract/60\">",
"       60",
"      </a>",
"      ]. Patients were treated during the period of exacerbation with doses adjusted to attain normal midluteal progesterone levels. After three months, 18 women (72 percent) experienced a decline in seizure frequency. Overall, the average daily seizure frequency of complex partial and secondary generalized motor seizures declined by 54 and 58 percent. Women with ILP cycles experienced a greater reduction in average daily seizure frequency compared to women with perimenstrual seizures (59 versus 49 percent). Among 15 women who continued treatment with progesterone and their original AED, the mean reductions in focal and generalized seizures at a three-year follow-up period was 62 and 74 percent, respectively, and three women were seizure-free [",
"      <a class=\"abstract\" href=\"UTD.htm?22/59/23480/abstract/61\">",
"       61",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Treatment is well tolerated; a few patients in each study experienced transient fatigue and depression [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23480/abstract/59,60\">",
"     59,60",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    These results are promising for the use of natural progesterone as a treatment for catamenial seizure exacerbations, and a randomized, double-blind, placebo-controlled trial is underway.",
"   </p>",
"   <p>",
"    Natural progesterone, trade name Prometrium&reg;, is available by prescription in 100 mg and 200 mg tablets. It is FDA-approved for obstetrical and gynecological uses, not for the treatment of epilepsy. However, natural progesterone is an off-label treatment option for catamenial epilepsy, particularly for women with ILP cycles and is usually given during the luteal phase at 100-200 mg twice daily or three times daily, based on a combination of clinical response",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    midluteal serum progesterone levels of 20 to 40",
"    <span class=\"nowrap\">",
"     ng/ml",
"    </span>",
"    and tapered off at the onset of menses. A sample regimen is [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23480/abstract/62\">",
"     62",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      200 mg twice daily for days 15 to 25",
"     </li>",
"     <li>",
"      100 mg twice daily for days 26, 27",
"     </li>",
"     <li>",
"      50 mg twice daily for day 28, then discontinue",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Others",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Oral contraceptive pills appear to help some women in isolated case reports, but have not been systematically studied. Progestin-only contraceptive therapy appeared to be helpful in one case series [",
"      <a class=\"abstract\" href=\"UTD.htm?22/59/23480/abstract/63\">",
"       63",
"      </a>",
"      ], but not in another [",
"      <a class=\"abstract\" href=\"UTD.htm?22/59/23480/abstract/64\">",
"       64",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?23/22/23909?source=see_link\">",
"       Clomiphene",
"      </a>",
"      , an estrogen receptor analog used to treat infertility due to oligoanovulation or anovulation, reduced seizures by 50 percent in 10 of 12 women with refractory epilepsy and menstrual disorders [",
"      <a class=\"abstract\" href=\"UTD.htm?22/59/23480/abstract/65\">",
"       65",
"      </a>",
"      ]. However, this drug is associated with a number of adverse effects and prolonged treatment is generally not recommended. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?9/25/9626?source=see_link\">",
"       \"Ovulation induction with clomiphene citrate\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The gonadotropin analog,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?9/11/9398?source=see_link\">",
"       triptorelin",
"      </a>",
"      , was evaluated in 10 women with refractory perimenstrual seizures and amenorrhea [",
"      <a class=\"abstract\" href=\"UTD.htm?22/59/23480/abstract/66\">",
"       66",
"      </a>",
"      ]. Three women became seizure free; an additional four had reduced seizure frequency. A case report suggested efficacy of another gonadotropin analog,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?9/22/9574?source=see_link\">",
"       goserelin",
"      </a>",
"      , in a woman with recurrent catamenial episodes of status epilepticus [",
"      <a class=\"abstract\" href=\"UTD.htm?22/59/23480/abstract/67\">",
"       67",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Other \"neuroactive\" steroids are under investigation in the treatment of catamenial epilepsy [",
"      <a class=\"abstract\" href=\"UTD.htm?22/59/23480/abstract/3,4\">",
"       3,4",
"      </a>",
"      ]. Ganaxolone, a synthetic analog of allopregnanolone, has had promising results in pilot and phase II studies [",
"      <a class=\"abstract\" href=\"UTD.htm?22/59/23480/abstract/22,31,68\">",
"       22,31,68",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Longitudinal follow-up studies in women with catamenial epilepsy are limited. Some retrospective data suggest that seizure frequency decreases after menopause in these patients, but may increase during perimenopause [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23480/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Catamenial epilepsy refers to a clustering of seizures during a specific phase of a woman's menstrual cycle. Definitions vary, but one criterion requires that there is a doubling of seizure frequency during a specific menstrual phase.",
"     </li>",
"     <li>",
"      Approximately one-third of women with refractory epilepsy have a catamenial pattern of seizure exacerbations. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Catamenial seizures are most often described in women with partial epilepsy, but any epilepsy syndrome may be affected. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Clinical features'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Most women with catamenial epilepsy experience exacerbations during the perimenstrual phase. Other women experience increased seizure frequency during the periovulatory phase. Women with anovulatory or inadequate luteal phase cycles may have a pattern of seizure exacerbation during the ovulatory, midluteal, and menstrual phases. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Catamenial seizure patterns'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Catamenial seizure exacerbation is believed to be explained in part by cyclical fluctuations of hormone levels, specifically a low progesterone to estrogen ratio. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Pathophysiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Women with catamenial epilepsy should be treated with standard approaches. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?31/4/31818?source=see_link\">",
"       \"Initial treatment of epilepsy in adults\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?39/39/40570?source=see_link\">",
"       \"Overview of the management of epilepsy in adults\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Women with uncontrolled seizure may benefit from careful documentation of their seizures and menstrual cycle over a few months to establish a pattern of catamenial epilepsy that may respond to specific therapies. For women who appear to have a luteal pattern of seizure exacerbations, further testing to establish anovulatory or inadequate luteal phase cycles may be helpful. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For women with uncontrolled catamenial seizures, despite standard antiepileptic drug treatment, we suggest treatment trials with",
"      <a class=\"drug drug_general\" href=\"UTD.htm?5/39/5752?source=see_link\">",
"       acetazolamide",
"      </a>",
"      , intermittent benzodiazepines, intermittent increase in AED doses, or natural progesterone supplementation (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Management'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      We typically try intermittent benzodiazepines, AED dose modification, or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?5/39/5752?source=see_link\">",
"       acetazolamide",
"      </a>",
"      first in patients with perimenstrual or periovulatory patterns of seizures, while a trial of hormonal therapies may be prioritized in women with an ILP cycle pattern of seizures. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Hormonal therapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Use of intramuscular medroxyprogesterone is another potentially efficacious treatment option that requires the oversight of a gynecologist due to its potential side effects. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Medroxyprogesterone acetate'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Other treatment options for intractable epilepsy also apply to women with catamenial epilepsy. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?2/52/2890?source=see_link\">",
"       \"Evaluation and management of drug-resistant epilepsy\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23480/abstract/1\">",
"      Herzog AG. Catamenial epilepsy: definition, prevalence pathophysiology and treatment. Seizure 2008; 17:151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23480/abstract/2\">",
"      Herzog AG, Klein P, Ransil BJ. Three patterns of catamenial epilepsy. Epilepsia 1997; 38:1082.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23480/abstract/3\">",
"      Foldvary-Schaefer N, Falcone T. Catamenial epilepsy: pathophysiology, diagnosis, and management. Neurology 2003; 61:S2.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23480/abstract/4\">",
"      Reddy DS. The role of neurosteroids in the pathophysiology and treatment of catamenial epilepsy. Epilepsy Res 2009; 85:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23480/abstract/5\">",
"      Duncan S, Read CL, Brodie MJ. How common is catamenial epilepsy? Epilepsia 1993; 34:827.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23480/abstract/6\">",
"      El-Khayat HA, Soliman NA, Tomoum HY, et al. Reproductive hormonal changes and catamenial pattern in adolescent females with epilepsy. Epilepsia 2008; 49:1619.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23480/abstract/7\">",
"      Herzog AG, Harden CL, Liporace J, et al. Frequency of catamenial seizure exacerbation in women with localization-related epilepsy. Ann Neurol 2004; 56:431.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23480/abstract/8\">",
"      Quigg M, Smithson SD, Fowler KM, et al. Laterality and location influence catamenial seizure expression in women with partial epilepsy. Neurology 2009; 73:223.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23480/abstract/9\">",
"      Sherman BM, Korenman SG. Measurement of serum LH, FSH, estradiol and progesterone in disorders of the human menstrual cycle: the inadequate luteal phase. J Clin Endocrinol Metab 1974; 39:145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23480/abstract/10\">",
"      Herzog AG, Friedman MN. Menstrual cycle interval and ovulation in women with localization-related epilepsy. Neurology 2001; 57:2133.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23480/abstract/11\">",
"      Jones GS. The luteal phase defect. Fertil Steril 1976; 27:351.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23480/abstract/12\">",
"      Morrell MJ, Giudice L, Flynn KL, et al. Predictors of ovulatory failure in women with epilepsy. Ann Neurol 2002; 52:704.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23480/abstract/13\">",
"      Cummings LN, Giudice L, Morrell MJ. Ovulatory function in epilepsy. Epilepsia 1995; 36:355.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23480/abstract/14\">",
"      Herzog AG, Fowler KM, Sperling MR, et al. Variation of seizure frequency with ovulatory status of menstrual cycles. Epilepsia 2011; 52:1843.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23480/abstract/15\">",
"      Abbasi F, Krumholz A, Kittner SJ, Langenberg P. Effects of menopause on seizures in women with epilepsy. Epilepsia 1999; 40:205.",
"     </a>",
"    </li>",
"    <li>",
"     Backstrom, T, Landgren, S, Zetterlund, B , et al. Effects of ovarian steroid hormones on brain excitability and their relation to epilepsy seizure variation during the menstrual cycle. In: Advances in epileptology: XVth epilepsy international symposium, Porter, RJ (Ed). Raven press, New York 1984. p.269.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23480/abstract/17\">",
"      Buterbaugh GG. Estradiol replacement facilitates the acquisition of seizures kindled from the anterior neocortex in female rats. Epilepsy Res 1989; 4:207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23480/abstract/18\">",
"      Morrell MJ. Epilepsy in women: the science of why it is special. Neurology 1999; 53:S42.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23480/abstract/19\">",
"      Smith SS, Woolley CS. Cellular and molecular effects of steroid hormones on CNS excitability. Cleve Clin J Med 2004; 71 Suppl 2:S4.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23480/abstract/20\">",
"      LOGOTHETIS J, HARNER R, MORRELL F, TORRES F. The role of estrogens in catamenial exacerbation of epilepsy. Neurology 1959; 9:352.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23480/abstract/21\">",
"      Selye, H. The antagonism between anesthetic steroid hormones and pentamethylenetetrazol (Metrazol). J Lab Clin Med 1942; 27:1051.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23480/abstract/22\">",
"      Reddy DS, Rogawski MA. Neurosteroid replacement therapy for catamenial epilepsy. Neurotherapeutics 2009; 6:392.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23480/abstract/23\">",
"      Rociszewska D, Buntner B, Guz I, Zawisza L. Ovarian hormones, anticonvulsant drugs, and seizures during the menstrual cycle in women with epilepsy. J Neurol Neurosurg Psychiatry 1986; 49:47.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23480/abstract/24\">",
"      Herzog AG, Frye CA. Seizure exacerbation associated with inhibition of progesterone metabolism. Ann Neurol 2003; 53:390.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23480/abstract/25\">",
"      Reddy DS, Castaneda DC, O'Malley BW, Rogawski MA. Anticonvulsant activity of progesterone and neurosteroids in progesterone receptor knockout mice. J Pharmacol Exp Ther 2004; 310:230.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23480/abstract/26\">",
"      Majewska MD, Harrison NL, Schwartz RD, et al. Steroid hormone metabolites are barbiturate-like modulators of the GABA receptor. Science 1986; 232:1004.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23480/abstract/27\">",
"      Peters JA, Kirkness EF, Callachan H, et al. Modulation of the GABAA receptor by depressant barbiturates and pregnane steroids. Br J Pharmacol 1988; 94:1257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23480/abstract/28\">",
"      Smith SS, Gong QH, Hsu FC, et al. GABA(A) receptor alpha4 subunit suppression prevents withdrawal properties of an endogenous steroid. Nature 1998; 392:926.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23480/abstract/29\">",
"      Reddy DS, Rogawski MA. Enhanced anticonvulsant activity of neuroactive steroids in a rat model of catamenial epilepsy. Epilepsia 2001; 42:337.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23480/abstract/30\">",
"      Reddy DS, Kim HY, Rogawski MA. Neurosteroid withdrawal model of perimenstrual catamenial epilepsy. Epilepsia 2001; 42:328.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23480/abstract/31\">",
"      Reddy DS. Role of neurosteroids in catamenial epilepsy. Epilepsy Res 2004; 62:99.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23480/abstract/32\">",
"      Scharfman HE, MacLusky NJ. The influence of gonadal hormones on neuronal excitability, seizures, and epilepsy in the female. Epilepsia 2006; 47:1423.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23480/abstract/33\">",
"      Tuveri A, Paoletti AM, Orr&ugrave; M, et al. Reduced serum level of THDOC, an anticonvulsant steroid, in women with perimenstrual catamenial epilepsy. Epilepsia 2008; 49:1221.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23480/abstract/34\">",
"      Reddy DS. Pharmacology of endogenous neuroactive steroids. Crit Rev Neurobiol 2003; 15:197.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23480/abstract/35\">",
"      Harden CL, Pulver MC, Ravdin L, Jacobs AR. The effect of menopause and perimenopause on the course of epilepsy. Epilepsia 1999; 40:1402.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23480/abstract/36\">",
"      Harden CL. Issues for mature women with epilepsy. Int Rev Neurobiol 2008; 83:385.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23480/abstract/37\">",
"      R&oslash;ste LS, Taub&oslash;ll E, Svalheim S, Gjerstad L. Does menopause affect the epilepsy? Seizure 2008; 17:172.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23480/abstract/38\">",
"      Harden CL. Hormone replacement therapy: will it affect seizure control and AED levels? Seizure 2008; 17:176.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23480/abstract/39\">",
"      Harden CL, Herzog AG, Nikolov BG, et al. Hormone replacement therapy in women with epilepsy: a randomized, double-blind, placebo-controlled study. Epilepsia 2006; 47:1447.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23480/abstract/40\">",
"      Kumar N, Behari M, Ahuja GK, Jailkhani BL. Phenytoin levels in catamenial epilepsy. Epilepsia 1988; 29:155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23480/abstract/41\">",
"      Shavit G, Lerman P, Korczyn AD, et al. Phenytoin pharmacokinetics in catamenial epilepsy. Neurology 1984; 34:959.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23480/abstract/42\">",
"      Herzog AG, Blum AS, Farina EL, et al. Valproate and lamotrigine level variation with menstrual cycle phase and oral contraceptive use. Neurology 2009; 72:911.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23480/abstract/43\">",
"      B&auml;ckstr&ouml;m T, Jorpes P. Serum phenytoin, phenobarbital, carbamazepine, albumin; and plasma estradiol, progesterone concentrations during the menstrual cycle in women with epilepsy. Acta Neurol Scand 1979; 59:63.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23480/abstract/44\">",
"      B&auml;ckstr&ouml;m T. Epileptic seizures in women related to plasma estrogen and progesterone during the menstrual cycle. Acta Neurol Scand 1976; 54:321.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23480/abstract/45\">",
"      Morrell, MJ, Hamdy, SF, Seale, CG, Springer, EA. Self-reported reproductive history in women with epilepsy: puberty onset and effects of menarche and menstrual cycle on seizures. Neurology 1998; 50:448.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23480/abstract/46\">",
"      Marques-Assis L. [Influence of menstruation on epilepsy]. Arq Neuropsiquiatr 1981; 39:390.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23480/abstract/47\">",
"      Kalinin VV, Zheleznova EV. Chronology and evolution of temporal lobe epilepsy and endocrine reproductive dysfunction in women: relationships to side of focus and catameniality. Epilepsy Behav 2007; 11:185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23480/abstract/48\">",
"      Herzog AG, Fowler KM, NIH Progesterone Trial Study Group. Sensitivity and specificity of the association between catamenial seizure patterns and ovulation. Neurology 2008; 70:486.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23480/abstract/49\">",
"      Bauer J, Burr W, Elger CE. Seizure occurrence during ovulatory and anovulatory cycles in patients with temporal lobe epilepsy: a prospective study. Eur J Neurol 1998; 5:83.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23480/abstract/50\">",
"      Poser CH. Letter: Modification of therapy for exacerbation of seizures during menstruation. J Pediatr 1974; 84:779.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23480/abstract/51\">",
"      Ansell, B, Clarke, E. Acetazolamide in treatment of epilepsy. BMJ 1956; 1:650.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23480/abstract/52\">",
"      Lim LL, Foldvary N, Mascha E, Lee J. Acetazolamide in women with catamenial epilepsy. Epilepsia 2001; 42:746.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23480/abstract/53\">",
"      LOMBROSO CT, FORXYTHE I. A long-term follow-up of acetazolamide (diamox) in the treatment of epilepsy. Epilepsia 1960; 1:493.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23480/abstract/54\">",
"      Gilad R, Sadeh M, Rapoport A, et al. Lamotrigine and catamenial epilepsy. Seizure 2008; 17:531.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23480/abstract/55\">",
"      Feely M, Calvert R, Gibson J. Clobazam in catamenial epilepsy. A model for evaluating anticonvulsants. Lancet 1982; 2:71.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23480/abstract/56\">",
"      Feely M, Gibson J. Intermittent clobazam for catamenial epilepsy: tolerance avoided. J Neurol Neurosurg Psychiatry 1984; 47:1279.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23480/abstract/57\">",
"      Zimmerman AW, Holden KR, Reiter EO, Dekaban AS. Medroxprogesterone acetate in the treatment of seizures associated with menstruation. J Pediatr 1973; 83:959.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23480/abstract/58\">",
"      Mattson RH, Cramer JA, Caldwell BV, Siconolfi BC. Treatment of seizures with medroxyprogesterone acetate: preliminary report. Neurology 1984; 34:1255.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23480/abstract/59\">",
"      Herzog AG. Intermittent progesterone therapy and frequency of complex partial seizures in women with menstrual disorders. Neurology 1986; 36:1607.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23480/abstract/60\">",
"      Herzog AG. Progesterone therapy in women with complex partial and secondary generalized seizures. Neurology 1995; 45:1660.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23480/abstract/61\">",
"      Herzog AG. Progesterone therapy in women with epilepsy: a 3-year follow-up. Neurology 1999; 52:1917.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23480/abstract/62\">",
"      Pennell PB. Hormonal aspects of epilepsy. Neurol Clin 2009; 27:941.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23480/abstract/63\">",
"      Hall SM. Treatment of menstrual epilepsy with a progesterone-only oral contraceptive. Epilepsia 1977; 18:235.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23480/abstract/64\">",
"      Dana-Haeri J, Richens A. Effect of norethisterone on seizures associated with menstruation. Epilepsia 1983; 24:377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23480/abstract/65\">",
"      Herzog AG. Clomiphene therapy in epileptic women with menstrual disorders. Neurology 1988; 38:432.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23480/abstract/66\">",
"      Bauer J, Wildt L, Fl&uuml;gel D, Stefan H. The effect of a synthetic GnRH analogue on catamenial epilepsy: a study in ten patients. J Neurol 1992; 239:284.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23480/abstract/67\">",
"      Haider Y, Barnett DB. Catamenial epilepsy and goserelin. Lancet 1991; 338:1530.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23480/abstract/68\">",
"      Nohria V, Giller E. Ganaxolone. Neurotherapeutics 2007; 4:102.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 2216 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-61.234.146.186-D4E9CFABE8-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_59_23480=[""].join("\n");
var outline_f22_59_23480=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H21\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION AND DEFINITION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      PATHOPHYSIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      The normal menstrual cycle",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Inadequate luteal phase cycles",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Hormonal influences on seizure occurrence",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Changes in antiepileptic drug metabolism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      CLINICAL FEATURES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Epilepsy syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Catamenial seizure patterns",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Acetazolamide",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Intermittent benzodiazepines",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Modification of AED regimen",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Hormonal therapy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      - Medroxyprogesterone acetate",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Natural progesterone",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Others",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEURO/2216\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEURO/2216|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?14/16/14601\" title=\"figure 1\">",
"      Menstrual cycle",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?3/18/3367?source=related_link\">",
"      Causes of female infertility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/45/34522?source=related_link\">",
"      Depot medroxyprogesterone acetate for contraception",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?2/52/2890?source=related_link\">",
"      Evaluation and management of drug-resistant epilepsy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/9/25753?source=related_link\">",
"      Evaluation of the first seizure in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/6/26724?source=related_link\">",
"      Evaluation of the menstrual cycle and timing of ovulation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/4/31818?source=related_link\">",
"      Initial treatment of epilepsy in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/39/40570?source=related_link\">",
"      Overview of the management of epilepsy in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/25/9626?source=related_link\">",
"      Ovulation induction with clomiphene citrate",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/32/37385?source=related_link\">",
"      Pathophysiology of seizures and epilepsy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/61/43994?source=related_link\">",
"      Pharmacology of antiepileptic drugs",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/2/27685?source=related_link\">",
"      Physiology of the normal menstrual cycle",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f22_59_23481="Subendothelial deposits in mixed cryo EM";
var content_f22_59_23481=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F69200&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F69200&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Subendothelial deposits in mixed cryoglobulinemia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 378px; height: 243px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Electron micrograph in mixed cryoglobulinemia shows subendothelial deposits (D) under the glomerular basement membrane (GBM) with some of the granular material present within an infiltrating macrophage (arrows). The latter represents a phagocytic process that would remove the cryoprecipitate if no further deposition occurred.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Helmut Rennke, MD.",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 450px\">",
"   <div class=\"ttl\">",
"    Electron micrograph of a normal glomerulus",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 377px; height: 266px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Electron micrograph of a normal glomerular capillary loop showing the fenestrated endothelial cell (Endo), the glomerular basement membrane (GBM), and the epithelial cells with its interdigitating foot processes (arrow). The GBM is thin, and no electron dense deposits are present. Two normal platelets are seen in the capillary lumen.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Helmut Rennke, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_59_23481=[""].join("\n");
var outline_f22_59_23481=null;
var title_f22_59_23482="Platelet function testing";
var content_f22_59_23482=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Platelet function testing",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/59/23482/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/59/23482/contributors\">",
"     Paul Harrison, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/59/23482/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/59/23482/contributors\">",
"     Lawrence LK Leung, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?22/59/23482/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?22/59/23482/contributors\">",
"     Jennifer S Tirnauer, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?22/59/23482/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Sep 28, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Platelets play a key role in both hemostasis and thrombosis. Accordingly, not only is accurate measurement of platelet function critical for identifying patients with platelet dysfunction or hyperfunction but it also is becoming increasingly important for the monitoring of modern antiplatelet therapy.",
"   </p>",
"   <p>",
"    The history of platelet function testing began over 100 years ago when platelets were first identified as distinct circulating cells, rather than fragments, and it was found that they were vital for both hemostasis and thrombosis [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/1\">",
"     1",
"    </a>",
"    ]. Despite these early observations, for the majority of the 20th century the only means of assessing platelet function were a small number of fairly unreliable tests (eg, manual platelet count, inspection of the peripheral blood smear, bleeding time).",
"   </p>",
"   <p>",
"    A major problem concerning the testing of platelet function is the difficulty in simulating hemostasis in vitro. In addition, platelets are sensitive to manipulation, and are prone to artifactual in vitro activation. Early attempts to simulate hemostasis in vitro included methods in which platelets were counted before and after exposure to foreign surfaces (eg, glass columns) or thrombus formation was monitored within closed plastic tube loops. Many of these early tests remained as research tools because of their technical difficulty, and were thus restricted to specialized centers.",
"   </p>",
"   <p>",
"    The ability to test platelet function in the routine laboratory improved with the introduction of platelet aggregometry [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/2\">",
"     2",
"    </a>",
"    ]. Remarkably, further advances in laboratory platelet analysis have lagged behind both the functional and molecular analysis of the",
"    <span class=\"nowrap\">",
"     coagulation/fibrinolytic",
"    </span>",
"    system. The table (",
"    <a class=\"graphic graphic_table graphicRef59857 \" href=\"UTD.htm?24/38/25196\">",
"     table 1",
"    </a>",
"    ) illustrates the small number of tests that were available up to the late 1980s. The availability of newer and more reliable platelet function analyzers, flow cytometry, and molecular biological techniques is changing our approach to platelet function analysis. Another table (",
"    <a class=\"graphic graphic_table graphicRef52144 \" href=\"UTD.htm?6/62/7149\">",
"     table 2",
"    </a>",
"    ) lists a number of relatively new platelet function tests that are currently available.",
"   </p>",
"   <p>",
"    This topic review will present a brief history of platelet function testing, and will review major advances in the analysis of platelet function. Congenital and acquired disorders of platelet function are discussed separately [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/9/29850?source=see_link\">",
"     \"Congenital and acquired disorders of platelet function\"",
"    </a>",
"    .) The general topic of automated hematology instrumentation is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/54/35690?source=see_link\">",
"     \"Automated hematology instrumentation\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PLATELET COUNTING METHODS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Manual platelet counting",
"    </span>",
"    &nbsp;&mdash;&nbsp;The platelet count continues to be utilized as a first line test of platelet function. Before the introduction of automated cell counters, the platelet count was performed manually. In fact, the manual count, using phase contrast microscopy, is still the gold standard international reference method [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/5,6\">",
"     5,6",
"    </a>",
"    ]. However, this procedure is imprecise, with typical coefficients of variation (CV) in the range of 15 to 25 percent, making this method totally impractical for calibrating automated cell counters [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/7\">",
"     7",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Automated cell counter methods",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although modern automated cell counters are rapid, precise, and reproducible, they tend to overestimate the platelet count in samples that contain cellular debris (eg, thalassemia, thrombotic thrombocytopenic purpura, leukemia). Conversely, in patients with large platelets, as in immune thrombocytopenia (ITP) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/8\">",
"     8",
"    </a>",
"    ], the platelet count is underestimated [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/9\">",
"     9",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/54/35690?source=see_link&amp;anchor=H7#H7\">",
"     \"Automated hematology instrumentation\", section on 'Platelet counting'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    An accurate estimation of the peripheral blood platelet count, especially in patients with extreme degrees of thrombocytopenia, is becoming extremely relevant, given that the platelet transfusion threshold is now set at",
"    <span class=\"nowrap\">",
"     10,000/microL",
"    </span>",
"    and that certain degrees of thrombocytopenia may initiate different treatment decisions [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/8,10-14\">",
"     8,10-14",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/6/20586?source=see_link&amp;anchor=H558395341#H558395341\">",
"     \"Clinical and laboratory aspects of platelet transfusion therapy\", section on 'Specific clinical scenarios'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h3\">",
"     Optical counting methods",
"    </span>",
"    &nbsp;&mdash;&nbsp;Advances in commercial analyzers have led to the development of optical counting methods, in which platelets are identified by their light scattering properties or via fluorescence following addition of a suitable dye [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/15,16\">",
"     15,16",
"    </a>",
"    ]. These methods increase the accuracy of the count, as compared with impedance methods, as both normal and large sized platelets are easily discriminated from noise, cellular debris, and other cell populations. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/54/35690?source=see_link&amp;anchor=H9#H9\">",
"     \"Automated hematology instrumentation\", section on 'Cell counting by light scattering'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h3\">",
"     Flow cytometric methods",
"    </span>",
"    &nbsp;&mdash;&nbsp;Optical counters agree more closely with a flow cytometric procedure. In this latter method, platelets are identified via analysis of samples incubated with a fluorescent monoclonal antibody directed against an antigen on the surface of the platelet (eg, anti-CD61 and anti-CD41a) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/7,17,18\">",
"     7,17,18",
"    </a>",
"    ]. The platelet count is derived by dividing the number of fluorescent platelets counted by the number of red blood cell events (RBC ratio) and then multiplying this ratio by the RBC count provided by a suitably calibrated impedance analyzer.",
"   </p>",
"   <p>",
"    This method is independent of both pipetting and dilution artifacts, provided that sufficient platelets are counted and that samples are optimally diluted to insure that cells are counted one by one, rather than in groups of two or more. The derived platelet counts are not only highly accurate, but are also precise, with typical coefficients of variation (CVs) of less than 5 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/7,17\">",
"     7,17",
"    </a>",
"    ]. Given the clear superiority of this method to the manual count, the",
"    <span class=\"nowrap\">",
"     ICSH/ISLH",
"    </span>",
"    have proposed that the method could become the new international reference method [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The immunoplatelet CD61 method is also available on an automated cell counter, the Abbott CELL DYN 4000 [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/18,20,21\">",
"     18,20,21",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/54/35690?source=see_link&amp;anchor=H11#H11\">",
"     \"Automated hematology instrumentation\", section on 'Immunologic counting of platelets'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/54/35690?source=see_link&amp;anchor=H29#H29\">",
"     \"Automated hematology instrumentation\", section on 'Abbott Cell-Dyn 4000, Sapphire'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In a comparative study, the optical and CD61 immunoplatelet methods were found to be in good agreement for platelet counts in the range of 25,000 to",
"    <span class=\"nowrap\">",
"     547,000/&micro;L",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/18\">",
"     18",
"    </a>",
"    ]. However, for platelet counts",
"    <span class=\"nowrap\">",
"     &lt;25,000/&micro;L,",
"    </span>",
"    the optical method tended to overestimate the platelet count (",
"    <a class=\"graphic graphic_figure graphicRef80032 \" href=\"UTD.htm?18/57/19359\">",
"     figure 1",
"    </a>",
"    ). The lowest absolute platelet count which these methods could reliably distinguish from true zero was",
"    <span class=\"nowrap\">",
"     1730/&micro;L",
"    </span>",
"    for the optical method and 20 and",
"    <span class=\"nowrap\">",
"     9/&micro;L",
"    </span>",
"    for the anti-CD41a and the anti-CD61 immunoplatelet methods, respectively.",
"   </p>",
"   <p>",
"    Given these improvements, increasing the accuracy of platelet counting in the ranges encountered in patients with severe thrombocytopenia (ie, platelet counts",
"    <span class=\"nowrap\">",
"     &lt;20,000/microL)",
"    </span>",
"    might result in further reduction in the platelet transfusion threshold to as low as",
"    <span class=\"nowrap\">",
"     5000/microL,",
"    </span>",
"    without an associated increase in bleeding risk. This could result in further cost savings by decreasing the frequency of unnecessary platelet transfusions [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    However, it has been suggested that the majority of full blood counters overestimate platelet counts in patients with severe thrombocytopenia and that, as a result, patients may be undertransfused [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/23,24\">",
"     23,24",
"    </a>",
"    ]. Further work is in progress to study the full impact of inaccurate platelet counting in thrombocytopenic patients.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Platelet count ratio method for platelet function testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;When platelets within anticoagulated whole blood samples are stimulated by agonists (eg, adenosine diphosphate [ADP], epinephrine, ristocetin), they form aggregates, with a resulting reduction in the number of free platelets (see",
"    <a class=\"local\" href=\"#H8\">",
"     'Platelet aggregometry'",
"    </a>",
"    below). By counting the number of platelets in a control sample and a sample that has been activated by ADP, it is possible to assess platelet function via a platelet count ratio (ie, the control platelet count divided by the platelet count after addition of an appropriate agonist). This ratio correlates well with the results of platelet aggregometry [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/25\">",
"     25",
"    </a>",
"    ], and can be performed on available automated cell counters, using commercially available reagents (Plateletworks, Array Medical, Somerville, NJ).",
"   </p>",
"   <p>",
"    A whole blood platelet function assay utilizing the ICHOR&trade; Point of Care Hematology Counter has been developed to count samples pre- and post-activation [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/26\">",
"     26",
"    </a>",
"    ]. This instrument provides a means of assessing both platelet count and function within an acute care environment [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Platelet counting can also be performed before and after exposure of samples to foreign surfaces (eg, glass columns; see below).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     PLATELET AGGREGOMETRY",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Classical platelet aggregometry",
"    </span>",
"    &nbsp;&mdash;&nbsp;Turbidometric platelet aggregometry, developed in the 1960s, revolutionized the ability to identify and diagnose alterations in platelet function [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/2\">",
"     2",
"    </a>",
"    ], and soon became the \"gold standard\" for platelet function testing. In this technique, blood is centrifuged at sufficiently low force to obtain platelet-rich plasma (PRP), which is stirred in a cuvette at 37&ordm;C between a light source and a measuring photocell. Upon addition of an agonist, such as ADP, platelets aggregate; the resultant increased transmission of light (ie, reduced turbidity of the PRP) is detected and recorded as a function of time after addition of the reagent. These changes reflect the formation of relatively large platelet aggregates, which are in turn derived from microaggregates.",
"   </p>",
"   <p>",
"    The use of a panel of platelet agonists (eg, collagen, ADP, epinephrine, ristocetin) at a range of concentrations triggers classical platelet responses, including shape change as well as primary and secondary aggregation. The recorded response depends upon the normal functioning of the platelet, the presence of inhibitors of platelet function, as well as the concentration of agonist, facilitating detection of classical platelet disorders based upon the pattern of aggregation [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/28\">",
"     28",
"    </a>",
"    ]. A number of classical examples are shown on the accompanying figure and table (",
"    <a class=\"graphic graphic_figure graphicRef56188 \" href=\"UTD.htm?21/1/21533\">",
"     figure 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef69518 \" href=\"UTD.htm?20/10/20652\">",
"     table 3",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    A great deal of information can be obtained via aggregometry, although the test is labor intensive, requires careful quality control, and a fair degree of technical expertise in its performance and interpretation. Although modern aggregometers with multi-channel capability, computer control, and the ability to measure ADP release via luminescence have improved the technology, the test is currently limited to specialized laboratories and is not well standardized [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/29-31\">",
"     29-31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There are a number of efforts in progress to improve standardization, including new guidelines from various societies.",
"   </p>",
"   <p>",
"    Comparative testing (see below) suggests that turbidimetric aggregometry underestimates both the degree and duration of inhibition by anti-Gp",
"    <span class=\"nowrap\">",
"     IIb/IIIa",
"    </span>",
"    therapy (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?6/15/6392?source=see_link\">",
"     abciximab",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/32\">",
"     32",
"    </a>",
"    ]. Evidence has also been accumulating that turbidimetric aggregometry is not sensitive enough to monitor the formation of platelet micro-aggregates or for monitoring platelet function [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/33,34\">",
"     33,34",
"    </a>",
"    ]. For example, it has been suggested that aggregates comprised of less than 100 platelets cannot be detected by the turbidometric technique [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/35\">",
"     35",
"    </a>",
"    ]. Aggregometry is thus relatively insensitive for either detecting preexisting aggregates or monitoring the early phase of aggregation. This may be particularly important for studying aggregates in patients with platelet hyperfunction.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Whole blood aggregometry",
"    </span>",
"    &nbsp;&mdash;&nbsp;Measurement of platelet aggregation within whole blood by electrical impedance was developed in response to the difficulties inherent in aggregometry noted above [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/36\">",
"     36",
"    </a>",
"    ]. In this method, whole blood is stirred at 37&ordm;C between two platinum wire electrodes set at a fixed distance [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/37\">",
"     37",
"    </a>",
"    ]. The electrode becomes covered with platelets, with further adhesion of platelet aggregates after addition of agonists. The mass of platelets sticking onto the electrodes changes the impedance with time, which is monitored on a recorder.",
"   </p>",
"   <p>",
"    Comparative studies indicate that this method gives results similar to those obtained via classical turbidimetric aggregometry, and outperforms turbidometric methods when monitoring anti-platelet therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/25,32,38\">",
"     25,32,38",
"    </a>",
"    ]. Similar to conventional aggregometry, whole blood aggregation impedance methods are relatively insensitive to the presence of smaller platelet aggregates. Within-donor variation tends to be slightly higher than with conventional aggregometry and the test still requires technical expertise and is relatively expensive. A multichannel (5 channels) impedance-based analyzer (Multiplate system) has become available and includes disposable cuvettes and standardized reagents [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This method is proving to be useful for diagnosing platelet defects and monitoring",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    and",
"    <a class=\"drug drug_general\" href=\"UTD.htm?34/9/34969?source=see_link\">",
"     clopidogrel",
"    </a>",
"    , and is in widespread use in Europe [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/40\">",
"     40",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Light scattering methods",
"    </span>",
"    &nbsp;&mdash;&nbsp;Particle size analysis by flow cytometry is very accurate, not only for the enumeration of platelets (see above) but also for monitoring formation of small (and large) aggregates during the early aggregation phase [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/41\">",
"     41",
"    </a>",
"    ]. Continuous measurement of platelet aggregation is not possible with this method alone, and disaggregation can occur during dilution procedures if the samples are not appropriately handled.",
"   </p>",
"   <p>",
"    An aggregometer (PA-200, Kowa Ltd, Tokyo, Japan) has been developed that uses a combination of laser light scattering and aggregometry to monitor the continuous formation of platelet microaggregates [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/42,43\">",
"     42,43",
"    </a>",
"    ]. The test is sensitive enough to detect aggregates containing only two or three platelets. The method employed by this apparatus is based on the observation that the intensity of light scatter is proportional to the size of the aggregates formed. This is accomplished by focusing on a limited area of the platelet-rich plasma in the cuvette and detecting high intensity light scatter at 90 degrees, via a series of lenses.",
"   </p>",
"   <p>",
"    Platelet aggregation assessed in this manner correlates well with conventional aggregometry in samples showing gross changes in light transmission. However, the light scatter technique can detect small aggregates (the primary aggregation response) that are not detectable via light transmission in the conventional aggregometer; the larger aggregates (the secondary aggregation response) are detected by both methods. The instrument not only measures both the size and number of platelet aggregates but also utilizes more physiologic concentrations of agonists, at concentrations which may be reduced by up to three orders of magnitude, compared with those used in light transmission techniques.",
"   </p>",
"   <p>",
"    This technology may prove useful for detecting platelet hyperreactivity in a variety of disease states (eg, acute coronary syndromes, stroke, and thrombotic thrombocytopenic purpura) in response to low concentrations of various agonists. As an example, spontaneous formation of small aggregates (&lt;100 platelets) has been observed in patients with acute coronary syndromes, but not in controls [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/44\">",
"     44",
"    </a>",
"    ]. Further, upon agonist stimulation the EC50 for epinephrine-induced primary aggregation was 50 times lower in these patients than in controls, while the EC50 for secondary aggregation was only two times lower. This observation suggests that platelet hypersensitivity is only detectable by primary aggregation of microaggregates in these patients.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     The VerifyNow Assay",
"    </span>",
"    &nbsp;&mdash;&nbsp;This test was previously known as the Ultegra Rapid Platelet Function Assay (RPFA).",
"   </p>",
"   <p>",
"    Data from recent clinical trials (eg, EPIC, EPILOG) have suggested that &gt;80 percent of platelet receptors need to be blocked in order to achieve significant clinical efficacy with antiplatelet agents [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/45\">",
"     45",
"    </a>",
"    ]. Monitoring of receptor blockade is thus becoming crucial in order to ensure optimal dosing and maximal clinical benefit for individual patients at risk of developing ischemic complications (eg, during percutaneous coronary intervention) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/46\">",
"     46",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/31/19961?source=see_link&amp;anchor=H2#H2\">",
"     \"Early trials of platelet glycoprotein IIb/IIIa receptor inhibitors in coronary heart disease\", section on 'The platelet GP IIb/IIIa receptor'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Previously employed tests such as radiolabeled antibody binding assays, aggregometry, and flow cytometry, although suitable, are time consuming, expensive, and require a fair degree of technical expertise and quality control [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/47\">",
"     47",
"    </a>",
"    ]. Given the increased use of both oral and infused Gp",
"    <span class=\"nowrap\">",
"     IIb/IIIa",
"    </span>",
"    antagonists, there exists a demand for a simple, cheap, and rapid method that could be utilized at the bedside and clinic in order to monitor anti-platelet therapy in a standardized fashion [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/48-50\">",
"     48-50",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A modified platelet aggregometry device has been developed in order to provide a simple and rapid functional means of monitoring anti-Gp",
"    <span class=\"nowrap\">",
"     IIb/IIIa",
"    </span>",
"    therapy (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?6/15/6392?source=see_link\">",
"     abciximab",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/51\">",
"     51",
"    </a>",
"    ]. The VerifyNow Gp",
"    <span class=\"nowrap\">",
"     IIb/IIIa",
"    </span>",
"    Assay is based upon the principle that fibrinogen-coated beads will agglutinate in whole blood in proportion to the number of available platelet",
"    <span class=\"nowrap\">",
"     GpIIb/IIIa",
"    </span>",
"    receptors. A disposable cartridge employed for this test contains fibrinogen-coated beads and a platelet activator (TRAP &ndash; Thrombin Receptor Activating Peptide) within reaction wells [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/50\">",
"     50",
"    </a>",
"    ]. A citrated whole blood sample is inserted into the cartridge within the instrument; TRAP activates the platelets, resulting in",
"    <span class=\"nowrap\">",
"     GpIIb/IIIa",
"    </span>",
"    exposure and binding of the fibrinogen-coated beads to the platelet receptors that are not blocked with the drug in question; results (percent inhibition) are available within a few minutes.",
"   </p>",
"   <p>",
"    Comparative evaluations demonstrate that the instrument mirrors both platelet aggregometry and the degree of",
"    <span class=\"nowrap\">",
"     GpIIb/IIIa",
"    </span>",
"    blockade [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/49,50\">",
"     49,50",
"    </a>",
"    ]. There are 2 other cartridges (VerifyNow",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     Aspirin",
"    </a>",
"    and VerifyNow P2Y12) available for monitoring either aspirin or P2Y12 inhibition, respectively. The aspirin and P2Y12 cartridges contain arachidonic acid and ADP as agonists, respectively. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?18/60/19401?source=see_link&amp;anchor=H21311381#H21311381\">",
"     \"Nonresponse and resistance to aspirin\", section on 'Clinical and epidemiologic observations'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     THE IN VIVO BLEEDING TIME",
"    </span>",
"    &nbsp;&mdash;&nbsp;The bleeding time invented by Duke in 1910 [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/52\">",
"     52",
"    </a>",
"    ] was the first in vivo test of platelet function. Although the test has been refined by the Ivy technique [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/53,54\">",
"     53,54",
"    </a>",
"    ], it is poorly reproducible, invasive, insensitive, and time consuming [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/55\">",
"     55",
"    </a>",
"    ]. It is impractical to use serially or during surgical procedures, and requires experienced operators to judge the subjective endpoint of the test.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A normal bleeding time does not predict the safety of surgical procedures, nor does an abnormal bleeding time predict for excessive surgical bleeding. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?31/43/32439?source=see_link&amp;anchor=H7#H7\">",
"       \"Preoperative assessment of hemostasis\", section on 'Bleeding time'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Despite the above, the bleeding time is still often utilized as a first line clinical screening test, and can be particularly useful for identifying patients with severe hemostatic defects (eg, von Willebrand disease, Glanzmann's thrombasthenia) [",
"      <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/56,57\">",
"       56,57",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?5/3/5178?source=see_link&amp;anchor=H13#H13\">",
"       \"Approach to the adult patient with a bleeding diathesis\", section on 'Bleeding time'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The clear advantage of the bleeding time as a platelet function test is that it studies natural hemostasis, does not require expensive specialized equipment, and is not prone to anticoagulation artifacts. However, given the many problems with the method, the introduction of reliable in vitro tests that simulate primary hemostasis might eventually result in the phasing out of the bleeding time.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     INSTRUMENTS THAT SIMULATE PLATELET FUNCTION IN VITRO",
"    </span>",
"    &nbsp;&mdash;&nbsp;Platelet aggregometry does not mimic the physiological processes of platelet adhesion, activation, and aggregation that occur during hemostasis in vivo. A number of investigators have developed other tests in an attempt to mimic or simulate the processes that occur in vivo during vessel wall damage. Accordingly, many platelet adhesion tests have been developed to study shear-induced platelet activation [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/58,59\">",
"     58,59",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Clot signature analyzer",
"    </span>",
"    &nbsp;&mdash;&nbsp;An instrument called the hemostatometer was developed for testing global hemostasis [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/60\">",
"     60",
"    </a>",
"    ]. The methodology involves punching holes within a tube that contains flowing non-anticoagulated blood under controlled conditions. Consequent platelet activation results in the formation of a primary hemostatic plug with clot stabilization via fibrin formation. Alternatively, the blood sample can be exposed to a small amount of collagen, which results in thrombus formation and complete stenosis of the tube.",
"   </p>",
"   <p>",
"    A commercial form of this instrument, called the clot signature analyzer (CSA), measures both hemostatic plug formation in the \"punch\" and collagen channels within a disposable plastic cassette [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/61,62\">",
"     61,62",
"    </a>",
"    ], providing a global assessment of hemostasis under controlled conditions. The formation of the hemostatic plugs within both channels is shear-dependent",
"    <span class=\"nowrap\">",
"     (&gt;10,000/second",
"    </span>",
"    in the punch channel and",
"    <span class=\"nowrap\">",
"     6,200/second",
"    </span>",
"    in the collagen channel) and relies upon functioning GpIb, von Willebrand factor, and",
"    <span class=\"nowrap\">",
"     GpIIb/IIIa.",
"    </span>",
"    The test is applicable to detecting abnormalities in both primary hemostasis (ie, platelet activation) and coagulation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Thrombotic status analyzer",
"    </span>",
"    &nbsp;&mdash;&nbsp;The thrombotic status analyzer (TSA) measures both thrombotic and thrombolytic activities within non-anticoagulated blood samples [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/63\">",
"     63",
"    </a>",
"    ]. The test involves drawing whole blood through a capillary tube. The resulting hemodynamic forces induce platelet activation and capillary tube occlusion. After stabilization and upon compression of the platelet-rich thrombus, thrombolysis can also be measured. The test is capable of detecting defective or excessive platelet function and monitoring both anti-platelet and thrombolytic therapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     The platelet function analyzer",
"    </span>",
"    &nbsp;&mdash;&nbsp;The principle behind this platelet function analyzer (PFA-100), originally developed in 1985 [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/64\">",
"     64",
"    </a>",
"    ], is to expose platelets within citrated whole blood to high shear (5000 to",
"    <span class=\"nowrap\">",
"     6000/sec)",
"    </span>",
"    within a capillary tube and monitor the drop in flow rate as the platelets form a hemostatic plug within the center of a membrane coated with collagen and either ADP or epinephrine [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/65,66\">",
"     65,66",
"    </a>",
"    ]. The test records a parameter called the closure time (CT).",
"   </p>",
"   <p>",
"    The test is simple, rapid, does not require specialist training, and is a potential screening tool for assessing hemostatic abnormalities [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/67,68\">",
"     67,68",
"    </a>",
"    ]. It is particularly advantageous in the pediatric setting [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/69\">",
"     69",
"    </a>",
"    ]. The test could potentially replace the in vivo bleeding time [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/70\">",
"     70",
"    </a>",
"    ] and serve as a screening tool for assessing platelet dysfunction [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/67,71\">",
"     67,71",
"    </a>",
"    ]. As with the in vivo bleeding time, this test is sensitive to both the platelet count and hematocrit [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/72,73\">",
"     72,73",
"    </a>",
"    ]; it is therefore recommended that a complete blood count be performed along with each test.",
"   </p>",
"   <p>",
"    Although abnormal closure times are an indication of platelet dysfunction, they are not specific for any disorder, and should not be used for general screening purposes without knowledge of other variables that influence the test (eg, VWF levels, complete blood count, other platelet function tests) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/74-76\">",
"     74-76",
"    </a>",
"    ]. This test also has limited value in the diagnosis of patients presenting with mucocutaneous bleeding, due to its low sensitivity for the detection of primary secretion defects and storage pool disease [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/77\">",
"     77",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h3\">",
"     Use in von Willebrand disease",
"    </span>",
"    &nbsp;&mdash;&nbsp;Data confirm that the above testing system is highly dependent on von Willebrand factor (VWF), and is useful for evaluating patients with von Willebrand disease as well as monitoring therapy with DDAVP [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/78,79\">",
"     78,79",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/13/24794?source=see_link&amp;anchor=H9#H9\">",
"     \"Clinical presentation and diagnosis of von Willebrand disease\", section on 'Laboratory testing'",
"    </a>",
"    .) However, a number of limitations have been noted:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The test appears to be coagulation factor independent, as blood from patients with hemophilia A or B, factor VII deficiency, or afibrinogenemia all exhibit normal closure times in the instrument.",
"     </li>",
"     <li>",
"      Comparison studies have shown that the PFA-100&trade; is more sensitive (&gt;70 percent) than the bleeding time (20 to 30 percent) in detecting all subtypes of von Willebrand disease (vWD) [",
"      <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/80\">",
"       80",
"      </a>",
"      ]. The exception is type 2N vWD, in which the hemostatic defect resides in the Factor VIII binding site on vWF [",
"      <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/81\">",
"       81",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?43/8/44169?source=see_link\">",
"       \"Classification and pathophysiology of von Willebrand disease\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      <a class=\"drug drug_general\" href=\"UTD.htm?0/12/198?source=see_link\">",
"       Factor VIII concentrates",
"      </a>",
"      containing vWF or even vWF concentrates often fail to correct the closure time in patients with type 3 von Willebrand disease, suggesting that either platelet vWF is critical in the test or that the PFA-100&trade; is extremely sensitive to the absence of the highest molecular weight multimers in these concentrates [",
"      <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/78,79\">",
"       78,79",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h3\">",
"     Use in platelet secretion defects",
"    </span>",
"    &nbsp;&mdash;&nbsp;This test may also be useful for the diagnosis and monitoring of patients with platelet secretion defects [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/82\">",
"     82",
"    </a>",
"    ]. The",
"    <span class=\"nowrap\">",
"     collagen/epinephrine",
"    </span>",
"    cartridge appears to be not only more sensitive to these defects but also gives a prolonged closure time (CEPI-CT) in subjects who have ingested",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    &nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/68,83,84\">",
"     68,83,84",
"    </a>",
"    ], and may identify patients who are aspirin insensitive. The closure time using the",
"    <span class=\"nowrap\">",
"     collagen/adenosine",
"    </span>",
"    diphosphate cartridge (CADP-CT) is normal in subjects taking aspirin [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/84\">",
"     84",
"    </a>",
"    ]; thus, performance of both tests may allow differentiation between an aspirin-like defect and other platelet function disorders [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/85\">",
"     85",
"    </a>",
"    ]. The PFA-100&trade; may also be useful for monitoring other anti-platelet drugs, such as",
"    <span class=\"nowrap\">",
"     GpIIb/IIIa",
"    </span>",
"    antagonists.",
"   </p>",
"   <p>",
"    If the screening test obtained by the PFA-100&trade; is normal, it is highly likely that the patient has no severe primary platelet function defect, and other platelet tests would not be required. However, normal results may not always exclude milder platelet function defects (eg, storage and release defects). Therefore, if the clinical suspicion of a platelet defect is high, further diagnostic tests should always be performed [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/86\">",
"     86",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Cone and plate(let) analyzer",
"    </span>",
"    &nbsp;&mdash;&nbsp;This test of platelet function is based upon the adhesion of platelets to extracellular matrix (ECM) under flow conditions [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/87-89\">",
"     87-89",
"    </a>",
"    ]. The system consists of a cone and plate device in which a blood sample is exposed to a plate under arterial flow conditions for a few minutes. Platelet adhesion and aggregation on the surface of the plate are monitored by an image analyzer. The interaction of platelets with the substrate is totally dependent upon presence of Gp",
"    <span class=\"nowrap\">",
"     IIb/IIIa,",
"    </span>",
"    Gp Ib, and plasma vWF.",
"   </p>",
"   <p>",
"    The CPA, either as a semi- or fully automated system, has been utilized to monitor defects in primary hemostasis,",
"    <span class=\"nowrap\">",
"     anti-GpIIb/IIIa",
"    </span>",
"    therapy, hyperreactive platelets, to monitor thrombocytopenic patients for bleeding risk, and for early diagnosis and treatment monitoring in patients with thrombotic thrombocytopenic purpura [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/87,89,90\">",
"     87,89,90",
"    </a>",
"    ]. The main advantages of this system are that it uses a small volume of blood (150 to 250 microL), yields results in 5 to 15 minutes, and exhibits a close resemblance to in vivo physiological conditions.",
"   </p>",
"   <p>",
"    The test is now commercially available as the IMPACT (immediate microscopic platelet adhesion cone and plate technology) device and uses disposable polystyrene plates. The test measures platelet adhesion and aggregation using 130 microL of whole blood that has been pipetted onto the polystyrene plate and exposed to a shear rate of",
"    <span class=\"nowrap\">",
"     1800/second",
"    </span>",
"    for two minutes. Surface bound platelets are imaged and quantified by image analysis software after washing and staining. The test displays two parameters: surface coverage (SC) and average size (AS). The SC is a measure of the percentage of the plate covered by platelets, and the AS is the means size of surface bound objects. The test is apparently sensitive to afibrinogenemia, VWD, Glanzmann's Thrombasthenia and Bernard Soulier syndrome. However, widespread experience with this device is limited.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     High shear filterometer",
"    </span>",
"    &nbsp;&mdash;&nbsp;A simple method for assessing high shear-dependent platelet function has been developed [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/91\">",
"     91",
"    </a>",
"    ]. In this test, anticoagulated blood is forced under controlled pressure through a fine glass fiber filter. The combination of shear forces and foreign surfaces activates the platelets, resulting in aggregate formation culminating in a blockade of the filter. Platelets are counted prior to filtration and at various time points thereafter in order to calculate the percentage of platelets retained in the filter. Because of the high shear conditions, the test is highly dependent upon GpIb, vWf and",
"    <span class=\"nowrap\">",
"     GpIIb/IIIa,",
"    </span>",
"    and theoretically can be utilized as a sensitive test for various types of platelet dysfunction.",
"   </p>",
"   <p>",
"    In one study of over 2500 men, tests of platelet function were performed to determine whether they could predict development of myocardial infarction or stroke [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/92\">",
"     92",
"    </a>",
"    ]. Retention of platelets in the high-shear test was found to be non-predictive of either event.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     PLATELET MEDIATED THROMBIN GENERATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Estimates suggest that platelets can accelerate thrombin generation by five to six orders of magnitude. The mechanisms by which platelets accomplish this include the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Blood coagulation occurs more efficiently on cell surfaces. In particular the interaction between platelets and clotting factors occurs with many different proteins and at many different levels of the coagulation cascade.",
"     </li>",
"     <li>",
"      The exposure of negatively charged phospholipids during platelet activation (platelet factor 3) provides a surface on which both the Tenase and Prothrombinase complexes can generate thrombin. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?26/35/27194?source=see_link&amp;anchor=H14#H14\">",
"       \"Overview of hemostasis\", section on 'Multicomponent complexes'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Thrombin, which converts fibrinogen to fibrin, is a potent activator of platelets.",
"     </li>",
"     <li>",
"      <span class=\"nowrap\">",
"       Anti-GpIIb/IIIa",
"      </span>",
"      antagonists (eg, 7E3 and RGDS) inhibit thrombin generation [",
"      <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/93\">",
"       93",
"      </a>",
"      ]. As platelets from patients with Glanzmann's thrombasthenia, who have congenital defects in Gp",
"      <span class=\"nowrap\">",
"       IIb/IIIa,",
"      </span>",
"      also exhibit reduced thrombin generation, Gp",
"      <span class=\"nowrap\">",
"       IIb/IIIa",
"      </span>",
"      appears to influence the conversion of prothrombin to thrombin. This is probably mediated by direct binding of prothrombin on both resting and activated platelets [",
"      <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/94\">",
"       94",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Accordingly, measurement of thrombin generation in the presence of platelets provides a simple assessment of an important physiologic function of platelets. Although most assays have been based upon coagulation [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/95\">",
"     95",
"    </a>",
"    ] or use of thrombin specific chromogenic substrates, a simple instrument has been developed to measure this activity [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/96\">",
"     96",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Hemostatus device",
"    </span>",
"    &nbsp;&mdash;&nbsp;Point of care measurements of the prothrombin time, activated partial thromboplastin time, and the platelet count have all been used to identify patients who are at risk of bleeding. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/3/5178?source=see_link&amp;anchor=H11#H11\">",
"     \"Approach to the adult patient with a bleeding diathesis\", section on 'Laboratory testing'",
"    </a>",
"    .) A point of care instrument has been developed to assess platelet function by analysis of the effects of platelet activating factor (PAF) on the kaolin-activated clotting time [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/97,98\">",
"     97,98",
"    </a>",
"    ]. This test measures the effect of four different concentrations of PAF on the shortening of the clotting time. The hemostatus test accurately identifies a bleeding tendency, especially when platelet counts are",
"    <span class=\"nowrap\">",
"     &lt;70,000/&micro;L.",
"    </span>",
"    The test is insensitive to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    and GpIb function, but is sensitive to abnormalities in Gp",
"    <span class=\"nowrap\">",
"     IIb/IIIa.",
"    </span>",
"    Thus the test may be useful for monitoring",
"    <span class=\"nowrap\">",
"     GpIIb/IIIa",
"    </span>",
"    inhibitors and identifying patients with Glanzmann's thrombasthenia [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/99\">",
"     99",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Instruments measuring physical properties of the clot",
"    </span>",
"    &nbsp;&mdash;&nbsp;The balance among clot formation, retraction, and lysis reflects the ability of the hemostatic plug to perform its hemostatic function. Thus, by measuring various properties of the clot during hemostasis one can potentially detect a number of acquired and congenital platelet abnormalities.",
"   </p>",
"   <p>",
"    The process of clot retraction may be measured either in whole blood or platelet rich plasma by incubation in the presence of calcium in glass tubes and either calculating differences in volumes pre- and post- clotting or by visual assessment of the clot with time. Abnormal clot retraction may reflect deficiencies in platelet number, platelet glycoproteins, release of activating agents, or fibrinogen levels. A number of instruments have been developed that can accurately measure various physical properties of the clot with time. Two such commercial instruments will be discussed here: the thromboelastography (TEGR) and Hemodyne devices.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h3\">",
"     Thromboelastography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Thromboelastography (TEG) tests both platelet function and coagulation by assaying several parameters of clot formation dynamically in whole blood. There are several devices available commercially to measure TEG at the bedside or point of care. While the specifics of the devices vary, they all measure the same general parameters. As examples:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The TEG and related rapid TEG (r-TEG) devices monitor the interaction of platelets within the fibrin mesh of the clot during clot formation and lysis over time. The physical property of the clot is measured by use of a cylindrical cup that holds a whole blood sample at 37&ordm;C and is oscillated to and fro with a rotation cycle of 10 seconds. As the clot forms, the torque of the rotating cup is transmitted to an immersed pin. The degree of pin rotation is converted to an electrical signal via a transducer and monitored via a chart recorder. The strength of the developing clot increases the magnitude of the output, whereas during clot lysis, the bonds between the cup and the pin are broken, and the signal decreases. The forces that are generated are used to measure the clotting time, kinetics of clot initiation, clot strength, and clot lysis over time (",
"      <a class=\"graphic graphic_table graphicRef74954 \" href=\"UTD.htm?41/10/42156\">",
"       table 4",
"      </a>",
"      and",
"      <a class=\"graphic graphic_figure graphicRef64213 \" href=\"UTD.htm?2/33/2591\">",
"       figure 3",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      The ROTEM (Rotational Thromboelastometry) device is an adaptation of the TEG in which the cup remains stationary and the pin rotates directly in the sample. Results obtained are essentially identical to the TEG.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    TEG has been utilized successfully as a point of care test within surgical departments (especially in trauma and orthotopic liver transplantation) and to predict for thromboembolic events in surgical patients. The usefulness of TEG in general hematologic practice remains uncertain. Further information regarding the use of TEG in surgical patients is presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/44/23242?source=see_link\">",
"     \"Coagulopathy associated with trauma\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Of note, the TEG instrument may be insensitive to samples from patients who have taken",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/100-102\">",
"     100-102",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h3\">",
"     Platelet contractile force",
"    </span>",
"    &nbsp;&mdash;&nbsp;Platelet contractile force (PCF) is a clinically useful and sensitive measure of global platelet function. During platelet activation, contractile forces within the cytoskeleton mediate both shape change and pseudopod formation. The platelets then adhere to the fibrin mesh via surface receptors (eg, Gp",
"    <span class=\"nowrap\">",
"     IIb/IIIa)",
"    </span>",
"    on the pseudopods. Once the clot is fully formed, the platelets begin a process of clot retraction, placing the entire clot under stress, resulting in the collapse of the clot and reduction in size.",
"   </p>",
"   <p>",
"    The Hemodyne instrument, based on a previously described technique [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/103\">",
"     103",
"    </a>",
"    ], facilitates a direct measurement of these forces. The test is performed by placing a small sample (800 &micro;L) of either citrated whole blood or platelet rich plasma within a sample cup between two parallel plates. Upon addition of thrombin or other agonists, platelets within the sample attach to the plates and extend their pseudopodia along polymerizing strands of fibrin. Once the",
"    <span class=\"nowrap\">",
"     fibrin/platelet",
"    </span>",
"    network is sufficiently formed, platelet contractile forces begin to transmit outwards to the plates and are detected by a transducer, the output of which is proportional to the generated force. Two key properties are measured simultaneously:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Platelet contractile force (PCF) &mdash; the force exerted by activated platelets on the fibrin network",
"     </li>",
"     <li>",
"      Elastic modulus (EM) &mdash; the elastic modulus (clot rigidity), a measure of the physical structure of the",
"      <span class=\"nowrap\">",
"       fibrin/cellular",
"      </span>",
"      network [",
"      <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/104\">",
"       104",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    PCF is decreased in thrombocytopenia, various acquired and congenital platelet abnormalities (eg, uremia, Glanzmann's thrombasthenia, during cardiopulmonary bypass) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/105\">",
"     105",
"    </a>",
"    ], and Gp",
"    <span class=\"nowrap\">",
"     IIb/IIIa",
"    </span>",
"    inhibitors [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/106\">",
"     106",
"    </a>",
"    ]. Clot EM is influenced by fibrinogen concentration and is measurable in the absence of platelets. It may also be sensitive to clotting factor deficiencies, anticoagulant effects, and in multiple myeloma. Overall, low PCF values appear to predict a bleeding risk, while high",
"    <span class=\"nowrap\">",
"     PCF/EM",
"    </span>",
"    values may predict a thrombotic tendency (eg, coronary artery disease) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/107\">",
"     107",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h1\">",
"     MEASUREMENT OF PLATELET ACTIVATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of tests have been developed to measure reactivity of circulating platelets",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    to show that platelets have been activated in vivo. The difficulty with these methods is the prevention of artifactual platelet activation during the processing of the blood sample. The earliest measurements included the detection of platelet aggregates within blood samples [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/108,109\">",
"     108,109",
"    </a>",
"    ], measuring threshold aggregation responses to ADP or arachidonate, and testing for the presence of spontaneous aggregation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     Soluble activation markers",
"    </span>",
"    &nbsp;&mdash;&nbsp;Another method of assessing platelet activation is measurement of platelet release products within platelet poor plasma, some of which, however, are not specific to platelets. In these methods, blood samples are usually collected into tubes containing inhibitors of platelet activation (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?29/31/30200?source=see_link\">",
"     theophylline",
"    </a>",
"    and PGE1).",
"   </p>",
"   <p>",
"    The most useful tests are assays for platelet-specific proteins, such as platelet factor 4 and beta thromboglobulin. These proteins are released from the alpha granules upon platelet activation and aggregation, although careful venipuncture and blood handling are essential to avoid artifactually high levels. The ratio of these two proteins often indicates if there has been a problem with artifactually induced activation.",
"   </p>",
"   <p>",
"    Other platelet activation assays have included thromboxane B2 measurement (a metabolite of thromboxane A2) within both plasma and urine, as well as uptake and release of radiolabeled serotonin from the dense granules. These assays have a number of disadvantages, including false elevation of levels due to sample handling, insensitivity, need for radioactive materials, and high cost.",
"   </p>",
"   <p>",
"    Soluble P-selectin is also derived from activated platelets and can be measured as a marker of platelet activation in platelet poor plasma [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/110\">",
"     110",
"    </a>",
"    ]. P-Selectin or CD62p is an alpha granular membrane protein, which is expressed only on the surface of activated platelets and can be detected by flow cytometry (see below). The soluble protein is derived by enzymatic cleavage of the membrane bound form. In vivo studies have demonstrated that degranulated platelets rapidly lose their surface P-Selectin and continue to circulate and function [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/111\">",
"     111",
"    </a>",
"    ]. Although soluble P-selectin is specific for platelet activation in normal subjects, some may also be derived from endothelial",
"    <span class=\"nowrap\">",
"     activation/damage",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/110\">",
"     110",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h2\">",
"     Flow cytometric analysis of platelets and activation markers",
"    </span>",
"    &nbsp;&mdash;&nbsp;Whole blood flow cytometry is a very powerful but relatively new laboratory technique for assessing platelet activation and function [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/112,113\">",
"     112,113",
"    </a>",
"    ]. Flow cytometry can be utilized to measure activated platelets, platelet hypo- or hyper-reactivity, platelet-leukocyte aggregates, platelet microparticles, and platelet turnover. These assays may be of particular use in identifying patients at risk for thrombosis. Specific flow cytometric assays have also been developed for monitoring",
"    <span class=\"nowrap\">",
"     anti-GpIIb/IIIa",
"    </span>",
"    antagonist therapy, as well as diagnosing congenital deficiencies in platelet glycoproteins, storage pool disease, and heparin-induced thrombocytopenia.",
"   </p>",
"   <p>",
"    The use of whole blood in these assays has several advantages over either purified platelets or platelet rich plasma [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/112,114\">",
"     112,114",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Platelets are analyzed in the presence of leukocytes and erythrocytes and only small quantities of blood are required (2 to 5 &micro;L). Providing the venipuncture technique is well standardized, the minimal manipulation of fresh samples results in very little artifactual in vitro activation.",
"     </li>",
"     <li>",
"      It is possible to study platelets from patients with thrombocytopenia",
"     </li>",
"     <li>",
"      In vivo activation state and dose response to classical agonists (eg, thrombin, TRAP, ADP) can be studied by these extremely sensitive assays",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Platelet activation markers that are commonly measured include exposure of granule membrane markers (eg, CD62p, CD63, LAMP-1 and CD40L), activation dependent changes in the conformation of the",
"    <span class=\"nowrap\">",
"     GpIIb/IIIa",
"    </span>",
"    complex (eg, PAC-1, Ligand Induced Binding site (LIBS), and Receptor Induced Binding site (RIBS) antibodies), binding of secreted proteins (eg, TSP and Multimerin), and exposure of phosphatidyl serine (Factor Va or VIIIa binding, Annexin-V).",
"   </p>",
"   <p>",
"    As discussed above, surface expressed CD62p (P-selectin) is rapidly cleaved to release soluble P-selectin into the plasma [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/111\">",
"     111",
"    </a>",
"    ]. Thus, the levels of CD62p on the platelet surface may not be a true reflection of the in vivo activation state of platelets and should be complemented by measurements of all other markers including soluble P-selectin. A full spectrum of all activation markers should be measured, especially since the time frame of expression for each marker is unknown.",
"   </p>",
"   <p>",
"    Activated platelets have been demonstrated in a wide variety of disorders, including acute coronary syndromes [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/112,115,116\">",
"     112,115,116",
"    </a>",
"    ], stroke [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/117,118\">",
"     117,118",
"    </a>",
"    ], antiphospholipid syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/119\">",
"     119",
"    </a>",
"    ], and during angioplasty [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/120\">",
"     120",
"    </a>",
"    ]. The study of platelet activation markers thus has the potential to optimize antiplatelet therapy (eg anti-Gp",
"    <span class=\"nowrap\">",
"     IIb/IIIa",
"    </span>",
"    drugs) and to be used as a predictor of thrombotic events after invasive techniques (eg, angioplasty) [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/120\">",
"     120",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    One of the problems with measuring the activation status or reactivity of circulating platelets is that the clinical picture is incomplete, since fully activated platelets within thrombi and clots are unlikely to circulate. Measurement of platelet-leukocyte complexes may be a more sensitive marker of in vivo platelet activation. By using a double labeling technique, it is possible to study aggregates of platelets with both neutrophils and monocytes by flow cytometry [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/121\">",
"     121",
"    </a>",
"    ]. When platelets become activated they can bind to monocytes and neutrophils by a number of different receptor-ligand pairs or bridges (eg, CD62p &ndash; PSGL1, CD36 &ndash; TSP &ndash; CD36, Mac1 &ndash; Fg &ndash;",
"    <span class=\"nowrap\">",
"     GpIIb/IIIa,",
"    </span>",
"    and CD40L &ndash; CD40). Increased numbers of circulating platelet-leukocyte complexes have been demonstrated in patients with myocardial infarction, unstable and stable angina [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/115\">",
"     115",
"    </a>",
"    ], and during cardiopulmonary bypass.",
"   </p>",
"   <p>",
"    Circulating monocyte-platelet complexes may be a relatively stable and a more sensitive marker than other activation dependent markers (eg P-Selectin). The platelets induce tissue factor expression after binding to monocytes, perhaps increasing a prothrombotic tendency in such conditions as meningococcal sepsis [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/122\">",
"     122",
"    </a>",
"    ], sickle cell disease [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/123\">",
"     123",
"    </a>",
"    ], preeclampsia, and acute coronary syndromes.",
"   </p>",
"   <p>",
"    Flow cytometric analysis of platelets can also be utilized to count platelets accurately (see",
"    <a class=\"local\" href=\"#H2\">",
"     'Platelet counting methods'",
"    </a>",
"    above), diagnose various glycoprotein deficiencies (eg, Bernard Soulier syndrome and Glanzmann's thrombasthenia) and to study platelets from patients with defective aggregation, secretion, microparticle generation, or procoagulant activity [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/123-125\">",
"     123-125",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    By using the dye Mepacrine in conjunction with platelet activation in vitro it is possible to diagnose dense granule deficiency and storage pool disease (both storage and release defects) in a simple and reproducible assay [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/126,127\">",
"     126,127",
"    </a>",
"    ]. This assay is simpler than either the luminescence or HPLC assays that measure intracellular or released ADP [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/128\">",
"     128",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h3\">",
"     Reticulated platelets",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nucleic acid-specific dyes can be utilized to measure young platelets that contain residual RNA. These young platelets are analogous to red cell reticulocytes and have thus been termed reticulated platelets. Although there is evidence to support that the youngest platelets are being measured [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/129,130\">",
"     129,130",
"    </a>",
"    ], it is possible that the dense granular component of the larger young platelets is also contributing to the signal [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/131,132\">",
"     131,132",
"    </a>",
"    ]. Assays can now be optimized in order to control for this problem [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/133\">",
"     133",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/54/35690?source=see_link&amp;anchor=H12#H12\">",
"     \"Automated hematology instrumentation\", section on 'Reticulated platelets'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The assay for reticulated platelets is a simple, noninvasive method of assessing platelet turnover or thrombopoiesis in different types of thrombocytopenia, is a simple predictor of bone marrow recovery after transplantation, and can be utilized to monitor the response to therapy with growth factors such as thrombopoietin [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/134\">",
"     134",
"    </a>",
"    ]. Additional clinical studies will need to be performed before the assay may be reliably used as a predictor of thrombosis in patients with myeloproliferative syndromes, such as essential thrombocythemia [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/135\">",
"     135",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The test is now available as an additional fully automated complete blood count parameter called the Immature Platelet Fraction (IPF) that uses IPF master software within the Sysmex XE2100 analyzer [",
"    <a class=\"abstract\" href=\"UTD.htm?22/59/23482/abstract/136,137\">",
"     136,137",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18121816\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to the evaluation of platelet numbers and morphology by examination of the peripheral blood smear, a number of tests of platelet function are available to the clinician (",
"    <a class=\"graphic graphic_table graphicRef59857 \" href=\"UTD.htm?24/38/25196\">",
"     table 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_table graphicRef52144 \" href=\"UTD.htm?6/62/7149\">",
"     table 2",
"    </a>",
"    ). These are described in the text and include the following major tests:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Manual and automated platelet counting, including presence of reticulated (young) platelets",
"     </li>",
"     <li>",
"      Platelet aggregometry",
"     </li>",
"     <li>",
"      The platelet function analyzer",
"     </li>",
"     <li>",
"      In vivo bleeding time",
"     </li>",
"     <li>",
"      Platelet mediated thrombin generation",
"     </li>",
"     <li>",
"      Thromboelastography",
"     </li>",
"     <li>",
"      Measurement of platelet activation",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/1\">",
"      Bizzozero J. On a new blood particle and its role in thrombosis and blood coagulation. Virchows Arch B Cell Pathol Incl Mol Pathol 1982; 90:261.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/2\">",
"      BORN GV. Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 1962; 194:927.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/3\">",
"      George JN, Shattil SJ. The clinical importance of acquired abnormalities of platelet function. N Engl J Med 1991; 324:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/4\">",
"      Nurden AT. Inherited abnormalities of platelets. Thromb Haemost 1999; 82:468.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/5\">",
"      BRECHER G, SCHNEIDERMAN M, CRONKITE EP. The reproducibility and constancy of the platelet count. Am J Clin Pathol 1953; 23:15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/6\">",
"      England JM, Rowan RM, Bins M, et al. Recommended methods for the visual determination of white cell and platelet counts. WHO LAB 1988; 3:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/7\">",
"      Harrison P, Horton A, Grant D, et al. Immunoplatelet counting: a proposed new reference procedure. Br J Haematol 2000; 108:228.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/8\">",
"      Bowles KM, Bloxham DM, Perry DJ, Baglin TP. Discrepancy between impedance and immunofluorescence platelet counting has implications for clinical decision making in patients with idiopathic thrombocytopenia purpura. Br J Haematol 2006; 134:320.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/9\">",
"      Ault K. Platelet Counting: Is there room for improvement. Laboratory Hematology 1996; 2:265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/10\">",
"      Gm&uuml;r J, Burger J, Schanz U, et al. Safety of stringent prophylactic platelet transfusion policy for patients with acute leukaemia. Lancet 1991; 338:1223.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/11\">",
"      Ancliff PJ, Machin SJ. Trigger factors for prophylactic platelet transfusion. Blood Rev 1998; 12:234.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/12\">",
"      Norfolk DR, Ancliffe PJ, Contreras M, et al. Consensus Conference on Platelet Transfusion, Royal College of Physicians of Edinburgh, 27-28 November 1997. Synopsis of background papers. Br J Haematol 1998; 101:609.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/13\">",
"      Rebulla P, Finazzi G, Marangoni F, et al. The threshold for prophylactic platelet transfusion in adults with acute myeloid leukemia. N Eng J Med 1997; 337:1870.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/14\">",
"      Schiffer CA, Anderson KC, Bennett CL, et al. Platelet transfusion for patients with cancer: clinical practice guidelines of the American Society of Clinical Oncology. J Clin Oncol 2001; 19:1519.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/15\">",
"      Stanworth SJ, Denton K, Monteath J, Patton WN. Automated counting of platelets on the Bayer ADVIA 120 analyser. Clin Lab Haematol 1999; 21:113.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/16\">",
"      Briggs C, Harrison P, Grant D, et al. New quantitative parameters on a recently introduced automated blood cell counter--the XE 2100. Clin Lab Haematol 2000; 22:345.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/17\">",
"      Davis B, Bigelow N. Indirect immunoplatelet counting by flow cytometry as a reference method for platelet count calibration. Laboratory Hematology 1999; 5:15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/18\">",
"      Kunz D, Kunz WS, Scott CS, Gressner AM. Automated CD61 immunoplatelet analysis of thrombocytopenic samples. Br J Haematol 2001; 112:584.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/19\">",
"      Harrison P, Ault KA, Chapman S, et al. An interlaboratory study of a candidate reference method for platelet counting. Am J Clin Pathol 2001; 115:448.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/20\">",
"      Ault KA, Mitchell J, Knowles C, Van Hove L. Implementation of the immunological platelet count on a hematology analyser, the Abbot CELL-DYN 4000. Laboratory Hematology 1997; 3:125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/21\">",
"      Kickler TS, Rothe M, Blosser L, et al. Improving platelet transfusion therapy using the ImmunoPLT method on the CELL-DYN 4000. Laboratory Hematology 1998; 4:80.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/22\">",
"      Arroyo JL, Garc&iacute;a-Marcos MA, L&oacute;pez A, et al. Evaluation of a CD61 MoAb method for enumeration of platelets in thrombocytopenic patients and its impact on the transfusion decision-making process. Transfusion 2001; 41:1212.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/23\">",
"      Segal HC, Briggs C, Kunka S, et al. Accuracy of platelet counting haematology analysers in severe thrombocytopenia and potential impact on platelet transfusion. Br J Haematol 2005; 128:520.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/24\">",
"      Harrison P, Segal H, Briggs C, et al. Impact of immunological platelet counting (by the platelet/RBC ratio) on haematological practice. Cytometry B Clin Cytom 2005; 67:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/25\">",
"      Nicholson NS, Panzer-Knodle SG, Haas NF, et al. Assessment of platelet function assays. Am Heart J 1998; 135:S170.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/26\">",
"      Carville DG, Schleckser PA, Guyer KE, et al. Whole blood platelet function assay on the ICHOR point-of-care hematology analyzer. J Extra Corpor Technol 1998; 30:171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/27\">",
"      Campbell J, Ridgway H, Carville D. Plateletworks: a novel point of care platelet function screen. Mol Diagn Ther 2008; 12:253.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/28\">",
"      Hayward CP, Pai M, Liu Y, et al. Diagnostic utility of light transmission platelet aggregometry: results from a prospective study of individuals referred for bleeding disorder assessments. J Thromb Haemost 2009; 7:676.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/29\">",
"      Cattaneo M, Hayward CP, Moffat KA, et al. Results of a worldwide survey on the assessment of platelet function by light transmission aggregometry: a report from the platelet physiology subcommittee of the SSC of the ISTH. J Thromb Haemost 2009; 7:1029.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/30\">",
"      Jennings I, Woods TA, Kitchen S, Walker ID. Platelet function testing: practice among UK National External Quality Assessment Scheme for Blood Coagulation participants, 2006. J Clin Pathol 2008; 61:950.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/31\">",
"      Quiroga T, Goycoolea M, Matus V, et al. Diagnosis of mild platelet function disorders. Reliability and usefulness of light transmission platelet aggregation and serotonin secretion assays. Br J Haematol 2009; 147:729.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/32\">",
"      Mascelli MA, Worley S, Veriabo NJ, et al. Rapid assessment of platelet function with a modified whole-blood aggregometer in percutaneous transluminal coronary angioplasty patients receiving anti-GP IIb/IIIa therapy. Circulation 1997; 96:3860.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/33\">",
"      Born GV, Hume M. Effects of the numbers and sizes of platelet aggregates on the optical density of plasma. Nature 1967; 215:1027.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/34\">",
"      Frojmovic MM, Milton JG, Duchastel A. Microscopic measurements of platelet aggregation reveal a low ADP-dependent process distinct from turbidometrically measured aggregation. J Lab Clin Med 1983; 101:964.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/35\">",
"      Thompson NT, Scrutton MC, Wallis RB. Particle volume changes associated with light transmittance changes in the platelet aggregometer: dependence upon aggregating agent and effectiveness of stimulus. Thromb Res 1986; 41:615.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/36\">",
"      Cardinal DC, Flower RJ. The electronic aggregometer: a novel device for assessing platelet behavior in blood. J Pharmacol Methods 1980; 3:135.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/37\">",
"      Mackie IJ, Jones R, Machin SJ. Platelet impedance aggregation in whole blood and its inhibition by antiplatelet drugs. J Clin Pathol 1984; 37:874.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/38\">",
"      Storey RF, May JA, Wilcox RG, Heptinstall S. A whole blood assay of inhibition of platelet aggregation by glycoprotein IIb/IIIa antagonists: comparison with other aggregation methodologies. Thromb Haemost 1999; 82:1307.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/39\">",
"      Seyfert UT, Haubelt H, Vogt A, Hellstern P. Variables influencing Multiplate(TM) whole blood impedance platelet aggregometry and turbidimetric platelet aggregation in healthy individuals. Platelets 2007; 18:199.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/40\">",
"      Sibbing D, Braun S, Morath T, et al. Platelet reactivity after clopidogrel treatment assessed with point-of-care analysis and early drug-eluting stent thrombosis. J Am Coll Cardiol 2009; 53:849.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/41\">",
"      Solis RT, Wright CB, Gibbs MB. Electronic particle size measurements of platelet aggregates formed in vitro. J Appl Physiol 1975; 38:739.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/42\">",
"      Ozaki Y, Satoh K, Yatomi Y, et al. Detection of platelet aggregates with a particle counting method using light scattering. Anal Biochem 1994; 218:284.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/43\">",
"      Yamamoto T, Egawa Y, Shirasawa Y, et al. A laser light scattering in situ system for counting aggregates in blood platelet aggregation. Meas Sci Technol 1995; 6:174.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/44\">",
"      Eto K, Takeshita S, Ochiai M, et al. Platelet aggregation in acute coronary syndromes: use of a new aggregometer with laser light scattering to assess platelet aggregability. Cardiovasc Res 1998; 40:223.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/45\">",
"      Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. The EPIC Investigation. N Engl J Med 1994; 330:956.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/46\">",
"      Coller BS. Monitoring platelet GP IIb/IIIa antagonist therapy. Circulation 1998; 97:5.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/47\">",
"      Cox D. Methods for monitoring platelet function. Am Heart J 1998; 135:S160.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/48\">",
"      Frelinger AL, Hillman RS. Novel methods for assessing platelet function. Am Heart J 1998; 136:S184.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/49\">",
"      Smith JW, Steinhubl SR, Lincoff AM, et al. Rapid platelet-function assay: an automated and quantitative cartridge-based method. Circulation 1999; 99:620.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/50\">",
"      Kereiakes DJ, Mueller M, Howard W, et al. Efficacy of abciximab induced platelet blockade using a rapid point of care assay. J Thromb Thrombolysis 1999; 7:265.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/51\">",
"      Coller BS, Lang D, Scudder LE. Rapid and simple platelet function assay to assess glycoprotein IIb/IIIa receptor blockade. Circulation 1997; 95:860.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/52\">",
"      Duke WW. The relation of blood platelets to hemorrhagic disease. JAMA 1910; 55:1185.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/53\">",
"      Ivy AC, Shapiro PF, Melnick P. The bleeding time in Jaundice. Surgery, Gynecol Obstet 1935; 60:781.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/54\">",
"      Mielke CH Jr, Kaneshiro MM, Maher IA, et al. The standardized normal Ivy bleeding time and its prolongation by aspirin. Blood 1969; 34:204.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/55\">",
"      Rodgers RP, Levin J. A critical reappraisal of the bleeding time. Semin Thromb Hemost 1990; 16:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/56\">",
"      Yardumian DA, Mackie IJ, Machin SJ. Laboratory investigation of platelet function: a review of methodology. J Clin Pathol 1986; 39:701.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/57\">",
"      Guidelines on platelet function testing. The British Society for Haematology BCSH Haemostasis and Thrombosis Task Force. J Clin Pathol 1988; 41:1322.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/58\">",
"      Proceedings on the symposium: Novel techniques involving platelet activity in flow. Florence, Italy. Thromb Res 1997; 92:S23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/59\">",
"      Dickinson KJ, Troxler M, Homer-Vanniasinkam S. The surgical application of point-of-care haemostasis and platelet function testing. Br J Surg 2008; 95:1317.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/60\">",
"      G&ouml;r&ouml;g P, Ahmed A. Haemostatometer: a new in vitro technique for assessing haemostatic activity of blood. Thromb Res 1984; 34:341.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/61\">",
"      Li CK, Hoffmann TJ, Hsieh PY, et al. Xylum CSA: automated system for assessing hemostasis in simulated vascular flow. Clin Chem 1997; 43:1788.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/62\">",
"      Conan K, Li N, Hoffmann TJ, et al. The Xylum Clot Signature Analyser: A dynamic flow sytstem that simulates vascular injury. Thromb Res 1998; 92:S677.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/63\">",
"      Gorog DA, Kovacs IB. Thrombotic status analyser. Measurement of platelet-rich thrombus formation and lysis in native blood. Thromb Haemost 1995; 73:514.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/64\">",
"      Kratzer MA, Born GV. Simulation of primary hemostasis in vitro. Hemostasis 1985; 5:357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/65\">",
"      Kundu SK, Heilmann EJ, Sio R, et al. Description of an in vitro platelet function analyzer--PFA-100. Semin Thromb Hemost 1995; 21 Suppl 2:106.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/66\">",
"      Kundu SK, Heilmann EJ, Sio R, et al. Characterization of an In vitro Platelet Function Analyser, PFA-100TM. Clin Appl Thromb hemost 1996; 2:241.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/67\">",
"      Mammen EF, Comp PC, Gosselin R, et al. PFA-100 system: a new method for assessment of platelet dysfunction. Semin Thromb Hemost 1998; 24:195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/68\">",
"      Harrison P, Robinson MS, Mackie IJ, et al. Performance of the platelet function analyser PFA-100 in testing abnormalities of primary haemostasis. Blood Coagul Fibrinolysis 1999; 10:25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/69\">",
"      Carcao MD, Blanchette VS, Dean JA, et al. The Platelet Function Analyzer (PFA-100): a novel in-vitro system for evaluation of primary haemostasis in children. Br J Haematol 1998; 101:70.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/70\">",
"      Francis J, Francis D, Larson L, et al. Can the Platelet Function Analyzer (PFA)-100 test substitute for the template bleeding time in routine clinical practice? Platelets 1999; 10:132.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/71\">",
"      Carcao MD, Blanchette VS, Stephens D, et al. Assessment of thrombocytopenic disorders using the Platelet Function Analyzer (PFA-100). Br J Haematol 2002; 117:961.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/72\">",
"      Zupan IP, Sabovic M, Salobir B, et al. Utility of in vitro closure time test for evaluating platelet-related primary hemostasis in dialysis patients. Am J Kidney Dis 2003; 42:746.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/73\">",
"      Zupan IP, Sabovic M, Salobir B, et al. The study of anaemia-related haemostasis impairment in haemodialysis patients by in vitro closure time test. Thromb Haemost 2005; 93:375.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/74\">",
"      Harrison P. The role of PFA-100 testing in the investigation and management of haemostatic defects in children and adults. Br J Haematol 2005; 130:3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/75\">",
"      Haubelt H, Anders C, Vogt A, et al. Variables influencing Platelet Function Analyzer-100 closure times in healthy individuals. Br J Haematol 2005; 130:759.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/76\">",
"      Roschitz B, Thaller S, Koestenberger M, et al. PFA-100 closure times in preoperative screening in 500 pediatric patients. Thromb Haemost 2007; 98:243.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/77\">",
"      Quiroga T, Goycoolea M, Mu&ntilde;oz B, et al. Template bleeding time and PFA-100 have low sensitivity to screen patients with hereditary mucocutaneous hemorrhages: comparative study in 148 patients. J Thromb Haemost 2004; 2:892.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/78\">",
"      Fressinaud E, Veyradier A, Sigaud M, et al. Therapeutic monitoring of von Willebrand disease: interest and limits of a platelet function analyser at high shear rates. Br J Haematol 1999; 106:777.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/79\">",
"      Cattaneo M, Federici AB, Lecchi A, et al. Evaluation of the PFA-100 system in the diagnosis and therapeutic monitoring of patients with von Willebrand disease. Thromb Haemost 1999; 82:35.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/80\">",
"      Posan E, McBane RD, Grill DE, et al. Comparison of PFA-100 testing and bleeding time for detecting platelet hypofunction and von Willebrand disease in clinical practice. Thromb Haemost 2003; 90:483.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/81\">",
"      Fressinaud E, Veyradier A, Truchaud F, et al. Screening for von Willebrand disease with a new analyzer using high shear stress: a study of 60 cases. Blood 1998; 91:1325.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/82\">",
"      Cattaneo M, Lecchi A, Agati B, et al. Evaluation of platelet function with the PFA-100 system in patients with congenital defects of platelet secretion. Thromb Res 1999; 96:213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/83\">",
"      Marshall PW, Williams AJ, Dixon RM, et al. A comparison of the effects of aspirin on bleeding time measured using the Simplate method and closure time measured using the PFA-100, in healthy volunteers. Br J Clin Pharmacol 1997; 44:151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/84\">",
"      Homoncik M, Jilma B, Hergovich N, et al. Monitoring of aspirin (ASA) pharmacodynamics with the platelet function analyzer PFA-100. Thromb Haemost 2000; 83:316.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/85\">",
"      Jilma-Stohlawetz P, Hergovich N, Homoncik M, et al. Impaired platelet function among platelet donors. Thromb Haemost 2001; 86:880.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/86\">",
"      Hayward CP, Harrison P, Cattaneo M, et al. Platelet function analyzer (PFA)-100 closure time in the evaluation of platelet disorders and platelet function. J Thromb Haemost 2006; 4:312.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/87\">",
"      Varon D, Dardik R, Shenkman B, et al. A new method for quantitative analysis of whole blood platelet interaction with extracellular matrix under flow conditions. Thromb Res 1997; 85:283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/88\">",
"      Varon D, Lashevski I, Brenner B, et al. Cone and plate(let) analyzer: monitoring glycoprotein IIb/IIIa antagonists and von Willebrand disease replacement therapy by testing platelet deposition under flow conditions. Am Heart J 1998; 135:S187.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/89\">",
"      Kenet G, Lubetsky A, Shenkman B, et al. Cone and platelet analyser (CPA): a new test for the prediction of bleeding among thrombocytopenic patients. Br J Haematol 1998; 101:255.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/90\">",
"      Shenkman B, Inbal A, Tamarin I, et al. Diagnosis of thrombotic thrombocytopenic purpura based on modulation by patient plasma of normal platelet adhesion under flow condition. Br J Haematol 2003; 120:597.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/91\">",
"      O'Brien JR, Salmon GP. Shear stress activation of platelet glycoprotein IIb/IIIa plus von Willebrand factor causes aggregation: filter blockage and the long bleeding time in von Willebrand's disease. Blood 1987; 70:1354.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/92\">",
"      Elwood PC, Beswick A, Pickering J, et al. Platelet tests in the prediction of myocardial infarction and ischaemic stroke: evidence from the Caerphilly Prospective Study. Br J Haematol 2001; 113:514.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/93\">",
"      Reverter JC, B&eacute;guin S, Kessels H, et al. Inhibition of platelet-mediated, tissue factor-induced thrombin generation by the mouse/human chimeric 7E3 antibody. Potential implications for the effect of c7E3 Fab treatment on acute thrombosis and \"clinical restenosis\". J Clin Invest 1996; 98:863.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/94\">",
"      Byzova TV, Plow EF. Networking in the hemostatic system. Integrin alphaiibbeta3 binds prothrombin and influences its activation. J Biol Chem 1997; 272:27183.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/95\">",
"      Hardisty RM, Hutton RA. Platelet aggregation and the availability of platelet factor 3. Br J Haematol 1966; 12:764.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/96\">",
"      Dargaud Y, Luddington R, Baglin T. Platelet-dependent thrombography: a method for diagnostic laboratories. Br J Haematol 2006; 134:323.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/97\">",
"      Despotis GJ, Levine V, Filos KS, et al. Evaluation of a new point-of-care test that measures PAF-mediated acceleration of coagulation in cardiac surgical patients. Anesthesiology 1996; 85:1311.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/98\">",
"      Despotis GJ, Levine V, Saleem R, et al. Use of point-of-care test in identification of patients who can benefit from desmopressin during cardiac surgery: a randomised controlled trial. Lancet 1999; 354:106.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/99\">",
"      Coiffic A, Cazes E, Janvier G, et al. Inhibition of platelet aggregation by abciximab but not by aspirin can be detected by a new point-of-care test, the hemostatus. Thromb Res 1999; 95:83.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/100\">",
"      Trentalange MJ, Walts LF. A comparison of thromboelastogram and template bleeding time in the evaluation of platelet function after aspirin ingestion. J Clin Anesth 1991; 3:377.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/101\">",
"      Orlikowski CE, Payne AJ, Moodley J, Rocke DA. Thrombelastography after aspirin ingestion in pregnant and non-pregnant subjects. Br J Anaesth 1992; 69:159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/102\">",
"      Blais N, Pharand C, Lordkipanidz&eacute; M, et al. Response to aspirin in healthy individuals. Cross-comparison of light transmission aggregometry, VerifyNow system, platelet count drop, thromboelastography (TEG) and urinary 11-dehydrothromboxane B(2). Thromb Haemost 2009; 102:404.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/103\">",
"      Carr ME Jr, Zekert SL. Measurement of platelet-mediated force development during plasma clot formation. Am J Med Sci 1991; 302:13.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/104\">",
"      Carr ME Jr. Measurement of platelet force: the Hemodyne hemostasis analyzer. Clin Lab Manage Rev 1995; 9:312.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/105\">",
"      Greilich PE, Carr ME Jr, Carr SL, Chang AS. Reductions in platelet force development by cardiopulmonary bypass are associated with hemorrhage. Anesth Analg 1995; 80:459.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/106\">",
"      Carr ME Jr, Carr SL, Hantgan RR, Braaten J. Glycoprotein IIb/IIIa blockade inhibits platelet-mediated force development and reduces gel elastic modulus. Thromb Haemost 1995; 73:499.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/107\">",
"      Greilich PE, Carr ME, Zekert SL, Dent RM. Quantitative assessment of platelet function and clot structure in patients with severe coronary artery disease. Am J Med Sci 1994; 307:15.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/108\">",
"      Wu KK, Hoak JC. A new method for the quantitative detection of platelet aggregates in patients with arterial insufficiency. Lancet 1974; 2:924.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/109\">",
"      Bowry SK, Prentice CR, Courtney JM. A modification of the Wu and Hoak method for the determination of platelet aggregates and platelet adhesion. Thromb Haemost 1985; 53:381.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/110\">",
"      Fijnheer R, Frijns CJ, Korteweg J, et al. The origin of P-selectin as a circulating plasma protein. Thromb Haemost 1997; 77:1081.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/111\">",
"      Michelson AD, Barnard MR, Hechtman HB, et al. In vivo tracking of platelets: circulating degranulated platelets rapidly lose surface P-selectin but continue to circulate and function. Proc Natl Acad Sci U S A 1996; 93:11877.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/112\">",
"      Michelson AD. Flow cytometry: a clinical test of platelet function. Blood 1996; 87:4925.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/113\">",
"      Michelson AD, Furman MI. Laboratory markers of platelet activation and their clinical significance. Curr Opin Hematol 1999; 6:342.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/114\">",
"      Schmitz G, Rothe G, Ruf A, et al. European Working Group on Clinical Cell Analysis: Consensus protocol for the flow cytometric characterisation of platelet function. Thromb Haemost 1998; 79:885.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/115\">",
"      Furman MI, Benoit SE, Barnard MR, et al. Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery disease. J Am Coll Cardiol 1998; 31:352.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/116\">",
"      Ault KA, Cannon CP, Mitchell J, et al. Platelet activation in patients after an acute coronary syndrome: results from the TIMI-12 trial. Thrombolysis in Myocardial Infarction. J Am Coll Cardiol 1999; 33:634.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/117\">",
"      Grau AJ, Ruf A, Vogt A, et al. Increased fraction of circulating activated platelets in acute and previous cerebrovascular ischemia. Thromb Haemost 1998; 80:298.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/118\">",
"      Zeller JA, Tschoepe D, Kessler C. Circulating platelets show increased activation in patients with acute cerebral ischemia. Thromb Haemost 1999; 81:373.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/119\">",
"      Joseph JE, Donohoe S, Harrison P, et al. Platelet activation and turnover in the primary antiphospholipid syndrome. Lupus 1998; 7:333.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/120\">",
"      Tschoepe D, Schultheiss HP, Kolarov P, et al. Platelet membrane activation markers are predictive for increased risk of acute ischemic events after PTCA. Circulation 1993; 88:37.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/121\">",
"      Li N, Goodall AH, Hjemdahl P. A sensitive flow cytometric assay for circulating platelet-leucocyte aggregates. Br J Haematol 1997; 99:808.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/122\">",
"      Nieuwland R, Berckmans RJ, McGregor S, et al. Cellular origin and procoagulant properties of microparticles in meningococcal sepsis. Blood 2000; 95:930.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/123\">",
"      Shet AS, Aras O, Gupta K, et al. Sickle blood contains tissue factor-positive microparticles derived from endothelial cells and monocytes. Blood 2003; 102:2678.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/124\">",
"      Weiss HJ. Scott syndrome: a disorder of platelet coagulant activity. Semin Hematol 1994; 31:312.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/125\">",
"      Horstman LL, Ahn YS. Platelet microparticles: a wide-angle perspective. Crit Rev Oncol Hematol 1999; 30:111.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/126\">",
"      Gordon N, Thom J, Cole C, Baker R. Rapid detection of hereditary and acquired platelet storage pool deficiency by flow cytometry. Br J Haematol 1995; 89:117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/127\">",
"      Wall JE, Buijs-Wilts M, Arnold JT, et al. A flow cytometric assay using mepacrine for study of uptake and release of platelet dense granule contents. Br J Haematol 1995; 89:380.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/128\">",
"      Summerfield GP, Keenan JP, Brodie NJ, Bellingham AJ. Bioluminescent assay of adenine nucleotides: rapid analysis of ATP and ADP in red cells and platelets using the LKB luminometer. Clin Lab Haematol 1981; 3:257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/129\">",
"      Ault KA, Knowles C. In vivo biotinylation demonstrates that reticulated platelets are the youngest platelets in circulation. Exp Hematol 1995; 23:996.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/130\">",
"      Dale GL, Friese P, Hynes LA, Burstein SA. Demonstration that thiazole-orange-positive platelets in the dog are less than 24 hours old. Blood 1995; 85:1822.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/131\">",
"      Robinson MS, Mackie IJ, Khair K, et al. Flow cytometric analysis of reticulated platelets: evidence for a large proportion of non-specific labelling of dense granules by fluorescent dyes. Br J Haematol 1998; 100:351.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/132\">",
"      Balduini CL, Noris P, Spedini P, et al. Relationship between size and thiazole orange fluorescence of platelets in patients undergoing high-dose chemotherapy. Br J Haematol 1999; 106:202.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/133\">",
"      Matic GB, Chapman ES, Zaiss M, et al. Whole blood analysis of reticulated platelets: improvements of detection and assay stability. Cytometry 1998; 34:229.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/134\">",
"      Harrison P, Robinson MS, Mackie IJ, Machin SJ. Reticulated platelets. Platelets 1997; 8:379.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/135\">",
"      Rinder HM, Schuster JE, Rinder CS, et al. Correlation of thrombosis with increased platelet turnover in thrombocytosis. Blood 1998; 91:1288.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/136\">",
"      Briggs C, Kunka S, Hart D, et al. Assessment of an immature platelet fraction (IPF) in peripheral thrombocytopenia. Br J Haematol 2004; 126:93.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?22/59/23482/abstract/137\">",
"      Harrison P, Goodall AH. \"Message in the platelet\"--more than just vestigial mRNA! Platelets 2008; 19:395.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4433 Version 11.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-118.195.65.247-6C4A8C19E1-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_59_23482=[""].join("\n");
var outline_f22_59_23482=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H18121816\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PLATELET COUNTING METHODS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Manual platelet counting",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Automated cell counter methods",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      - Optical counting methods",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      - Flow cytometric methods",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Platelet count ratio method for platelet function testing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      PLATELET AGGREGOMETRY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Classical platelet aggregometry",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Whole blood aggregometry",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Light scattering methods",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      The VerifyNow Assay",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      THE IN VIVO BLEEDING TIME",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      INSTRUMENTS THAT SIMULATE PLATELET FUNCTION IN VITRO",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Clot signature analyzer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Thrombotic status analyzer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      The platelet function analyzer",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      - Use in von Willebrand disease",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      - Use in platelet secretion defects",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Cone and plate(let) analyzer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      High shear filterometer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      PLATELET MEDIATED THROMBIN GENERATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Hemostatus device",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Instruments measuring physical properties of the clot",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      - Thromboelastography",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      - Platelet contractile force",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      MEASUREMENT OF PLATELET ACTIVATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      Soluble activation markers",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      Flow cytometric analysis of platelets and activation markers",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      - Reticulated platelets",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18121816\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"HEME/4433\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"HEME/4433|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?18/57/19359\" title=\"figure 1\">",
"      Automated platelet counting low",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?21/1/21533\" title=\"figure 2\">",
"      Platelet aggregometry",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?2/33/2591\" title=\"figure 3\">",
"      Normal thromboelastography tracing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"HEME/4433|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?24/38/25196\" title=\"table 1\">",
"      Platelet function tests",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?6/62/7149\" title=\"table 2\">",
"      Newer platelet function tests",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?20/10/20652\" title=\"table 3\">",
"      Platelet aggregation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?41/10/42156\" title=\"table 4\">",
"      Thromboelastography definitions",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/3/5178?source=related_link\">",
"      Approach to the adult patient with a bleeding diathesis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/54/35690?source=related_link\">",
"      Automated hematology instrumentation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?43/8/44169?source=related_link\">",
"      Classification and pathophysiology of von Willebrand disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/6/20586?source=related_link\">",
"      Clinical and laboratory aspects of platelet transfusion therapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/13/24794?source=related_link\">",
"      Clinical presentation and diagnosis of von Willebrand disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/44/23242?source=related_link\">",
"      Coagulopathy associated with trauma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/9/29850?source=related_link\">",
"      Congenital and acquired disorders of platelet function",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/31/19961?source=related_link\">",
"      Early trials of platelet glycoprotein IIb/IIIa receptor inhibitors in coronary heart disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/60/19401?source=related_link\">",
"      Nonresponse and resistance to aspirin",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/35/27194?source=related_link\">",
"      Overview of hemostasis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/43/32439?source=related_link\">",
"      Preoperative assessment of hemostasis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f22_59_23483="Terminology developmental dysplasia of the hip";
var content_f22_59_23483=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F88588&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=0\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F88588&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=0\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Terminology for developmental dysplasia of the hip",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Term",
"       </td>",
"       <td class=\"subtitle1\">",
"        Definition",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Dislocation",
"       </td>",
"       <td>",
"        Complete loss of contact between the femoral head and the acetabulum.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Subluxation",
"       </td>",
"       <td>",
"        The femoral head is partially outside of the acetabulum but remains in contact with it.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Dislocatable",
"       </td>",
"       <td>",
"        The femoral head is reduced (ie, within the acetabulum) at rest, but can dislocate in other positions or with examination maneuvers. This is a hip with",
"        <strong>",
"         instability",
"        </strong>",
"        .",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Subluxatable/subluxable",
"       </td>",
"       <td>",
"        The femoral head is reduced at rest but can be partially dislocated or subluxated with examination maneuvers. This is a hip with",
"        <strong>",
"         mild instability or laxity",
"        </strong>",
"        .",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Reducible",
"       </td>",
"       <td>",
"        The hip is dislocated at rest, but the femoral head can be positioned into the acetabulum with manipulation (generally flexion and abduction).",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Dysplasia",
"       </td>",
"       <td>",
"        Abnormality of the shape of the hip joint (usually shallowness of the acetabulum, involving the superior and anterior margins).",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_59_23483=[""].join("\n");
var outline_f22_59_23483=null;
var title_f22_59_23484="Tumor skull base synd";
var content_f22_59_23484=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F64650&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F64650&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Tumor-related base of skull syndromes in cancer patients",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1\">",
"       Syndrome",
"      </td>",
"      <td class=\"subtitle1\">",
"       Characteristics",
"      </td>",
"     </tr>",
"     <tr>",
"      <td rowspan=\"2\">",
"       Orbital syndrome",
"      </td>",
"      <td>",
"       Increasing pain in the retroorbital and supraorbital regions of the affected eye",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Associated problems include blurred vision, diplopia, proptosis, chemosis (conjunctival edema), external ophthalmoplegia, ipsilateral papilledema, and decreased sensation in the ophthalmic division of the trigeminal nerve",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Parasellar syndrome",
"      </td>",
"      <td>",
"       Neoplastic invasion in the parasellar region can lead to unilateral supraorbital and frontal headache, as well as diplopia",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Middle cranial fossa syndrome",
"      </td>",
"      <td>",
"       Pain and sensory changes in the distribution of the mandibular and maxillary divisions of the trigeminal nerve. May be associated with headache, diplopia, dysarthria, dysphagia, facial numbness, paresthesias, or pain referred to the cheek or jaw.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td rowspan=\"2\">",
"       Jugular foramen and hypoglossal syndrome",
"      </td>",
"      <td>",
"       Afffects the glossopharyngeal, vagus, and accessory nerves. Throat pain, hoarseness, dysphasia, deep aching in the ipsilateral mastoid region, and glossopharyngeal neuralgia with or without bradycardia and syncope.",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Neurological signs may include Horner's syndrome and weakness of the palatal muscles, sternocleidomastoid, or trapezius muscles",
"      </td>",
"     </tr>",
"     <tr>",
"      <td rowspan=\"3\">",
"       Occipital condyle syndrome",
"      </td>",
"      <td>",
"       Presents with severe unilateral occipital pain that is worsened by neck flexion, neck stiffness",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Almost always includes concomitant involvement of hypoglossal canal leading to paresis and atrophy of ipsilateral tongue",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Physical examination may reveal head tilt, limited movement of neck, tenderness to palpation over occipito-nuchal junction",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Clivus syndrome",
"      </td>",
"      <td>",
"       Severe headache maximally experienced at vertex and worse with neck flexion, sixth nerve palsy",
"      </td>",
"     </tr>",
"     <tr>",
"      <td rowspan=\"2\">",
"       Sphenoid sinus syndrome",
"      </td>",
"      <td>",
"       Bifrontal headache radiating to the temples and retroorbital areas",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       May present with associated nasal congestion and diplopia from sixth nerve palsy",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Fracture of the odontoid process (dens)",
"      </td>",
"      <td>",
"       Posterior headache, worse on neck flexion. Instability of the cervical spine or mass effect from tumor may cause spinal cord or brainstem compression.",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_59_23484=[""].join("\n");
var outline_f22_59_23484=null;
var title_f22_59_23485="DDx of rash by appearance 1";
var content_f22_59_23485=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F52167&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F52167&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Differential diagnosis of fever and rash based upon appearance of the rash",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Macules, papules, nodules, or plaques",
"       </td>",
"       <td class=\"subtitle1\">",
"        Vesicles, bullae, or pustules",
"       </td>",
"       <td class=\"subtitle1\">",
"        Purpuric macules, purpuric papules, or purpuric vesicles",
"       </td>",
"       <td class=\"subtitle1\">",
"        Followed widespread erythema with or without edema by desquamation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"4\">",
"        Bacterial",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        <p>",
"         Arcanobacterium haemolyticum",
"        </p>",
"        <p>",
"         Bacillus anthracis",
"        </p>",
"        <p>",
"         Bartonella bacilliformis",
"        </p>",
"        <p>",
"         Bartonella henselae (cat scratch disease)",
"        </p>",
"        <p>",
"         Bartonella quintana (trench fever)",
"        </p>",
"        <p>",
"         Borrelia burgdorferi (Lyme disease)*",
"        </p>",
"        <p>",
"         Borrelia spp (relapsing fever)",
"        </p>",
"        <p>",
"         Brucella spp (brucellosis)*",
"        </p>",
"        <p>",
"         Calymmatobacterium granulomatis (donovanosis)*",
"        </p>",
"        <p>",
"         Chlamydia psittaci (psittacosis)",
"        </p>",
"        <p>",
"         Ehrlichiosis*",
"        </p>",
"        <p>",
"         Ehrlichia chafeensis (HME)",
"        </p>",
"        <p>",
"         Human granulocytic erlichiosis (HGE)",
"        </p>",
"        <p>",
"         Erypsipelothrix rhusiopathiae (erysipeloid)",
"        </p>",
"        <p>",
"         Francisella tularensis (tularemia)",
"        </p>",
"        <p>",
"         Listeria monocytogenes",
"        </p>",
"        <p>",
"         Leptospira sp (leptospirosis)*",
"        </p>",
"        <p>",
"         Mycobacterium leprae*",
"        </p>",
"        <p>",
"         Mycobacterium marinum*",
"        </p>",
"        <p>",
"         Mycobacterium tuberculosis",
"        </p>",
"        <p>",
"         Mycoplasma pneumoniae",
"        </p>",
"        <p>",
"         Neisseria gonorrhoeae (gonorrhea)*",
"        </p>",
"        <p>",
"         Neisseria meningitidis (meningococcemia)*",
"        </p>",
"        <p>",
"         Pseudomonas aeruginosa",
"        </p>",
"        <p>",
"         Rickettsia akari (rickettsialpox)",
"        </p>",
"        <p>",
"         Rickettsia prowazekii (epidemic/louse- borne typhus)",
"        </p>",
"        <p>",
"         Rickettsia rickettsii (RMSF-early lesions)*",
"         <sup>",
"          &bull;",
"         </sup>",
"        </p>",
"        <p>",
"         Rickettsia orientalis/tsutsugamushi (scrub typhus)",
"        </p>",
"        <p>",
"         Rickettsia typhi (endemic/murine typhus)",
"        </p>",
"        <p>",
"         Salmonella typhi (typhoid fever)*",
"        </p>",
"        <p>",
"         Spirillum minor (rat-bite fever)",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         Bacillus anthracis",
"        </p>",
"        <p>",
"         Ehrlichia canis",
"        </p>",
"        <p>",
"         Listeria monocytogenes",
"        </p>",
"        <p>",
"         Mycoplasma pneumoniae",
"        </p>",
"        <p>",
"         Neisseria gonorrhoeae*",
"        </p>",
"        <p>",
"         Neisseria meningitidis*",
"        </p>",
"        <p>",
"         Pseudomonas aeruginosa",
"        </p>",
"        <p>",
"         Rickettsia akari",
"        </p>",
"        <p>",
"         Rickettsia rickettsii*",
"        </p>",
"        <p>",
"         Staphylococcus aureus (TSS, SSSS)",
"        </p>",
"        <p>",
"         Streptococcus group A",
"        </p>",
"        <p>",
"         Treponema pallidum (secondary syphilis)",
"        </p>",
"        <p>",
"         Vibrio vulnificus",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         Bacteremia",
"         <sup>",
"          &Delta;",
"         </sup>",
"        </p>",
"        <p>",
"         Borrelia spp",
"        </p>",
"        <p>",
"         Clostridium spp",
"        </p>",
"        <p>",
"         Infective endocarditis (many species)",
"        </p>",
"        <p>",
"         Haemophilus influenzae type B",
"        </p>",
"        <p>",
"         Neisseria gonorrhoeae (disseminated gonococcal infection)*",
"         <sup>",
"          &bull;",
"         </sup>",
"        </p>",
"        <p>",
"         Neisseria meningitidis (acute or chronic meningococcemia)*",
"         <sup>",
"          &bull;",
"         </sup>",
"        </p>",
"        <p>",
"         Pseudomonas aeruginosa",
"        </p>",
"        <p>",
"         Rickettsia prowazekii",
"        </p>",
"        <p>",
"         Rickettsia rickettsii",
"         <sup>",
"          &bull;",
"         </sup>",
"        </p>",
"        <p>",
"         Spirillum minor",
"        </p>",
"        <p>",
"         Staphylococcus aureus (bacteremia)",
"        </p>",
"        <p>",
"         Streptobacillus moniliformis",
"        </p>",
"        <p>",
"         Streptococcus group A (streptococcal toxic shock syndrome, scarlet fever)",
"        </p>",
"        <p>",
"         Streptococcus pneumoniae (asplenic patient)",
"        </p>",
"        <p>",
"         Vibrio vulnificus",
"        </p>",
"        <p>",
"         Yersinia pestis",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         Streptococcus group A (scarlet fever, streptococcal toxic shock syndrome)",
"        </p>",
"        <p>",
"         Stapylococcus aureus (toxic shock syndrome [TSS], scalded skin syndrome [SSSS])",
"        </p>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Reportable disease.",
"     <br>",
"      <span class=\"bullet\">",
"       &bull;",
"      </span>",
"      May have arthralgia or musculoskeletal pain.",
"      <br>",
"       &Delta; Specific therapy available.",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Adapted with permission from: Sanders CV. Diagnosis of the patient with fever and rash. In: The Skin and Infection: A Color Atlas and Text, Sanders CV, Nesbitt LT (Eds), Williams &amp; Wilkins, Baltimore, 1995. Originally modified with permission from Fitzpatrick TB, et al: Color Atlas &amp; Synopsis of Clinical Dermatology - Common and Serious Diseases. Fitzgerald TB, et al (Eds), McGraw-Hill, New York, 1992.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_59_23485=[""].join("\n");
var outline_f22_59_23485=null;
var title_f22_59_23486="Flow volume loops in lung disease";
var content_f22_59_23486=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F55880&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F55880&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 572px\">",
"   <div class=\"ttl\">",
"    Flow-volume curves in obstructive and restrictive lung disease",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 552px; height: 361px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Sample flow-volume curves during a maximal forced expiration in normals and in obstructive and restrictive lung disease. The normal expiratory portion of the flow volume curve is characterized by a rapid rise to the peak flow rate, followed by a nearly linear fall in flow as the patient exhales toward residual volume. With obstructive disease, maximal expiration begins and ends at higher lung volumes and lower flow rates than normal. With restrictive disease, the lung volumes and flow rates are reduced but the flow in relation to lung volume is actually higher than normal.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Levitzky MG. Pulmonary Physiology, Seventh Edition. McGraw-Hill, New York 2007. Copyright &copy; 2007 The McGraw-Hill Companies, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_59_23486=[""].join("\n");
var outline_f22_59_23486=null;
var title_f22_59_23487="Aneurysmal bone cyst ulna";
var content_f22_59_23487=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F68448&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F68448&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Aneurysmal bone cyst periosteal reaction",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 227px; height: 386px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Distal ulna. Note the large, expansile aneurysmal bone cyst affecting the distal portion of the ulna. Periosteal new bone formation near the peripheral margins of the lesion creates a buttressing effect, which is characteristic of aneurysmal bone cyst (arrows).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Yochum TR, Rowe LJ. Yochum and Rowe's Essentials of Skeletal Radiology, Third Edition. Philadelphia: Lippincott Williams &amp; Wilkins, 2004. Copyright &copy; 2004 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f22_59_23487=[""].join("\n");
var outline_f22_59_23487=null;
